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Abstract 
 
Proinflammatory cytokines such as TNF-α and IL-1β are implicated in the pathogenesis of 
inflammatory disease states such as sepsis. In sepsis, myocardial depression is a leading 
cause of death. To design novel therapeutic targets, it is essential that we understand how 
these cytokines mediate the cellular basis of this cardiac dysfunction. Previous studies, 
including Greensmith and Nirmalan (2013), demonstrate that perturbed intracellular calcium 
handling and contractility can account for many aspects of myocardial depression. However, 
many of these studies suffer important limitations in that (A) small mammal models were 
used in which the translational relevance is questionable and (B) it remains unclear how 
proinflammatory cytokines affect certain key aspects of cellular function. To address this, we 
re-characterised the effects of TNF-α and IL-1β on intracellular calcium handling using a large 
animal model then investigated their effects on the ryanodine receptor (RyR) and 
myofilament sensitivity to calcium. 
 
Sheep ventricular myocytes were used for all experiments. All procedures used accord with 
the Animals (Scientific Procedures) Act, UK, 1986 and Directive 2010/63/EU of the European 
Parliament. Intracellular calcium and contractility dynamics were measured by epi-
fluorescent photometry and video sarcomere detection respectively. In all experiments, cells 
were separately exposed to 50 ng/ml TNF-α and IL-1β acutely. When required, cells were 
excited using field stimulation at a rate of 0.5 Hz. To indicate changes to RyR properties, 
intracellular Ca2+ waves were facilitated using 0.3 mM Ouabain and 5 mM Ca2+. SR Ca2+ 
content was estimated using the amplitude of 10 mM caffeine-evoked Ca2+ transients.  
 
TNF-α and IL-1β decreased SR Ca2+ content by 27 and 41 % respectively accounting for a 17 
and 24 % decrease of systolic calcium. Only with TNF-α did this reduction in systolic Ca2+ 
translate to reduced systolic shortening (20 %). We observed no negative effect on the rate 
of systolic or caffeine-evoked Ca2+ decay. TNF-α and IL-1β decreased Ca2+ wave amplitude by 
46 and 34 % and increased frequency by 38 and 28 %. Both cytokines reduced SR Ca2+ 
threshold for waves. In saponin-permeabilised cells the degree of sarcomere shortening over 
equivalent calcium ranges was attenuated. 
xx 
 
These findings confirm that in sheep, TNF-α and IL-1β decrease SR Ca2+ content leading to 
reduced systolic Ca2+. The increase of Ca2+ wave frequency and decrease of amplitude 
suggests both cytokines increase ryanodine receptor open probability; confirmed by a 
decreased SR Ca2+ threshold for waves. So while the reduction of SR Ca2+ content does not 
appear to be SERCA-dependent increased RyR leak may contribute. The loss of contractile 
response to increased Ca2+ suggests that both cytokines reduce myofilament Ca2+ sensitivity.    
These findings advance our understanding of cytokine-mediated cardiac intracellular Ca2+ 
dysregulation and provide additional cellular substrates for myocardial depression in sepsis. 
 
1 
 
 
Chapter 1 
 
General introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
1.1  Sepsis 
 
Sepsis is the inflammatory response to systemic infection. In a localised infection, leukocytes 
congregate at the site of infection and the production of cytokines at this site increases. This 
local inflammatory response is necessary to mediate the immune response against the 
infection. In sepsis, the increased cytokine production is elevated further, generating a 
cytokine storm, which is widespread across the body. Instead of aiding the immune 
response, inflammation becomes an additional burden and can induce multiple organ 
dysfunction, including heart failure. In severe cases, sepsis can lead to death. Even in those 
who survive sepsis, some forms of organ dysfunction can be permanent (A. Kumar et al., 
1996). 
 
 
1.1.1  The burden of sepsis 
 
Fleischmann et al. (2016) used reports of hospital-treated sepsis acquired between 2005 and 
2015 to predict the global impact of sepsis and estimated that there are 31.5 million 
incidences of sepsis each year. 19.4 million of these cases were deemed severe and 5.3 
million led to death. However, the study acknowledged that these figures may under-
represent the true global impact of sepsis due to various limitations. One limitation is lack of 
publications – and therefore data acquired – from lower income countries, as high-income 
countries only amount to 13 % of the global population. Another limitation is international 
classification of diseases (ICD) miscoding and differences defining of sepsis by in-hospital 
administrative reports, as it is believed some cases of sepsis have been overlooked or 
misdiagnosed. What is clear, is sepsis remains a leading cause of morbidity and mortality 
worldwide. 
 
In the UK alone, current estimations indicate that approximately 260,000 cases of sepsis 
occur annually, resulting in 44,000 fatalities (Daniels et al., 2017). Based on these incidence 
figures, it was estimated that the total cost of sepsis in the United Kingdom (UK) on the 
National Health Service (NHS) is £11.25 billion each year. This figure includes direct costs 
such as hospital costs and long-term complications in survivors.  Amputation, kidney 
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dysfunction and the impact on mental health, were estimated at approximately £1.5 billion, 
in addition to financial losses due to legal action and loss of productivity. Whilst the 
resistance or sensitivity to antibiotics does not impact the proportion of patients affected by 
sepsis, the burden and cost of hospitalization is greater with antibiotic resistant strains due 
to the additional treatment required and longer hospital stays (Zilberberg, Nathanson, 
Sulham, Fan, & Shorr, 2017). 
 
 
1.1.2   Epidemiology of sepsis 
 
The prevalence of sepsis within a population can be determined by the region, due to the 
level of exposure to pathogens. In developing countries or warmer climates where exposure 
to a wider variety of pathogens is possible, this increases the susceptibility to infection and 
sepsis in those who live there (Teparrukkul, Hantrakun, Day, West, & Limmathurotsakul, 
2017; Vugia et al., 1993). 
 
A number of host factors can impact susceptibility to development of sepsis as well as 
severity and mortality. Age is an important factor determining vulnerability to sepsis. 
Increased age in adults with sepsis is associated with increased mortality, earlier fatalities 
and an increased need for continued care in survivors (Martin, Mannino, & Moss, 2006). The 
risk of sepsis development is 13.1 fold greater in individuals over the age of 65, with a 1.54 
fold increase in the likelihood of death (Liang, 2016). Martin et al. (2006) reported that over 
2 decades in the United States (US), 64.9 % of hospitalised patients with sepsis were over the 
age of 65. The occurrence of conditions associated with sepsis development such as urinary 
tract infections (UTI) and pneumonia are also higher in the elderly (Liang, 2016). At any age, 
individuals – predominantly males – with a history of gout, frequent UTIs or renal 
dysfunction are also more likely to develop severe sepsis or septic shock (Lee et al., 2016). 
 
Bacteria (see 1.1.3) already present in the genital tract in health can become pathogenic in 
sepsis in immunocompromised individuals or pregnant women (Kalin, Acosta, Kurinczuk, 
Brocklehurst, & Knight, 2015). Sepsis can encourage complications in pregnancy such as 
preterm birth and severe pre-eclampsia and contributes to maternal morbidity and mortality 
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globally. In high income countries, sepsis as a result of genital tract infection leads to 2.1 % 
of maternal deaths (Acosta, Bhattacharya, Tuffnell, Kurinczuk, & Knight, 2012; van Dillen, 
Zwart, Schutte, & van Roosmalen, 2010). Severe sepsis is the cause of ~14.4 % of maternal 
critical care admissions in the UK with ~10.6 % developing septic shock. The young age of the 
mother (under 25 years old) is a risk factor for ante- or post-natal sepsis development. 
Additional risk factors include obesity, delivery by caesarean section and multiple births 
(Acosta et al., 2012; Acosta et al., 2016).  
 
New-borns have a high risk of infection and sepsis. This risk of late-onset sepsis development 
is elevated further in premature infants with a gestational age below 32 weeks and lower 
birth weights, especially those who require a central venous catheter (Mohseny et al., 2018; 
Stoll et al., 2002). 
 
Individuals with a compromised immune system or prior health conditions are vulnerable to 
infection and thus sepsis. The immune system can also be suppressed by a secondary 
infection, as is the case in human immunodeficiency virus (HIV) positive individuals. HIV-
positive individuals have an increased risk of developing sepsis, especially fungal sepsis, 
when compared to those who are HIV seronegative.  Co-infection with HIV also increases the 
likelihood of a fatal outcome in those with sepsis (Vugia et al., 1993). 
 
Surgery to treat existing conditions can increase patient vulnerability to infection. Following 
colorectal surgery, patients have a high predisposition for sepsis and septic shock. In this 
patient group, severity is higher in females and adults over the age of 65 (Sheka, Tevis, & 
Kennedy, 2016). 
 
Due to the high severity and mortality of sepsis in the UK and worldwide, and the impact on 
vulnerable groups, it is important to increase understanding of the events that occur in 
sepsis, as this may further establish a clinical definition of sepsis and aid treatment, through 
providing novel targets for therapeutics to be used alongside those fighting the causative 
infection. 
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1.1.3  Aetiology of sepsis 
 
It is important to note that sepsis is the response to infection. As such, there is no definitive 
causative organism and so any bacterial, fungal or viral infection can lead to sepsis. If 
pathogen invasion ceases to be localised and becomes systemic, so does the immune 
response.  It is this wide-scale and overwhelming immune response that results in multi-
organ failure, which shall be discussed further in section 1.1.5. 
 
Although it is true that sepsis can develop from any pathogenic infection, sepsis is commonly 
associated with an acute respiratory bacterial infection, especially pneumonia-causing 
bacteria such as Streptococcus pneumoniae and Klebsiella pneumoniae (Opal et al., 2003). In 
the elderly, pneumonia-associated gram-negative bacterial sepsis is particularly prominent 
(Martin et al., 2006). In developing countries, sepsis caused by rarer bacterial pathogens 
such as rickettsia and leptospira are also found (Vugia et al., 1993). 
 
Urinary tract infections are another common cause of sepsis. When caused by bacteria 
belonging to the enterobacteriaceae family – including Escherichia coli, Klebsiella 
pneumonia, Klebsiella oxytoca, Enterobacter cloacae and Enterobacter aerogenes – the risk 
of severe sepsis or septic shock development is greater. Some enterobacteriaceae can also 
cause pneumonia (Lee et al., 2016; Opal et al., 2003; Zilberberg et al., 2017). Post-operative 
UTI, resulting from early removal of the catheter following colorectal surgery, also 
contributes to elevated risk of bacteraemia and septic shock (Sheka et al., 2016). 
 
In pregnant women, respiratory infections and genital tract infections are the most common 
causes of sepsis. There are many causes of maternal sepsis however Streptococcus pyogenes 
and Streptococcus agalactiae are commonly involved in progression to severe sepsis. 
Maternal deaths however are most commonly associated with pneumonia respiratory 
infections (Acosta et al., 2016; Kalin et al., 2015; van Dillen et al., 2010). 
 
Gram-positive infections are more common in premature new-borns, particularly 
Streptococcus infection, and increases mortality of sepsis more than 2 fold (Stoll et al., 2002). 
In the UK, Streptococcus agalactiae is the highest cause of neonatal sepsis, however Candida 
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albicans infection, a yeast infection, is another major cause, especially in the form of at UTI 
(Kalin et al., 2015; Mohseny et al., 2018). 
 
The type of the microorganism causing sepsis can determine patient mortality. Recorded 
incidence is highest for gram positive and negative bacterial sepsis (at 25.2 and 23.8 % 
respectively), both with a mortality of approximately 30 %, while fungal infections causing 
sepsis are less prevalent but have a higher mortality. Infections with Candida species are the 
predominant cause of fungal sepsis and contribute to increased mortality. Candida infection 
is opportunistic as Candida species are present in normal flora. The majority of the 
remaining invasive fungal infections are caused by Aspergillus species, which can also lead to 
sepsis, especially in immunocompromised individuals (Delaloye & Calandra, 2014). 
 
Sepsis can also be produced by a viral infection; however, data suggests the incidence of 
viral infection may be lower than other causes. In addition to the systemic dysregulation 
which occurs in sepsis, viruses can also directly cause tissue damage. Common viral causes of 
sepsis include influenza viruses, enteroviruses and Herpes simplex virus (HSV). Once again, 
immunosuppressed individuals such as those with pre-existing conditions, neonates, the 
young, the elderly and pregnant women, are more susceptible to viral sepsis. Viral sepsis is 
also more common in South Asia, and Dengue viruses are a primary cause of viral sepsis in 
these tropical regions (Lin, McGinley, Drysdale, & Pollard, 2018; Shane, Sanchez, & Stoll, 
2017; Teparrukkul et al., 2017; "Vaccines against influenza WHO position paper - November 
2012," 2012).  
 
As such, determining the primary cause of sepsis is as important as is its treatment. In the UK 
an intervention described by Daniels, Nutbeam, McNamara, and Galvin (2011) has been 
implemented. This requires blood cultures to be acquired and antibiotic treatment given 
within an hour of diagnosis to improve patient prognosis. 
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1.1.4  Classification of sepsis 
 
The definition and classification of sepsis is important as this can lead to variation in reports 
which determine incidence and mortality. Whilst sepsis has long been known to exist, the 
definition and criteria for diagnosis varied considerably until the first internationally 
recognised definition of sepsis was provided by Bone et al. (1992). Bone et al. (1992) 
described sepsis as the development of systemic inflammatory response syndrome (SIRS) in 
response to infection. At this time the clinical diagnosis of sepsis solely required patients to 
meet 2 of the 4 SIRS criteria; abnormal body temperature, tachycardia (>90/min), elevated 
white blood cell count (>12 000/mm3) and respiratory rate (>20/min). SIRS criteria remain 
important for diagnosis of sepsis however Levy et al. (2003) addressed that both tachycardia 
and elevated white blood cell count were also present in the absence of infection and 
therefore do not distinguish sepsis from other inflammatory conditions. More recently, 
Singer et al. (2016) highlighted improved understanding of the pathophysiology of sepsis and 
the preference of previous definitions to focus entirely on inflammation. Sepsis is now 
accepted to involve both proinflammatory and anti-inflammatory responses.   
 
The term “severe sepsis” was coined to define sepsis with organ dysfunction. Sepsis 
manifests differently between patients, as such the site and magnitude of dysfunction can 
vary. Severe sepsis can further progress into “septic shock”, in which hypotension is induced 
and persists despite fluid resuscitation (Bone et al., 1992). Septic shock presents in two 
stages; the first stage is determined by high pulse rate, cardiac output and warm extremities.  
In some individuals this can progress to a hypovolemic stage, which presents as low cardiac 
output and cold, moist skin. Both stages result in high lactate and metabolic acidosis, further 
contributing to cardiac dysfunction. Patients with a high cardiac performance (cardiac index 
> 2.8 L/min/m2) have a higher chance of survival, as progression to hypovolemia has been 
associated with increased mortality (Clowes, Vucinic, & Weidner, 1966; MacLean, Mulligan, 
McLean, & Duff, 1967).  
 
Current management of sepsis in the UK implements the Sepsis 6 intervention developed by 
Daniels et al. (2011). Since implementation, mortality has decreased by two-fold and the 
average length of hospitalisation (for survivors) has reduced considerably. This intervention 
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prioritises medical procedures which can be used to assess the stage of sepsis and treat 
symptoms. These therapeutic interventions include measurement of serum lactate, as this is 
known to be high in septic shock it can determine sepsis severity. Oxygen is administered to 
allow for elevated respiratory rate and prevent metabolic acidosis. In order to manage blood 
pressure, urine output is monitored whilst an intravenous drip allows fluid resuscitation 
(Bone et al., 1992; Daniels et al., 2011; MacLean et al., 1967; Sheka et al., 2016). 
 
 
1.1.5  General organ dysfunction in sepsis 
 
As per 1.1.3, respiratory infection is a leading cause of sepsis. As such many patients with 
sepsis often present with acute respiratory distress syndrome (ARDS). ARDS can also be 
induced by non-septic lung injury such as trauma, however the risk of ARDS development 
and mortality are increased in sepsis-associated ARDS. The characteristics of ARDS are 
similar in septic and non-septic patients (Sheu et al., 2010), rapidly presenting with 
pulmonary oedema and severe hypoxaemia (PaO2/FIO2 ratio <200). Diagnosis of ARDS 
involves measurement of pulmonary arterial wedge pressure (<18 mm Hg), which can be 
influenced in sepsis by pulmonary infiltrates and left ventricular failure, which are associated 
with increased left atrial pressure (Enriquez-Sarano, Rossi, Seward, Bailey, & Tajik, 1997; 
Wheeler & Bernard, 2007). 
  
Acute kidney injury (AKI), a form of renal dysfunction, while not specific to sepsis, is another 
common manifestation. During sepsis, renal volume increases, largely attributed to oedema, 
by which capillary leakage and immune cell infiltration are thought to contribute (Sasaguri, 
Yamaguchi, Nakazono, Mizuguchi, & Irie, 2016). A reduction in blood pressure is found in 
approximately 80 % of sepsis-associated AKI cases, a possible result of decreased cardiac 
output from myocardial depression. Loss of contractility in the left ventricle results in an 
elevated end-diastolic ventricular volume thus cardiac preload, which can stimulate 
sympathetic nerve activity and release of vasoconstrictive hormones. The resulting 
vasoconstriction and decreased blood pressure may further contribute to AKI development, 
through ischemic damage and renal hypo-perfusion, leading to reduction in glomerular 
filtration rate and renal blood flow (Bougle & Duranteau, 2011; Wang et al., 2002). 
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Neurological dysfunction such as sepsis-associated encephalopathy (SAE) and sepsis-
associated delirium (SAD), conditions responsible for confusion, cognitive impairment and 
seizures, present in a large proportion of severe sepsis patients and correspond with an 
increased mortality. While inflammation is thought to contribute to SAE, dysfunction can be 
induced by decreased blood pressure and the resulting lower cerebral perfusion. Cerebral 
vasoconstriction has been associated with SAE, and its presence increase the risk of SAD. The 
cardiovascular autoregulation required to respond to changes in blood pressure are often 
impaired in SAD, promoting further injury (Pierrakos et al., 2014; Schramm et al., 2012). The 
long-term psychological impact of sepsis on its survivors are also evident, with development 
of anxiety, depression and post-traumatic stress disorder-like symptoms including delusions 
(Jones & Griffiths, 2013). 
 
In addition to vasoconstriction, decreased perfusion and tissue injury can also be influenced 
by enhanced coagulation. In response to endotoxin release in sepsis, coagulative pathways 
are promoted while anticoagulation is simultaneously downregulated, inducing 
disseminated intravascular coagulation (DIC). DIC describes thrombosis formation in small 
vessels across the body. This reduces blood perfusion to tissues, leading to injury and organ 
failure. Activation of complement-derived C5a also contributes to clot formation, by inducing 
aggregation of neutrophils and other leukocytes. Attempts to treat DIC with anti-coagulators 
to lyse clots have been dangerous, encouraging bleeding and in some cases further 
promoting coagulation through platelet agglutination (Hardaway, Williams, & Vasquez, 
2001; Parrillo, 1989; Tsao, Ho, & Wu, 2015).  
 
While sepsis can lead to multiple organ dysfunction as detailed above, many sepsis related 
deaths are due to cardiac complications. 
 
 
1.1.6   Myocardial depression in sepsis 
 
A common manifestation of cardiac dysfunction in sepsis is myocardial depression. 
Myocardial depression involves both diastolic and systolic dysfunction. 
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1.1.6.1  Diastolic dysfunction 
 
 Diastolic dysfunction in myocardial depression includes ventricular dilation and reduced 
compliance. This reduction in compliance means that the myocardium is less able to distend 
during diastole in response to increased blood flow. Systolic dysfunction takes the form of 
depressed contractility resulting in a reduced ejection fraction (Ognibene, Parker, Natanson, 
Shelhamer, & Parrillo, 1988). 
 
Diastolic dysfunction in severe sepsis is associated with increased mortality (Clancy et al., 
2017). Impaired ventricular filling is the result of diastolic dysfunction in the left ventricle. In 
sepsis this left ventricular dysfunction is associated with both impaired relaxation and 
decreased compliance (Meierhenrich, Schutz, & Gauss, 2008). Left ventricular relaxation is 
impaired in ~ 20 % of patients with septic shock, although this is reversible upon recovery 
(Bouhemad et al., 2008). Reduced diastolic compliance in sepsis can be improved by fluid 
resuscitation – a common practice following the diagnosis of sepsis – however this has no 
effect on Ca2+ handling mechanisms or contractility (Daniels et al., 2011; Zhong, Adams, & 
Rubin, 1997). 
 
Sepsis alters the relationship between compliance and contractility, causing a downward 
shift in the Frank-Starling curve. Therefore any small elevation in end diastolic volume is 
unable to induce an increase in left ventricular performance to the same extent (Ognibene 
et al., 1988). Whilst end-diastolic volume increases in sepsis – possibly as a compensatory 
mechanism to maintain cardiac output – this is also an indicator of worsening myocardial 
relaxation and poor prognosis (Clancy et al., 2017). 
 
In sepsis cardiac dysfunction can also occur in the right ventricle. As with the left ventricle, 
diastolic right ventricular dysfunction can take form of ventricular dilation and loss of 
ventricular compliance. The latter impairs the relationship between right atrial pressure and 
right ventricular end diastolic volume (Court, Kumar, Parrillo, & Kumar, 2002; Kimchi et al., 
1984). In sepsis the right ventricular end-diastolic volume can become increased due to 
elevated pulmonary vascular resistance, as a result of acute lung injury. This pulmonary 
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vascular resistance to low cardiac output stage of septic shock and is associated with high 
mortality (Kimchi et al., 1984; Sibbald et al., 1978). 
 
 
1.1.6.2  Systolic dysfunction 
 
Systolic dysfunction in myocardial depression is clinically defined by the reduced left 
ventricular ejection fraction (LVEF). This LVEF occurs due to depressed contractility and 
results in a lower cardiac output and a reduction in left ventricular stroke volume. In the 
acute phase of sepsis LVEF is reduced to 25 %, during recovery this is restored to 50 %. With 
reduced LVEF the end-diastolic volume increases. In survivors of sepsis, cardiac function is 
fully recovered following 10 – 28 days (Ognibene et al., 1988; Parker et al., 1984; Parrillo, 
1989). 
 
Septic shock can further impair systolic function through impacting the hearts response to β-
adrenergic stimulation. Archer and Black (1975) found that the effect of adrenaline 
application on contraction and relaxation was depressed in an endotoxin-administered 
model of septic shock in the heart. 
 
Systolic dysfunction such as decreased right ventricular ejection fraction (RVEF) are found in 
some patients with sepsis, either alone or as a part of biventricular dysfunction.  RVEF can 
occur during both the high and low cardiac output stages of septic shock. This right 
ventricular dysfunction can occur due to either direct right ventricular myocardial depression 
or high end right ventricular diastolic volume (Court et al., 2002; Kimchi et al., 1984). 
 
The type of cardiac dysfunction can predict patient outcome, myocardial depression is 
associated with increased mortality. Some manifestations, such as left ventricular dilation 
and decreased ejection fraction, are more prominent in patients who go on to survive sepsis. 
It has been suggested that ventricular dilation helps to partially compensate for reduced 
ejection fraction. Survival is also higher in those presenting with an increased end diastolic 
volume index, resulting in a more distended ventricle during diastole and reduced 
compliance, whereas in non-survivors, cardiac performance is more likely to be maintained 
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initially, despite cardiac dysfunction. While these aspects of myocardial depression appear to 
facilitate survival, the decreased cardiac performance and therefore reduced cardiac output, 
lead to hypotension and ischemia which can contribute to dysfunction throughout the body 
(Court et al., 2002; Parker et al., 1984; Parker et al., 1989; Parrillo et al., 1990). 
 
Although sepsis can induce injury in multiple organs due to infection and inflammation, the 
depressive effect of sepsis on the myocardium is important, as not only is it a common 
injury, but this can facilitate progression of damage in other organs, contributing to 
hypoperfusion, vasoconstriction and the resulting ischemia. Hypotension is responsible for 
76 % of deaths in sepsis, contributed to by both myocardial depression and low systemic 
vascular resistance, with remaining deaths as a result of multiple organ dysfunction (Parrillo, 
1989). Myocardial depression in sepsis is not caused by ischemia, as Cunnion, Schaer, Parker, 
Natanson, and Parrillo (1986) found that coronary blood circulation and oxygen supply to 
the myocardium is maintained. 
 
 
1.1.7  Cardiac dysfunction in other inflammatory conditions 
 
In addition to sepsis, reversible myocardial depression can occur as a result of other 
inflammatory conditions, such as anaphylactic shock (Raper & Fisher, 1988), or in heart 
failure. Mediators of myocardial depression have been identified in the blood of heart failure 
patients with acute renal failure. Removal of these substances through haemodialysis has 
been cited as a means to improve cardiac function (Blake et al., 1996). In coronary artery 
disease, haemodialysis is also a common treatment. Frequent use of haemodialysis can 
however lead to ischemic cardiomyopathy. Myocardial depression appears sporadically with 
regular ischemic injury. As with sepsis, myocardial depression presents with reduced LVEF, 
and contributes to hypotension. While myocardial depression is still reversible in these 
cases, prolonged myocardial injury can lead to more permanent injury such as fibrosis (Alkar, 
Mattsson, & Magnusson, 2018; Burton, Jefferies, Selby, & McIntyre, 2009).  
 
Cardiac dysfunction in heart failure (HF) also shares some similarities with myocardial 
depression in sepsis. Chronic HF is classified by LVEF, ejection fraction (EF) is either 
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preserved, reduced (<40 %) or within a mid-range (40-49 %) (Tschope et al., 2019). The levels 
of morbidity and mortality are similar between these HF classifications (Borlaug & Paulus, 
2011). HF with preserved EF presents with diastolic dysfunction, while HF with reduced EF 
favours systolic dysfunction (van Heerebeek et al., 2006). 
 
In HF with preserved EF systolic left ventricular performance is normal, however relaxation is 
slower and diastolic stiffness is elevated. Reduced rate of relaxation contributes to 
decreased stroke volume, especially at higher heart rates. Passive diastolic stiffness can be 
induced by collagen deposition in the extracellular matrix (ECM) or up-regulation of titin. 
Blood pressure and end diastolic volumes are also increased in HF with preserved EF 
(Borlaug & Paulus, 2011). 
 
HF with a reduced EF occurs due to reduced ventricular contractility. This leads to a decrease 
in stroke volume and elevated end-diastolic volume. The loss of contractility found with this 
form of HF is caused by an initial injury, in 2/3 of cases this injury results from coronary 
artery disease. Myocardial injury induces secondary responses including increased cytokine 
production and release of ROS and NO. HF is generally left-sided, however right-sided HF can 
develop (Bloom et al., 2017). 
 
Given that myocardial depression and similar cardiac dysfunction presents in a number of 
conditions, it is therefore important to improve understanding of the mediators of 
myocardial depression. 
 
 
1.1.8  Mediators of myocardial depression in sepsis 
 
Parrillo et al. (1985) investigated a negative inotropic agent responsible for myocardial 
depression. The circulating myocardial depressant substance identified was a low molecular 
mass (10-30 KDa) macromolecule with protein characteristics. It is now accepted that the 
elevated presence of cytokines – especially proinflammatory cytokines – in septic serum 
mediates myocardial depression (Jha et al., 1993; A. Kumar et al., 1996). Reactive oxygen 
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species (ROS) are also known to mediate myocardial depression and contribute to 
cardiovascular dysfunction in septic shock (Potz, Sellke, & Abid, 2016). 
 
 
1.1.8.1  Reactive oxygen species and oxidative stress 
 
Oxidative stress occurs when production of reactive oxygen species exceeds the capacity of 
antioxidant enzymes. There are many forms of ROS including superoxide (O2
-), hydrogen 
peroxide (H2O2) and nitric oxide (NO). ROS production is increased in sepsis and high ROS 
levels are associated with cardiovascular dysfunction including myocardial depression. (Neri, 
Riezzo, Pomara, Schiavone, & Turillazzi, 2016; Potz et al., 2016). Oxidative stress is also 
known to play a role in HF, promoting the formation of bridges within the titin molecule, 
limiting elasticity in HF with preserved EF (Borlaug & Paulus, 2011). 
 
In health, ROS including NO produced by Ca2+-dependent NO synthase, aid regulation of 
blood pressure, however when ROS levels become high leading to oxidative stress, oxidative 
damage is induced (Neri et al., 2016; Schulz, Nava, & Moncada, 1992). High ROS can impair 
blood flow reducing oxygen delivery to organs, whilst also affecting metabolism. The 
resulting hypoxia and decreased energy production contributes to organ damage (Potz et al., 
2016). 
 
NO synthase is the enzyme responsible for NO production. NO acts as a messenger and 
effector molecule. In response to infection, NO levels increase, this is thought to be a 
defensive mechanism against pathogens due to the bactericidal properties of NO. As such, 
NO synthase activation increases in septic shock (Klabunde & Coston, 1995; Neri et al., 2016; 
Schulz et al., 1995). 
 
Prolonged exposure to TNF-α and IL-1β activates Ca2+-independent nitric oxide synthase 
expression in the left ventricular wall leading to an increase in NO production. Increased NO 
production has been implicated in the hypotension and impaired cardiac function found in 
septic shock (Neri et al., 2016; Schulz et al., 1992; Schulz et al., 1995). NO synthase is not 
solely responsible for myocardial depression, as Klabunde and Coston (1995) found that the 
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use of NO synthase inhibitors did not improve left ventricular function. Additionally, whilst 
NO synthase is induced at higher concentrations of TNF-α, myocardial depression can occur 
at the lower concentrations found in septic serum.  TNF-α must therefore be able to induce 
myocardial depression without stimulation of NO synthase (Muller-Werdan, Engelmann, & 
Werdan, 1998). Yokoyama et al. (1993) reflected that the reduced myocyte contractility and 
systolic Ca2+ resulting from perfusion with TNF-α was primarily due to a direct effect on Ca2+ 
handling rather than an indirect effect on protein synthesis or NO production, although the 
effect of TNF-α on the Ca2+ cycle was not further investigated. 
 
Although this study will not be directly measuring the effects of oxidative stress on 
ventricular myocytes, proinflammatory cytokines have been associated with increased NO 
and ROS production. It stands to reason that these molecules may be involved in the effects 
these cytokines mediate in the heart. 
 
 
1.1.8.2  Cytokines 
 
TNF-α and IL-1β are elevated in septic serum, and increase in concentration over time 
(Vincent et al., 1992). Other cytokines such as interferon gamma and interleukins (-2, -4, -6, -
8, -10) are also elevated in septic serum. A. Kumar et al. (1996) found that these cytokines 
do not produce the same magnitude of myocardial depressant effect as TNF-α and IL-1β. 
TNF-α is also elevated in other inflammatory conditions (Muller-Werdan et al., 1998). Alone 
TNF can reduce stroke volume in humans with sepsis. This was demonstrated by improved 
left ventricular function in patients treated with anti-TNF antibodies, although treatment 
only improved survival if administered early (Vincent et al., 1992). This has also been 
demonstrated in animal models, with TNF-α reducing the ventricular ejection fraction in 
dogs (Muller-Werdan et al., 1998). 
 
In studies investigating the effect of cytokines on isolated whole heart, simultaneous TNF-α 
and IL-1β exposure was found to temporarily increase cardiac work, output and peak systolic 
pressure, prior to a substantial reduction in coronary flow and cardiac work with prolonged 
exposure (Schulz et al., 1995). 
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Previous work in rat ventricular myocytes has also determined that TNF-α and IL-1β are 
capable of producing myocardial injury and impairing contraction (Greensmith & Nirmalan, 
2013; Radin, Holycross, Dumitrescu, Kelley, & Altschuld, 2008). These proinflammatory 
cytokines have been shown to synergistically induce concentration and time dependant 
myocardial depression (A. Kumar et al., 1996). 
 
Another component of septic serum is histamine; an endogenous mediator of inflammation 
elevated on a time dependent basis in sepsis. The outcome of histamine is dependent on the 
receptor activated. H3 receptor activation depresses cardiac function via adrenergic 
response inhibition, while activation of H1 and H2 receptors contributes to multiple organ 
dysfunction and enhanced TNF-α and IL-1β production. Histamine can therefore act as a 
myocardial depressant substance while up-regulating further myocardial depressant 
substances in the form of cytokines (Hattori et al., 2016; X. Li et al., 1998).   
 
It is well characterised that TNF-α and IL-1β are myocardial depressant substances (Odeh, 
1993; Vincent et al., 1992). The mechanism by which cytokines – particularly TNF-α and IL-1β 
– induce myocardial depression is not yet fully understood. Previous work by Greensmith 
and Nirmalan (2013) did however find that TNF-α contributes to myocardial depression 
through altered Ca2+ handling. Cytokines and their cellular effects shall be discussed further, 
in more detail in section 1.3. In order to understand how cytokines alter ventricular myocyte 
function, cell function in health must first be understood. 
 
 
1.2  Excitation-contraction coupling 
 
The mammalian heart is composed of four chambers; the right and left atrium and ventricles 
respectively. The contraction and subsequent relaxation of the heart occurs over 5 phases in 
a cardiac cycle. During atrial systole the atria contract expelling blood into ventricles, this is 
followed by ventricular contraction and ejection in ventricular systole releasing blood into 
system. During diastole the myocardium is in a state of relaxation allowing the chambers to 
refill with blood. Myocardial contraction is essential for cardiac function as it produces 
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stroke volume and regulates cardiac output, change to force of contractility alters cardiac 
output (Jacob, Dierberger, & Kissling, 1992). 
 
The contraction of the whole myocardium is due to the synchronous contraction of 
individual myocytes from which it is formed. As such in order to understand how the 
myocardium contracts, we need to understand the cellular basis of contraction. Cellular 
contraction is dependent on excitation-contraction coupling (ECC). ECC is responsible for 
translating excitation of a myocyte from an action potential to cellular contraction. Several 
ion channels and transporters regulate ECC and will be discussed in turn below. 
 
 
1.2.1   The importance of Ca2+ 
 
The experiments of Ringer (1883) were the first to demonstrate that Ca2+ is essential for 
cardiac contraction. Those experiments determined that the heart was only able to contract 
when Ca2+ was present. As such, when perfused with blood or a Ca2+ based solution, the 
heart will continue to beat for hours ex vivo. 
 
Ca2+ is an important secondary messenger involved in the regulation of multiple cellular 
pathways (Clapham, 2007). Ca2+ is required to activate myofilaments and therefore is 
important for contraction. In heart cells, the presence of extracellular Ca2+ allows the rise 
and fall of [Ca2+]i required for cell contraction then relaxation respectively (Eisner, 2018).  
 
During diastole intracellular Ca2+ ([Ca2+]i) remains low as Ca
2+ is stored primarily in the 
sarcoplasmic reticulum (SR); an intracellular compartment. Ca2+ is also present in 
extracellular matrix (ECM). The movement of Ca2+ between the SR, ECM and sarcoplasm is 
controlled in order to regulate this contraction. The speed and effectiveness of Ca2+ as a 
signalling molecule puts it at an evolutionary advantage when compared to other signalling 
mechanisms such as phosphorylation (Clapham, 2007). The cyclic rise and fall of Ca2+ couples 
excitation to contraction and relaxation. This process – known as excitation-contraction 
coupling (ECC) – is reliant on a series of Ca2+ channels, pumps and exchangers. A summary 
diagram for ECC will be provided in Fig 1-5. 
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Whilst intracellular [Ca2+]i regulates ECC, the majority (~99 %) of cytoplasmic Ca
2+ is bound to 
buffers, these include the sarcolemma, ATPase’s, contractile proteins and other ligands. Free 
[Ca2+]i is the Ca
2+ available to bind to myofilaments, and also fluorescent dye, as such, using 
fluorescence alone only free [Ca2+]i is measured. Ca
2+ buffering can be altered through 
change to the presence of these buffers in the cytoplasm, for example change in protein 
expression, and the affinity of these buffers for Ca2+. A change to Ca2+ buffering alters the 
proportion of free [Ca2+]i available, whilst the total cytoplasmic [Ca
2+]i remains the same 
(Smith & Eisner, 2019). 
 
 
1.2.2  Excitation 
 
The wave of excitation that ultimately excites each myocardial cell originates in the sinoatrial 
node (SAN). The membranes of cells within the SAN undergo spontaneous depolarisation to 
threshold by virtue of inward Na+ current (If) from hyperpolarization-activated cyclic 
nucleotide–gated (HCN) channels, generating the nodal action potential (Larsson, 2010; 
Shinagawa, Satoh, & Noma, 2000). This wave of excitation spreads through the atrium via 
intermodal pathways before it is slowed for ~100 ms by the atrioventricular (AV) node in the 
bottom of the right atria. This allows depolarisation and thus contraction to occur in the 
atria, prior to the ventricles. The signal continues to propagate down through the bundle of 
His then along the Purkinje network, until the wave of excitation reaches cells of the 
ventricles. Propagation of the action potential across a sheet of myocardium is aided by 
coupling of myocytes to adjacent cells via gap junctions (Rohr, 2004). 
 
Once the action potential reaches the surface membrane of ventricular myocytes it is able to 
propagate down sarcolemmal invaginations called transverse (t-) tubules (Fearnley, 
Roderick, & Bootman, 2011; Santana, Cheng, & Lederer, 2010; van Weerd & Christoffels, 
2016). This takes the cells own membrane to threshold potential, therefore evoking a 
cellular action potential. 
 
The ventricular action potential has 5 phases (Fig 1-1). During phase 0 rapid Na+ influx raises 
the diastolic membrane potential from -90 mV to +50 mV depolarizing the membrane. Phase 
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1 ceases following Na+ channel inactivation with inducing a brief repolarisation from +50 mV 
to +30 mV, this is called a repolarisation notch (phase 2).  Depolarisation also activates 
voltage gated channels called L-type Ca2+ channels (LTCC), (which shall be discussed further 
in 1.2.3.1) (Fearnley et al., 2011; Rohr, 2004; Santana et al., 2010). Here, LTCC opening and 
the resulting Ca2+ influx produces the characteristic plateau (phase 3) found in cardiac 
myocytes (Cooper, Soeller, & Cannell, 2010; Santana et al., 2010) as Ca2+ influx balances K+ 
efflux via K+ channels. Following LTCC inactivation K+ efflux dominates producing 
repolarisation (phase 4). This restores diastolic resting membrane potential of -90 mV, which 
remains constant in phase 4 until membrane depolarisation occurs again (Santana et al., 
2010; W. Zhu, Varga, & Silva, 2016). 
 
 
 
Figure 1-1. The ventricular action potential: (a) phase 0, (b) phase 1 depolarisation, (c) phase 
2 notch (d) phase 3 plateau and (e) phase 4 repolarisation. 
 
 
The morphology and duration of the ventricular action potential vary, but are generally 
much longer that of skeletal muscles, spanning ~400 ms.  The duration and frequency of the 
action potential can impact Ca2+ handling mechanisms. The action potential stimulation 
frequency determines heart rate and is determined by the SAN action potential firing rate in 
vivo (Santana et al., 2010). 
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1.2.3  Sarcolemmal Ca2+ entry 
 
As previously discussed, t-tubule depolarisation activates the LTCC contributing to the 
plateau of the action potential. This process also brings a small amount of calcium into the 
cell via Ca2+ entry and is the important first step of the Ca2+ cycle that produces contraction. 
 
 
1.2.3.1  L-type Ca2+ channels 
 
LTCC are voltage-gated channels that are selectively permeable to Ca2+. Their high 
conductance (11-25 pS) and the fact that there exists a 10,000 fold Ca2+ gradient across the 
sarcolemma means that, when open, these channels allow Ca2+ entry via an electro-chemical 
gradient (Bean, 1989; Zahradnikova & Zahradnik, 2012). 
 
CaV1.2 is the predominant cardiac form of LTCC. CaV1.2 is heterotetrameric and each of its 4 
subunits – α1c, α2δ, β and γ – have a different role. The α1c-subunit is composed of 4 
domains each with 6 transmembrane segments. Of these segments, 2 contribute to a pore 
formation with 0.6 nm diameter core, while the α-subunit segment acts as a voltage sensor, 
also known as a dihydropyridine receptor (DHPR) (Shaw & Colecraft, 2013; Zahradnikova, 
Zahradnik, Gyorke, & Gyorke, 1999). Both the α2δ and β subunits aid regulation of LTCC 
gating by altering the dependence of activation and inactivation on voltage (Buraei & Yang, 
2010; Shaw & Colecraft, 2013).  
 
LTCC are categorised by their large conductance, as oppose to T-type Ca2+ channels which 
have a lower or tiny conductance. LTCC also remain open for longer at ~500 ms (Nowycky, 
Fox, & Tsien, 1985; Treinys & Jurevicius, 2008). While T-type Ca2+ channels are also present 
in cardiac muscle, LTCC have a much larger role in Ca2+ influx. LTCC activity varies between 
cell types; the rate of activation and inactivation is 10 fold higher in cardiac myocytes when 
compared to that of skeletal muscle (Bean, 1989).  
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1.2.3.2  Voltage-dependent activation of L-type Ca2+ channels 
 
In response to an action potential the membrane depolarises. As LTCC are voltage 
dependent, this depolarisation activates the channel permitting Ca2+ entry and so generating 
the calcium current. The voltage sensing domain (S4) is activated once the membrane 
potential exceeds a threshold of -40 mV.  Collective activation of these domains provides 
pore stability when LTCC is open (Betzenhauser & Marks, 2010; Fearnley et al., 2011; W. Zhu 
et al., 2016). Depending on species, the optimal activation voltage is 0-10 mV resulting in the 
characteristic bell-shaped relationship between ICaL and voltage shown in Fig 1-2. The time 
taken to reach peak ICaL is also voltage dependent, following the same bell-shaped 
relationship (Pelzmann et al., 1998). 
 
 
Figure 1-2. Voltage dependence of L-type Ca2+ current; the I-V relationship. Adapted from a 
figure by Pelzmann et al. (1998) 
 
 
1.2.3.3  Inactivation of L-type Ca2+ channels 
 
Inactivation of LTCC is dependent on [Ca2+]i and voltage. The Ca
2+ dependency of CaV1.2 
accounts for 80 % of inactivation, while voltage dependent inactivation accounts for ~20 % 
(Lacinova & Hofmann, 2005). 
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Ca2+ dependent inactivation is mediated largely by calmodulin (CaM). CaM has 4 Ca2+ binding 
sites. At low [Ca2+]i CaM is able to bind to Ca
2+ with a high affinity, however not all 4 binding 
sites will be associated to Ca2+. The elevated Ca2+ resulting from Ca2+ influx enables increased 
Ca2+ binding to CaM.  The Ca2+-associated CaM binds to an IQ motif present on the α1c-
subunit of LTCC. Further Ca2+ influx ceases due to the subsequent inactivation of LTCC 
(Peterson, DeMaria, Adelman, & Yue, 1999). 
 
Current decay contributes to voltage dependent CaV1.2 inactivation. This occurs during 
phase 3 of the ventricular action potential, when elevated outward K+ drives repolarisation. 
The resulting reduction in the membrane potential increases the proportion of LTCC which 
are inactivated.  Full inactivation cannot occur between -45 and 40 mV, however all LTCC are 
expected to be closed below 40 mV, as this is the threshold for LTCC activation (Pelzmann et 
al., 1998; Santana et al., 2010). 
 
Both forms of LTCC inactivation are time dependent, following a biphasic inactivation time 
course of ICaL with an initial fast phase followed by a slower phase of recovery. The fast 
phase has no dependency on membrane potential, however the slow phase is highly voltage 
dependent, with maximum inactivation occurring at 20 mV. At 20 mV, ICaL is high and local 
[Ca2+]i is increased rapidly, therefore Ca
2+ dependent inactivation occurs at a faster rate than 
at other membrane potentials  (Pelzmann et al., 1998). 
 
Ca2+ influx via LTCC is not sufficient to produce contraction. It does however result in a much 
larger release of Ca2+ from the SR in a process known as calcium induced calcium releases 
(CICR). To understand CICR we must first understand the structural organisation of cell that 
permits it. 
 
 
1.2.4  Sarcoplasmic reticulum 
 
The sarcoplasmic reticulum (SR) is a specialised form of endoplasmic reticulum and the 
primary intercellular Ca2+ store. As the primary source of systolic Ca2+, this reserve 
represents that which is required for intracellular Ca2+ modulation (see section 1.2.8). 
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1.2.5  Ca2+-induced Ca2+-release 
 
Ca2+ influx from LTCC is not sufficient to increase global [Ca2+]i enough to fully activate 
myofilaments. ICaL can raise local [Ca
2+]i  initiating Ca
2+-induced Ca2+-release (CICR) from the 
SR. The SR Ca2+ release resulting from CICR is much larger than LTCC-mediated Ca2+ influx 
and leads to a much greater rise in global [Ca2+]i enabling myofilament activation (Chung, 
Biesiadecki, Ziolo, Davis, & Janssen, 2016). The structures involved in this process shall now 
be discussed in further detail. 
 
 
1.2.5.1  The ryanodine receptor 
 
Ryanodine receptors (RyR) are channels responsible for SR Ca2+ release, playing a large role 
in CICR. RyR is the largest known ion channel at over 2 MDa and has a homotetrameric 
structure. 3 mammalian RyR isoforms exist however expression of each differs between 
different mammalian striated muscles and as well as parts of the body. RyR1 is present in 
skeletal muscle and RyR3 in found the brain, while RyR2 is the cardiac form of the ryanodine 
receptor (Lanner, Georgiou, Joshi, & Hamilton, 2010).  In the heart, CICR is more sensitive to 
increased [Ca2+]i than skeletal muscle, suggesting RyR2 has a greater Ca
2+ sensitivity than 
other RyR isoforms (Fabiato & Fabiato, 1978). 
 
RyR2 is made up of 2 domains; cytoplasmic and transmembrane (Fill & Copello, 2002). The 
structure of these domains alters when the channel opens and closes. The cytoplasmic 
domain, also known as the central domain is composed of 10 sub domains.  These sub-
domains are collectively responsible for regulation of receptor function through binding of 
modulators; as such it holds multiple binding regions for Ca2+, caffeine and ATP (Walpoth & 
Erman, 2015). Binding to these regions initiates conformational changes which increase the 
open probability of the channel. Both Ca2+ and caffeine can bind to the C-terminal while ATP 
has specialised binding motif. ATP is capable of activating RyR under physiological conditions 
and thus the ATP binding motif has been implicated in Ca2+ leak from the SR (Blayney et al., 
2013; des Georges et al., 2016; Peng et al., 2016). The 4 homologous subunits of RyR2 each 
have a Ca2+ binding site, thus 4 Ca2+ are required to bind in order to activate a single RyR. 
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The binding of these Ca2+ initiates a conformation change which opens the channel. RyR 
activation has a time constant of 0.07-0.27 ms (Zahradnikova et al., 1999). The remaining 
fifth of the protein including at least 6 α-helix transmembrane domains spans the SR lumen 
and membrane, forming the 3 Å wide ion conducting pore or channel domain (Fill & Copello, 
2002; Lanner et al., 2010; Tunwell et al., 1996). 
 
 
1.2.5.2  Organisation of excitation-contraction coupling structures 
 
The arrangement of cellular structures including Ca2+ handling proteins and contractile 
machinery determines the efficiency of excitation-contraction coupling. Excitation reaches 
the inner points on the cell through t-tubules. Small structural differences exist between the 
arrangement of t-tubules and SR in large and small mammals. Ventricular myocytes from 
larger mammals have a less robust t-tubule network and lower t-tubule density than small 
mammals. Larger mammal myocardial t-tubules also have a wider diameter, with a t-tubule 
diameter of ~350 nM in humans. T-tubule density can be further impaired in 
cardiomyopathies and heart failure (Biesmans et al., 2011; Jayasinghe, Crossman, Soeller, & 
Cannell, 2012). 
 
In addition to the involvement of SR in CICR, the SR also forms a network across the myocyte 
interacting with the contractile machinery. SR junctions in dyadic structures are also closely 
associated with myofilaments. Luminal [Ca2+] varies throughout the SR with [Ca2+] ~50 % 
higher at junctions. Ca2+ release is also highest at SR junctions, however this increases the 
magnitude and rate of Ca2+ release at neighbouring regions less associated with t-tubules 
Non-junctional SR regions primarily serve as a reservoir of Ca2+ (Picht et al., 2011). 
 
 
1.2.5.3  The sub-cellular organisation of LTCC and RyR allows CICR 
 
RyR are present on the SR membrane at SR junctions adjacent to t-tubules. Ca2+ signalling is 
localised to dyadic cleft in which RyR are coupled to LTCC due to their close proximity 
(Zahradnikova & Zahradnik, 2012). The proximity to LTCC aids RyR activation, as [Ca2+] 
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increases locally to RyR. This amplifies Ca2+ signalling to promote activation of myofilaments. 
RyR are arranged in clusters, there are varying reports of the number of RyR within a cluster. 
Zahradnikova and Zahradnik (2012) suggested a cluster is composed of 40 RyR on average, 
while Fill and Copello (2002) suggested the number of RyR present in a cluster was between 
10 and 30. RyR arrangement varies between species with human myocardium having a 
smaller cluster density when compared to smaller mammals (Jayasinghe et al., 2012).  
 
The presence of dyadic junctions between the sarcolemma and terminal cisternae of the SR 
is beneficial to CICR. These dyadic junctions are small, narrow areas of cytoplasm, ~ 15 nm 
wide. These junctions provide high co-localisation of LTCC and RyR clusters (Jayasinghe et al., 
2012). In cardiac muscle RyR2 greatly outnumber the quantity of LTCC, with a single LTCC for 
every 5-10 RyR2 channels (Zahradnikova & Zahradnik, 2012). Due to the contained 
environment, dyadic junctions allow small influxes in Ca2+ to rapidly increase in local [Ca2+]i 
and activate RyR2 (Jayasinghe et al., 2012; McDonald, Cavalie, Trautwein, & Pelzer, 1986). 
While individual RyR2 have a low conductance, the association of ~ 3 RyR2 clusters within the 
same dyadic cleft forms a Ca2+ releasing unit with a much larger net conductance 
(Zahradnikova & Zahradnik, 2012). 
 
Multiple sub-populations of RyR exist based on their position in the myocyte. The majority of 
RyR clusters are associated with t-tubules, although this is not always the case, with 16 % of 
dyads forming with LTCC on the surface sarcolemma. While surface sarcolemmal dyads still 
have close proximity of RyR and LTCC, Ca2+ influx occurs at the myocytes’ periphery requiring 
more Ca2+ to diffuse inward across the cell. Dyads associated with t-tubules are therefore 
beneficial for activation of myofilaments (Biesmans et al., 2011; Jayasinghe et al., 2012). 
 
The association between RyR and LTCC permits CICR as the local rise in Ca2+ is much greater 
than if the same amount of Ca2+ had diffused across the cells. This allows small influxes of 
Ca2+ to activate the RyR. 
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1.2.5.4  Ca2+-dependent activation of RyR 
 
Open probability (Po) is the likelihood that a channel – in this case RyR2 – will be open at a 
single point in time. Approximately 35 -50 % of the SR Ca2+ content is released during systole 
(R. A. Bassani & Bers, 1995). Physiologically, the degree of fractional release is dependent on 
the two major regulators of RyR Po; SR Ca
2+ content and cytoplasmic [Ca2+]. Free calcium in 
the SR lumen is able to regulate SR Ca2+ release via RyR and modify [Ca2+]i. At rest, the 
mammalian cardiac SR contains ~1 mM Ca2+, as such Ca2+ release would be low (Fill & 
Copello, 2002; Picht et al., 2011). The dependence of RyR Po on cytoplasmic Ca
2+ is important 
in order to understand CICR, as Ca2+ influx via LTCC will primarily alter local [Ca2+]i, not SR 
Ca2+ content. 
 
 
1.2.5.5  Ca2+ sparks 
 
Local Ca2+ release from the SR can occur spontaneously when cell is at rest; these are termed 
Ca2+ sparks. A Ca2+ spark occurs as a result of summation of Ca2+ release events from 2.7-20 
RyR. The spatially proximity of these RyR contributes to local net increase in Ca2+. During 
diastole the open probability of RyR is low as [Ca2+]i is also low at 50-150 nM, Ca
2+ sparks 
therefore occur at a low frequency. During a single Ca2+ spark the local Ca2+ rises to 200-300 
nM in approximately 10 ms. Ca2+ release as a result of sparks may recruit adjacent RyR 
within the same cluster through increasing their Po (Betzenhauser & Marks, 2010; 
Zahradnikova & Zahradnik, 2012). During a Ca2+ spark RyR Po decreases over the 2 s 
following peak Po (Gyorke & Fill, 1993), this is attributed to rapid diffusion of Ca
2+ away from 
the dyadic cleft reducing local [Ca2+]i and therefore the Ca
2+ gradient is only briefly 
maintained (Fill & Copello, 2002). 
 
During systole sarcolemmal Ca2+ influx current driven by membrane depolarisation leads to 
an in increase in local [Ca2+]i within dyadic clefts across the cell as a result of  Ca
2+ influx from 
LTCC. The elevated [Ca2+]i increases RyR Po contributing to synchronised RyR opening (Fill & 
Copello, 2002; Zahradnikova et al., 1999). SR Ca2+ release via RyR usually occurs <15 ms after 
membrane depolarisation (Neco et al., 2010). RyR activation requires local [Ca2+]i to increase 
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to 0.3 – 10 µM.  At steady state the range of Ca2+ concentrations required to activate RyR are 
narrower at 0.5 – 5 µM. L-type Ca2+ influx increases local [Ca2+]i to 10-30 µM within the cleft, 
at these concentrations Po is between 5-50 %.  Open RyR2 are capable of transporting 1000 
µM Ca2+/s (Fill & Copello, 2002; Zahradnikova et al., 1999). Ca2+ release from the SR during 
systole elevates global [Ca2+]i  from approximately 100 nM to 1µM (Chung et al., 2016).  
 
 
1.2.5.6  Inactivation of RyR 
 
RyR inactivation is important as it mediates cessation of SR Ca2+ release and therefore allows 
SR refilling following systole. This enables Ca2+ removal to decrease [Ca2+]i, allowing 
relaxation, and SR Ca2+ content to be sustained during diastole.  
 
While low Ca2+ concentrations activate the RyR (0.3 – 10 µM), much higher Ca2+ 
concentrations (1-10 mM) bind to an inhibition site leading to Ca2+ dependent inactivation 
(Fill & Copello, 2002). Inactivation of RyR also requires dissociation of [Ca2+]i from the 
binding sites causing the channel to close (Zahradnikova et al., 1999).  Full RyR inactivation 
has a time constant of 5-6 ms. Decrease in local [Ca2+]i aids Ca
2+ dissociation and therefore 
Ca2+ dependent inactivation. Local [Ca2+]i is reduced through Ca
2+ removal from the 
cytoplasm, contributing to reduced RyR Po. The rate of RyR inactivation is dependent on 
activity of Ca2+ removal mechanisms, although rate of Ca2+ decay and inactivation are not 
equal. Rate of RyR inactivation is 10 fold slower than rate of Ca2+ removal (Fill & Copello, 
2002).  
 
 
1.2.6  Calcium removal 
 
The removal of calcium from the cytoplasm is important following systole to lower [Ca2+]i to 
diastolic levels, enabling relaxation. The majority of cytoplasmic Ca2+ is returned to the SR via 
the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA). Ca2+ efflux into the ECM 
occurs primarily via the sodium-calcium exchanger (NCX). Ca2+ uptake by SERCA is 3-4 fold 
faster than NCX-mediated Ca2+ efflux. The faster speed of Ca2+ uptake when compared to 
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Ca2+ extrusion explains why the majority of Ca2+ is taken up by SERCA during relaxation (R. A. 
Bassani, Bassani, & Bers, 1992). While other Ca2+ removal mechanisms exist, they do not 
contribute to the same extent as SERCA and NCX do to net Ca2+ removal following systole. 
The reduction of [Ca2+]i following contraction regulates the transition between systole and 
diastole. 
 
 
1.2.6.1  The sarcoplasmic endoplasmic reticulum Ca2+-ATPase (SERCA) 
 
Sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) is a Ca2+ pump on the SR 
membrane, responsible for SR Ca2+ uptake. In rodents SERCA accounts for ~ 90 % of Ca2+ 
removal (Milani-Nejad & Janssen, 2014), whereas human and sheep SERCA activity is 
responsible for 76 and 81.5 % of Ca2+ removal, respectively (Dibb, Rueckschloss, Eisner, 
Isenberg, & Trafford, 2004; Piacentino et al., 2003). 
 
SERCA is the primary Ca2+ removal mechanism responsible for lowering [Ca2+]i to diastolic 
levels following systole. There are three SERCA isoforms of which SERCA2 is most prevalent 
in the heart. Of the 3 SERCA2 variants – 2a, 2b and 2c – both SERCA2a and SERCA2c are 
found in cardiac muscle.  SERCA2a plays a large role in Ca2+ handling and has a high affinity 
to Ca2+ (Kranias & Hajjar, 2012). The removal of Ca2+ from the cytoplasm via SERCA enables 
relaxation of the myofilaments, whilst SR loading replenishes SR Ca2+ content for subsequent 
systolic Ca2+ release 
 
At steady state, Ca2+ release from the SR is fractional, thus the SR is not completely emptied 
and remains at a higher concentration than that of cytoplasmic Ca2+ (R. A. Bassani & Bers, 
1995). Ca2+ uptake into the SR therefore requires Ca2+ to move against a steep concentration 
gradient. SERCA has a high affinity binding site for ATP and uses ATP hydrolysis to enable 
Ca2+ uptake via active transport (Takenaka, Adler, & Katz, 1982). ATP hydrolysis 
phosphorylates SERCA2a forming a phosphoprotein. This reaction alters the structure of 
SERCA2a transporting the Ca2+ into the lumen of the SR. Reddy, Jones, Pace, and Stokes 
(1996) found that 2 Ca2+ bind to SERCA2a at once and are transported with the hydrolysis of 
a single ATP molecule. The maximum Ca2+ which can be taken up by individual SERCA in a 
29 
 
second is estimated to be between 10 and 15 Ca2+ (Levitsky, Benevolensky, Levchenko, 
Smirnov, & Chazov, 1981; Shigekawa, Finegan, & Katz, 1976).  
 
The rate of Ca2+ uptake by SERCA is similar across the SR network with time constants 
between 140 – 159 ms. (Picht et al., 2011). Its important role in Ca2+ handling means that in 
the absence of SERCA2a cardiac function would cease (Kranias & Hajjar, 2012). 
 
 
1.2.6.1.1 Regulation of SERCA 
 
SERCA is always active, however the level of activity can change under different conditions, 
therefore altering the rate of SR Ca2+ uptake. Direct modulation of SERCA is typically not 
possible as SERCA activity is not affected by direct phosphorylation (Reddy et al., 1996). 
SERCA activity must therefore be modulated by another means.  
 
The low molecular weight protein, phospholamban (PLN) is an important inhibitory 
accessory protein and a regulator of cardiac activity. In its monomeric inhibitory form, PLN 
forms a complex with SERCA2a. In this form PLN reduces the Ca2+ affinity of the pump, 
inhibiting SERCA2a function by 50 % and the reducing rate of Ca2+ uptake into the SR lumen 
by half following relaxation. The SERCA2a-PLN complex alters the rate of Ca2+ transport (KCa) 
from ~0.3 to ~1 µM. PLN does not have any effect on SR leak (Kranias & Hajjar, 2012; Reddy 
et al., 1996). 
 
PLN has a hydrophobic SR membrane-bound region and a hydrophilic cytosolic domain 
contain sites for phosphorylation. PLN can be modulated by phosphorylation at a non-
inhibitory cytoplasmic domain encouraging dissociation from SERCA2a. These dissociated 
PLN monomers combine to form much less active or inactive oligomers, predominantly 
pentamers (Kranias & Hajjar, 2012; MacLennan, Kimura, & Toyofuku, 1998). Phosphorylation 
prevents PLN from suppressing the rate of Ca2+ uptake, therefore stimulating SERCA2a 
activity. This phosphorylation reverses the PLN-induced Ca2+ affinity shift, increasing the Ca2+ 
affinity of the pump and thus rate of Ca2+ removal from the cytoplasm. As a result, 
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phosphorylation of PLN accelerates the rate of relaxation (Kranias & Hajjar, 2012; Reddy et 
al., 1996). 
 
PLN is more effective at low [Ca2+]i, as high [Ca
2+]i can induce PLN dissociation from SERCA2a 
in the absence of phosphorylation through Ca2+ binding to an inhibitory transmembrane 
domain (MacLennan et al., 1998). Elevated [Ca2+]i has a proportional positive effect on rate 
of Ca2+ uptake by the SR. In response to systolic [Ca2+]i Ca
2+ transport into the SR is 100-200 
µM Ca2+/s (R. A. Bassani & Bers, 1995) with a maximum rate of Ca2+ uptake peaks at 160 
nM/min/mg (Wimsatt, Hohl, Brierley, & Altschuld, 1990). At rest [Ca2+]i is low as is rate of 
Ca2+ uptake by SERCA at ~21 µM/s, this low Ca2+ uptake is able to account for any diastolic 
SR Ca2+ leak (R. A. Bassani & Bers, 1995). The free luminal [Ca2+] also plays a part is 
determining rate of Ca2+ uptake by SERCA through altering the concentration gradient (Picht 
et al., 2011). 
 
Rate of ATP hydrolysis to ADP is much higher than the rate of the reverse reaction 
phosphorylation of ADP to ATP. While both the rate of the forward and reverse reaction are 
increased at higher [Ca2+]i, the forward reaction is increased to a greater extent (Feher, 
1984). At steady state for every ~45 Ca2+ taken up by the SR, Ca2+ efflux is ~40 Ca2+, with > 80 
% of SR Ca2+ being exchanged with cytoplasmic Ca2+. This results in net Ca2+ uptake by the SR 
(Feher, 1984; Takenaka et al., 1982). The reverse reaction or ATP formation is thought to be 
driven by Mg2+ due to its involvement in the release of Pi from phosphoprotein (Shigekawa 
et al., 1976).  
 
 
1.2.6.2  The sodium-calcium exchanger (NCX) 
 
Na+ - Ca2+ exchanger (NCX) is a membrane protein responsible for the majority of Ca2+ efflux. 
Binding sites on NCX enable transport of Ca2+ and Na+. Data shows that  3 Na+ are exchanged 
for 1 Ca2+; this 3+ charge influx and 2+ charge efflux contributes to a 1+ net increase in 
intracellular charge and so is electrogenic (Brini & Carafoli, 2011; Schillinger, Fiolet, 
Schlotthauer, & Hasenfuss, 2003). 
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NCX belongs to a family of 3 isoforms; NCX1, NCX2 and NCX3. NCX1 is the most abundant 
isoform in cardiac sarcolemma (Schillinger et al., 2003). NCX1 is the main mechanism by 
which sarcolemma Ca2+ efflux occurs accounting for 15-35 % of Ca2+ removal following 
systole (R. A. Bassani et al., 1992; Dibb et al., 2004). The transport binding sites of NCX bind 
to Ca2+ with a low affinity aiding the rapid return of [Ca2+]i to diastolic concentrations (Brini & 
Carafoli, 2011). Physiologically both [Ca2+] and [Na+] are much lower in the cytoplasm than in 
the ECM. During systole, [Ca2+]i is ~1000-10000 fold lower than external Ca
2+ concentrations, 
this creates a Ca2+ gradient (Miura & Kimura, 1989; Philipson, Bersohn, & Nishimoto, 1982). 
This drives Ca2+ removal, allowing relaxation to occur. 
 
In addition to transport binding sites for Na+ and Ca2+, NCX has a high affinity Ca2+ regulatory 
binding site. This regulatory site found on the intracellular surface of NCX and is important 
for determining the magnitude of both Ca2+ influx and efflux (Levitsky, Fraysse, Leoty, Nicoll, 
& Philipson, 1996; Schillinger et al., 2003). Ca2+ influx via NCX is also possible due to 
reversible ion transport with an outward current resulting in Na+ efflux (Miura & Kimura, 
1989).  
 
 
1.2.6.2.1 Regulation of the sodium-calcium exchanger 
 
NCX1 are primarily responsible for sarcolemmal Ca
2+ efflux and if impaired cellular relaxation 
can be prolonged (Neco et al., 2010). NCX activity is dependent on Na+ and Ca2+ binding to 
NCX transport binding sites. Activation of forward mode NCX activity is dependent on [Na+]o 
and [Ca2+]i. The inward Na
+ gradient drives Ca2+ removal, even against its concentration 
gradient (Miura & Kimura, 1989). 
 
Intracellular Ca2+ regulates NCX1 activity through binding to one of 2 high Ca
2+ affinity 
regulatory binding sites distinct from the Na+ and Ca2+ transport binding site. A 
conformational change occurs to NCX once Ca2+ binds to this regulatory site, this reduces 
inhibition of Na+ /Ca2+ current. [Ca2+]i therefore has a concentration dependent effect on 
Ca2+ efflux, with high [Ca2+]i is therefore able to stimulate Ca
2+ efflux (Levitsky et al., 1996; 
Miura & Kimura, 1989). 
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As discussed in section 1.2.5.5, Ca2+ sparks can occur due to diastolic SR Ca2+ leak. Primarily 
Ca2+ is released from RyR however SERCA can also add to Ca2+ leak. Spark amplitude and 
duration are dependent of rate of SR Ca2+ release and rate of Ca2+ removal or diffusion away 
from the dyadic cleft.  This diastolic rise [Ca2+] must either be taken up by SERCA or extruded 
from the cell. The sensitivity of NCX to high local [Ca2+]i determines rate of Ca
2+ removal and 
with that Ca2+ spark dynamics (Biesmans et al., 2011; Neco et al., 2010). 
 
In addition to the primary role of NCX in Ca2+ extrusion, NCX are able to exchange Ca2+ and 
Na+ in reverse driving Ca2+ influx. Thomas et al. (2003) measured Ca2+ current from reverse-
mode NCX activity at 90 mV. Ca2+ influx from reverse-mode NCX activity is not able to induce 
SR Ca2+ release alone but primes the dyadic cleft with a small increase in [Ca2+]i. When 
combined with the Ca2+ influx from LTCC in response to a cardiac action potential it increases 
the efficiency of CIRC and therefore magnitude of SR Ca2+ release, regardless of SR Ca2+ load.  
Reverse-mode NCX activity or outward current is only activated when [Na+]i is high and 
therefore [Na+]i regulates amplitude and rate of SR Ca
2+ release through synergy between 
NCX and LTCC. High [Na+]i enhances CICR via reverse-mode NCX activity, reducing [Na
+]i, the 
now low [Na+]i drives NCX activity, elevating the rate of Ca
2+ efflux. This influence of [Na+]i 
helps maintain the equilibrium between sarcolemma Ca2+ influx and efflux  (Miura & Kimura, 
1989; Neco et al., 2010; Ramirez, Sah, Liu, Rose, & Backx, 2011). Through altering Ca2+ and 
Na+ concentrations in the ECM, NCX activity can also regulate Ca2+ handling in neighbouring 
cells (Thomas et al., 2003).  
 
Change to the membrane potential and heart rate impacts the proportions of reversed and 
forward NCX activity which occur throughout the cardiac cycle. This also alters the relative 
contribution of NCX to Ca2+ removal following systole. Increased duration of the action 
potential enhances the contribution of reversed mode NCX activity and Ca2+ influx, while 
reducing the duration of Ca2+ efflux via forward mode NCX activity. Increase in heart rate 
produces the opposite effect, prolonging the duration of forward mode NCX activity during 
diastole. The relative contribution of NCX to Ca2+ removal is higher, enhancing Ca2+ efflux. 
This reduces uptake of Ca2+ via SERCA and contributes to decreased SR Ca2+ content. The 
effect of increased heart rate on SR Ca2+ content explains why Ca2+ transient amplitude is 
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reduced with elevated frequency. This relationship can however differ between species (R. 
A. Bassani et al., 1992; Schillinger et al., 2003). 
 
Intracellular pH can alter the exchange of Na+ and Ca2+ via the NCX in either direction. Acidity 
decreases Na+ /Ca2+ current, ceasing flux completely at below pH 6, while alkalosis 
stimulates NCX activity. This pH-dependency on NCX activity is highest at lower intracellular 
[Ca2+] and [Na+] and is thought to occur due to competitive binding of H+ in the place of 
either Ca2+ or Na+ to intracellular ion binding sites on NCX (Philipson et al., 1982). 
 
Prolonged exposure to high [Na+]i induce Na
+-dependent inactivation NCX1. This enables 
inactivation of the exchanger once [Ca2+]i has been reduced to normal diastolic levels. 
Increased [Ca2+]i slows the rate of NCX inactivation (Hilgemann, Matsuoka, Nagel, & Collins, 
1992). Exchange activity is modulated by ATP. At physiological concentrations Mg-ATP can 
increase the rate of recovery from Na+-dependent inactivation and reactivation of 
inactivated Na+-Ca2+ exchange. This pathway alters the sensitivity of NCX to Ca2+ encouraging 
Ca2+ efflux to lower [Ca2+]i. If [Ca
2+]i remains high during diastole this mechanism prevents 
Ca2+ overload when intracellular Na+ is high.  Ca2+ accumulates in the ECM in preparation for 
the next Ca2+ cycle (Collins, Somlyo, & Hilgemann, 1992; Hilgemann et al., 1992). 
 
 
1.2.6.3  Other Ca2+ removal mechanisms 
 
Plasma membrane Ca2+ ATPase (PMCA) and mitochondrial Ca2+ uptake are responsible for 
the remainder of Ca2+ extrusion, collectively contributing to less than 1 % of total Ca2+ 
removal from the cytoplasm in humans. PMCA and mitochondrial Ca2+ uptake are 
respectively 37 and 50 fold slower than that of NCX (R. A. Bassani et al., 1992; Piacentino et 
al., 2003). 
 
PMCA is a sarcolemmal protein found in numerous cell types. It has a low activity rate and as 
such, a low rate of Ca2+ removal (Brini & Carafoli, 2011; Caride, Rega, & Garrahan, 1986). 
There are multiple isoforms of PMCA; PMCA1b and PMCA4b are thought to have the 
greatest involvement with Ca2+ removal in the heart (Dally et al., 2006). Despite its high 
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affinity for Ca2+, PMCA transports Ca2+ at approximately 1µM/s, this low contribution Ca2+ 
efflux can be attributed to the enzyme’s low capacity for Ca2+. If PMCA alone was 
responsible for Ca2+ efflux relaxation would take approximately 60s (R. A. Bassani et al., 
1992; Brini & Carafoli, 2011). PMCA expression is up-regulated in some cardiomyopathies, 
increasing beyond that of SERCA2a. In these cardiomyopathies this drives Ca2+ efflux, 
contributing to reduced SR Ca2+ content and Ca2+ transient amplitudes (Dally et al., 2006). 
 
PMCA activity is dependent on phosphorylation by ATP (Caride et al., 1986). ATP hydrolysis is 
coupled to Ca2+ extrusion with low efficiency and therefore is dependent on the availability 
of ATP. 1 Ca2+ is transported per ATP hydrolysis with a stoichiometry transport ration of 1:1. 
PMCA act as a pump exchanging Ca2+ for H+ (Brini & Carafoli, 2011; Filomatori & Rega, 2003). 
 
Phosphorylation of PMCA is Ca2+-dependent; increased [Ca2+]i elevates both rate and 
magnitude of phosphorylation by ATP. Ca2+ binds to the activation site on PMCA able to 
displace any Mg2+ already bound there. Mg2+ is not required for phosphorylation to occur, 
however its presence in the µM range can also accelerate the rate of phosphorylation and 
thus PMCA activation. Inhibition of PMCA is mediated by dephosphorylation. If Mg2+ were 
present during phosphorylation, the presence of Mg2+ during dephosphorylation can also 
increase rate of dephosphorylation up to a saturation point (Caride et al., 1986). 
 
 
1.2.7 Contraction 
 
The cyclic rise and fall of [Ca2+]i produces contraction and relaxation. Ca
2+ binds to 
myofilaments enabling cross bridges to form between them. Contraction occurs when these 
cross bridges allow myofilaments to slide past each other in parallel. As [Ca2+]i increases, as 
does the activation of myofilaments and the resulting cellular contraction. With dissociation 
and removal of Ca2+ from the cytoplasm the contractile unit relaxes. 
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1.2.7.1  Myofilaments  
 
In a mammalian left ventricular myocyte, contractile components called myofilaments make 
up ~54 % of the cell volume (Bossen, Sommer, & Waugh, 1981). Myofilaments are arranged 
in a specific parallel overlapping structure, forming contractile units called sarcomeres. The 
approximate length of the sarcomere at rest is 1.8 – 1.9 µm (Hanft, Korte, & McDonald, 
2008; Jayasinghe et al., 2012). 
 
The organisation of filaments within the sarcomere and their role in contraction were first 
identified by A. F. Huxley and Niedergerke (1954) and H. Huxley and Hanson (1954). The 
collective arrangement of sarcomeres leads to the overall striated appearance of the cardiac 
myocyte, with the alternating dark A-bands and light I-bands. At either end of the sarcomere 
Z-discs anchor the sarcomere to adjacent sarcomeres and structural cytoskeletal filaments. 
Thin actin filaments protrude from the Z-lines towards the centre of the sarcomere ending at 
the H-zone. Actin filaments are helical and double stranded, composed of polymerised 
globular actin monomers. These thin filaments run parallel to the myosin filaments 
overlapping over a 75 µm region (Hanft et al., 2008). The non-overlapping regions of actin 
make up the I-band which becomes narrower with contraction as the overlap between actin 
and myosin becomes larger (A. F. Huxley & Niedergerke, 1954) (see Fig 1-3). 
 
The A-band spans the width of the myosin filament tails, in addition to the overlapping actin 
regions. As the length of myosin remains the same during contraction, the A-band width is 
constant (H. Huxley & Hanson, 1954). The tail ends of two coiled myosin heavy chains, 
composed of 300 monomers, make up the thick filament (Hanft et al., 2008). Myosin is 
arranged in a hexameric structure with two myosin light chains for each heavy chain. 
Globular myosin heads protrude from the myosin filament tails and are responsible cross 
bridge formation between the myosin and actin filaments. Myosin heads have both an actin 
binding domain and a site for ATP hydrolysis. In the centre of the sarcomere, myosin 
filaments are connected by M-protein and myomesin (Spudich, 2001; Warrick & Spudich, 
1987).  
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Every seventh actin monomer is adhered to a troponin complex. Troponin (Tn) is comprised 
of 3 subunits, each with a specific function: TnC, TnI and TnT. TnC is the Ca2+ binding site, 
while TnI lowers the affinity of TnC for Ca2+, with a role in inhibition. Tropomyosin (Tm) is a 
short helical polymer found between the actin strands. TnT binds to Tm, allowing Tn to 
bridge actin with Tm (Moss, Razumova, & Fitzsimons, 2004; Solaro, Moir, & Perry, 1976). 
 
Titin is a structural protein found adhered to the Z-line. In this position titin can at as a 
scaffold to support myosin during contraction. Titin determines the stiffness or elasticity of 
the cell and therefore its ability to distend (Brady, 1991). High titin compliance increases 
both the length of a sarcomere and the strength of the interactions between myosin and 
actin. As such sarcomere length regulates myofilament sensitivity to Ca2+ and the maximum 
possible force which can be generated (K. L. Li et al., 2018). The sarcomere is able to stretch 
to extend up to ~2.3 µm in length with increased cardiac loading, contributing to length-
induced activation of myofilaments and a stronger contractile force (Hanft et al., 2008). 
 
 
 
Figure 1-3. The basic arrangement of myofilaments within the sarcomere. (A) during 
relaxation. (B) during contraction. 
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1.2.7.2  Myofilament Ca2+ binding and cross bridge cycling 
 
 The dyadic junctions where CIRC occurs due to connections between the SR and t-tubules 
are also associated with the sarcomere. The regions of the SR span the 2 compartments 
closest to the Z-line, as such the amplitude of Ca2+ release is highest here. Non-junctional SR 
crosses the remaining compartments of the sarcomere more closely associated with the M-
line. The rate of SR Ca2+ release is elevated with increased distance from the M-line, with 
Ca2+ release 8 ms faster at the Z-line (Picht et al., 2011). 
 
 [Ca2+]i is able to regulate the level of contractile force generated by sarcomeres. At low 
diastolic [Ca2+]i the interactions between TnI and actin, and  TnT and Tm, are strong,  holding 
tropomyosin in place. The position to tropomyosin blocks actin binding sites preventing 
myosin from interacting with actin, thus the number of cross bridges which are able to form 
are limited. Strong cross bridge formation makes it possible for some contraction to occur in 
the absence of Ca2+, however the magnitude of contraction would be minimal (Moss et al., 
2004). 
 
Tn and Tm collectively regulate myofilament activation. The systolic rise in [Ca2+]i due to 
CICR, increases the Ca2+ available to bind to TnC. Ca2+ binds to TnC with a low affinity 
inducing a conformational change in Tn. This manoeuvres Tm unblocking the actin binding 
site and increasing sensitivity to Ca2+.  This activates myofilaments enabling myosin-actin 
interactions (Moss et al., 2004). During contraction ~ 30 µM Ca2+ is bound to TnC (J. W. 
Bassani, Yuan, & Bers, 1995).  
 
The myosin head has 2 domains; S1 and S2. S1 binds to actin forming the cross bridge. S1 
acts as a motor; in response to phosphorylation by a single ATP molecule S1 undergoes a 
conformation change. This reaction adjusts the angle of the myosin head driving the power 
stroke. An individual power stroke results in a ~5-15 nm shortening step (Moss et al., 2004; 
Spudich, 2001). During maximal activation contraction of the sarcomere can shorten up to 
~65 % of resting length, at this point ~30 % of cross bridges interact at once and the I-band is 
no longer visible (Hanft et al., 2008; H. Huxley & Hanson, 1954). 
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Deactivation of myofilaments requires dissociation of cross bridges and prevention of 
further myofilament activation through removal of Ca2+ from the cytoplasm (Chung et al., 
2016). In addition, other factors can influence rate of deactivation. Sarcomere shortening 
can induce deactivation. As the sarcomere contracts the number of further strong cross 
bridges that can form are reduced and Ca2+ dissociates from TnC at a higher rate (Moss et 
al., 2004).  
 
ATP availability also impacts rate of activation and deactivation of myofilaments. Just as the 
presence of ATP can drive the power stroke, accumulation of Pi encourages reversal of the 
power stroke. This accelerates cross bridge deactivation and drives relaxation (Hanft et al., 
2008; Moss et al., 2004). The rate of contraction and relaxation alters when the rate of Ca2+ 
association and dissociation to TnC change by equal amounts in one direction. This does not 
impact the extent of sarcomere shortening unless the changes in rate are unequal (Chung et 
al., 2016). 
 
 
1.2.7.3  Regulation of contraction 
 
Myofilament sensitivity to Ca2+ is the sigmoidal relationship between the availability of Ca2+ 
to bind to TnC and the resultant force generation by the myofilaments (Fig 1-4). This 
relationship can shift in response to change in myofilament sensitivity to Ca2+. A left shift 
indicates increased Ca2+ sensitivity, therefore a greater force will be generated with the 
same [Ca2+]i. Decreased Ca
2+ sensitivity is denoted by right shift in relationship. With a 
decreased myofilament sensitivity to Ca2+, a larger [Ca2+]i is required to maintain a given 
force (Chung et al., 2016; Moss et al., 2004). 
 
Equivalent changes in rate of association and dissociation of Ca2+ from TnC can alter rate of 
contractility. Unequal or opposite changes in rate of Ca2+ association and dissociation from 
TnC alter the ratio (kd) between them leading to one outweighing the other, contributing to 
change in myofilament sensitivity to Ca2+. Increased Ca2+ sensitivity results from either an 
elevated rate of association or reduced rate of dissociation. Both decrease kd and increase 
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the force generated at a given [Ca2+]i, the former increases the rate of shortening, while the 
latter would slow relaxation (Chung et al., 2016).  
 
Ca2+ sensitivity is altered by the availability of ATP and ADP. Elevated cytoplasmic [MgADP] 
increases the strength of cross bridges. As the cross bridges formed are stronger, the rate of 
dissociation is reduced and therefore myofilament sensitivity to Ca2+ is increased (Moss et 
al., 2004). 
 
The pH of the cytoplasm can change under both physiological and pathological conditions 
and affect myofilament sensitivity to Ca2+. Acidosis has a depressive effect of myofilament 
contractility, through decreased Ca2+ sensitivity. A lower pH shifts the [Ca2+]i and contractile 
force relationship to the right, thus a greater threshold of free Ca2+ is required to generate 
the same level of contractile force, reducing the rate of contraction. The maximum force 
generated at saturating levels of free Ca2+ is limited with decreased pH. The afore mentioned 
effects of acidosis on SR Ca2+ uptake and release are thought to further exacerbate the 
depressive effect on myofilaments through reducing available Ca2+ (Fabiato & Fabiato, 
1978). 
 
 
1.2.8  Regulation and control of systolic Ca2+ 
 
The above explains the fundamental way in which Ca2+ rises and falls during systole, then 
diastole. Normal heart function requires that this process is regulated to maintain a stable 
level of inotropy for a given metabolic demand. As inotropy must also adapt to meet 
changes in metabolic demand, the process must be controllable. 
 
 
1.2.8.1  The relationship between systolic Ca2+ and force of contraction 
 
The Ca2+ transient amplitude regulates inotropy as the rise in global [Ca2+]i increases the free 
Ca2+ available to activate myofilaments. Anything that increases systolic Ca2+ will result in 
increased force of contraction. The relationship between [Ca2+]i and contractile force is 
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sigmoidal (Fig 1-4). The binding affinity of Ca2+ to TnC increases as more cross bridges form, 
this increases the strength of subsequent cross bridge formations. The contractile force 
generated increases exponentially after initial myofilament activation. At higher [Ca2+]i 
saturating levels are reached and the force of contraction cannot increase any further (Moss 
et al., 2004). The force of contraction is therefore highly dependent on systolic Ca2+. 
Autoregulation prevents beat-to-beat variability in systolic Ca2+, in order to maintain a 
steady state; this shall be discussed in section 1.2.8.3. 
 
 
 
Figure 1-4. The sigmoidal relationship between free cytoplasmic Ca2+ concentration and 
force of contraction 
 
 
1.2.8.2  What determines the amplitude of systolic Ca2+? 
 
The amplitude of systolic Ca2+ is dependent on the amount of Ca2+ that leaves the SR during 
systole. As the concentration of Ca2+ inside the SR is always much greater than in the 
cytoplasm, Ca2+ will flow into the cytoplasm when the RyR open during CICR (see 1.2.5.5). 
However, it is never the case that all SR Ca2+ is released during systole rather a fraction; 
termed fractional SR Ca2+ release. 
 
Fractional SR Ca2+ release is dependent on two fundamental phenomenon. (1) the amount of 
Ca2+ stored in the SR (SR Ca2+ content) and (2) peak Ca2+ influx on ICaL. For all other 
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parameters being equal, if either increases then so will fractional SR Ca2+ release thus systolic 
Ca2+. To understand why these relationships exist, it is important to remember RyR Po is 
dependent on cytoplasmic and intra-SR (luminal) Ca2+.  
 
It is convenient to consider the effect of peak ICaL first. As per section 1.2.5.5, mass systolic 
SR Ca2+ release occurs as a result of summation of Ca2+ sparks. This is because during CICR, 
Ca2+ influx via voltage gated Ca2+ channels, primarily LTCC, elevates local (to the RyR) dyadic 
Ca2+ increasing RyR Po so that enough will simultaneously open to produce mass SR Ca
2+ 
release. Peak ICaL represents the greatest point-in-time Ca
2+ flux via LTCC and so the greatest 
increase in dyadic Ca2+ concentration. Increasing peak ICaL means higher dyadic Ca
2+ 
concentrations are reached during CICR further elevating RyR Po. Under these conditions, 
stochastically, more will happen to open simultaneously thus increasing mass SR Ca2+ release 
(Fill & Copello, 2002; Gyorke & Fill, 1993; Zahradnikova et al., 1999). 
 
The dependence of fractional SR Ca2+ release on SR Ca2+ content is due to the fact that 
increasing SR Ca2+ also elevates RyR Po. Compared to the time course of Ca
2+ influx via LTCC, 
SR Ca2+ is relatively stable, so SR Ca2+ sets the basal RyR Po. Increasing SR Ca
2+ elevates that 
basal Po and so pre-sensitisation such that during CICR, a given peak ICaL results in increased 
simultaneous RyR opening thus mass SR Ca2+ release (Ching, Williams, & Sitsapesan, 2000). 
SR Ca2+ content itself is regulated by the rate of Ca2+ uptake. The rate of SERCA activity can 
therefore also impact inotropy, in addition to other Ca2+ dynamics, such as diastolic [Ca2+]i 
(Kranias & Hajjar, 2012).  
 
The dependence of fractional SR Ca2+ released on SR Ca2+ content is cubic making SR Ca2+ 
content a powerful modulator of inotropy. This also means that in the steady state, SR Ca2+ 
content must be tightly controlled via a process known as autoregulation. 
 
 
1.2.8.3  Autoregulation 
 
Autoregulation is the feedback mechanism by which SR Ca2+ content is modulated in order 
to ensure Ca2+ transient amplitude and the resultant inotropy are maintained at steady state. 
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Autoregulation is important as instability in Ca2+ handling can lead to beat-to-beat variations 
in cardiac contractility (Eisner, Choi, Diaz, O'Neill, & Trafford, 2000).  
 
Alterations to the activity of a single component of Ca2+ handling cannot induce a prolonged 
effect on fractional SR Ca2+ release and thus inotropy. In the absence of a change to the Ca2+ 
trigger, alteration of RyR Po alone has only a fleeting effect on inotropy. Increased RyR Po 
elevates SR Ca2+ release, resulting in brief, initial increase in systolic Ca2+, lasting for a single 
beat. The high Ca2+ during systole then increased forward-mode NCX activity driving a larger 
proportion of Ca2+ efflux. Due to the dependency of LTCC inactivation on [Ca2+]i,  the high 
Ca2+ during systole also increases the rate of Ca2+-induced inactivation of LTCC, reducing Ca2+ 
influx (Pelzmann et al., 1998). As Ca2+ efflux exceeds influx, this results in reduced [Ca2+]i for 
subsequent beats.  As [Ca2+]i is low, less Ca
2+ is available for SR Ca2+ uptake via SERCA, 
leading to a decreased rate of Ca2+ uptake and a reduced SR Ca2+ content (Kranias & Hajjar, 
2012). As described in section 1.2.8.2, SR Ca2+ content is one of the main determinants of 
systolic Ca2+, thus a reduction in SR Ca2+ content and reduced ICaL (or Ca
2+ trigger) 
compensate for the increased RyR Po. This allows steady state Ca
2+ transient amplitude, and 
the resulting inotropy, to be restored and maintained (Eisner et al., 2000; Miura & Kimura, 
1989). 
 
If RyR Po is reduced, SR Ca
2+ release is reduced and thus systolic [Ca2+]i is briefly reduced. 
[Ca2+]i increases due to low NCX-mediated Ca
2+ extrusion and a reduced rate of Ca2+-
dependent LTCC inactivation. High [Na+]i resulting from the previously higher rate of NCX-
mediated Ca2+ extrusion can also drive reverse mode NCX activity. This high [Ca2+]i promotes 
SR Ca2+ uptake via SERCA and thus increases SR Ca2+ content. In both cases, SR Ca2+ content 
is therefore altered to compensate for the change to RyR Po (R. A. Bassani & Bers, 1995; 
Eisner et al., 2000; Ramirez et al., 2011). 
 
Though SR Ca2+ content and therefore inotropy are tightly regulated in the steady state, 
cellular inotropy must be able to adapt to meet changes to metabolic demand. β-adrenergic 
stimulation therefore alters the inotropic set-point which autoregulation then maintains. 
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1.2.8.4  Beta-adrenergic stimulation 
 
During physiological conditions such as exercise and stress, β-adrenergic stimulation 
increases the production of cyclic AMP (cAMP), and therefore the activation of protein 
kinase A (PKA). PKA is able to phosphorylate multiple Ca2+ handling and regulatory proteins 
including PLN, LTCC and TnI. This phosphorylation increases the magnitude and force of 
contraction and rate of relaxation leading to sustained overall positive inotropy (Bers, 2002). 
As previously discussed in section 1.2.8.2, SR Ca2+ release, and the resulting changes to 
systolic Ca2+ and inotropy, are dependent on both ICaL and SR Ca
2+ content. Both ICaL and SR 
Ca2+ content can therefore be modulated to produce a change to inotropy. Positive inotropy 
occurs either through direct phosphorylation of LTCC – resulting in an increase in peak ICaL – 
or phosphorylation of PLN – the mediator of SERCA activity – increasing SR Ca2+ loading 
 
LTCC is affected by β-adrenergic stimulation altering the I/V relationship. The ICaL achieved at 
each change in membrane potential increases. This follows the same bell-curved relationship 
as shown in Fig 1-2, with inward Ca2+ current also peaking at 10 mV. β-adrenergic stimulation 
therefore contributes to increase Ca2+ influx (Pelzmann et al., 1998).  
 
β-adrenergic stimulation requires PLN to mediate its effects on SERCA activity. cAMP-
dependent phosphorylation of PLN promotes dissociation from SERCA. Ca2+/calmodulin-
dependent protein kinase II (CaMKII) can also act on PLN, independent of PKA. PLN 
dissociation increases the rate of SR Ca2+ uptake by SERCA, driving SR Ca2+ loading and rate 
of relaxation. The effect of phosphorylation PLN is reversible (Kranias & Hajjar, 2012; Reddy 
et al., 1996). PLN forms pentamers during β-adrenergic stimulation. It is the dissociation of 
PLN from these pentamers which enables them to reassociate with SERCA. Once the 
monomers are associated with SERCA, PLN returns to its inhibitory role (MacLennan et al., 
1998).  
 
RyR is also a target from phosphorylation by PKA. This alters RyR Po producing a short-lived 
increase in SR Ca2+ release (Kranias & Hajjar, 2012). As previously mentioned the effects of 
RyR potentiation on inotropy are not sustainable. The impact of LTCC phosphorylation on 
Ca2+ influx would however, have the same overall effect, driving CICR (Bers, 2002). 
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β-adrenergic stimulation can also impact myofilament sensitivity to Ca2+ through 
phosphorylation of myofilament-associated proteins, such as Tn. This does not alter Ca2+ 
handling but can impact inotropy. In response to β-adrenergic stimulation phosphorylation 
of TnI regulates cardiac activity in different ways dependent on site and the degree of 
phosphorylation. High PKA phosphorylation of TnI improves the affinity of TnC for Ca2+ and 
increases rate of association, thus the force of contractility is increased. TnI phosphorylation 
can reduce the sensitivity of the myosin ATPase to Ca2+ encouraging Ca2+ dissociation and 
therefore rate of relaxation.  This allows for a steady state of contraction and relaxation to 
be reached; at higher heart rates it is beneficial for new Ca2+ cycles to begin more rapidly 
(Bers, 2002; Solaro et al., 1976). 
 
The average basal heart rate varies in different mammals however the heart rate of sheep is 
similar to humans when compared to smaller mammal models such as rats. On average, the 
human myocardium beats at approximately 72 beats per minute (BPM), this is within the 
range of sheep at 60 – 120 BPM. Rat myocardium beat at a much faster pace (250-493 BPM) 
(Milani-Nejad & Janssen, 2014). β-adrenergic stimulation acts on the SA node contributing to 
increased firing rate, modulated by increased SR Ca2+ release in pacemaker cells (Ju & Allen, 
1999). At a higher heart rate relaxation time is reduced, decreasing the time for Ca2+ uptake 
by the SR. A reduction in SR Ca2+ loading contributes to decreased amplitude of subsequent 
Ca2+ releases at steady state (Santana et al., 2010; Schillinger et al., 2003).  
 
 
1.2.8.5  Modulation of Ca2+ handling by physiological agents 
 
While rapid changes in [Ca2+]i are primarily responsible for regulation of RyR2 activation and 
inactivation, RyR are not solely sensitive to Ca2+. Other physiological agents – Mg2+ and ATP – 
have the ability to further alter Po and modulate RyR, determining how RyR respond to 
change in Ca2+. This impacts the rate and magnitude of SR Ca2+ release.  
 
Mg2+ is capable of competitively binding to the non-specific high Ca2+ inhibition site of RyR 
(Fill & Copello, 2002). When compared to other RyR isoforms, RyR2 has a reduced sensitivity 
to Mg2+. High [Mg2+] at mM concentrations still have an inhibitory effect on RyR2 decreasing 
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Po (Tunwell et al., 1996; Valdivia, Kaplan, Ellis-Davies, & Lederer, 1995). Rate of RyR2 
activation is reduced with Mg2+ as RyR is less sensitive to elevated cytoplasmic Ca2+. Mg2+ 
also impacts the decay time of Po following Ca
2+ release, therefore once activated the 
channel can remain open longer, although with Mg2+ inactivation can occur at a lower [Ca2+]i, 
as such inactivation is 10 fold faster in the presence of Mg2+ (Fill & Copello, 2002; Valdivia et 
al., 1995).  
 
RyR2 activation does not require the presence of ATP however the sensitivity of RyR to Ca
2+ is 
increased when RyR is bound to ATP. RyR Po is increased at a lower [Ca
2+]i with ATP and so 
less [Ca2+]i is required to open the channel. With a higher rate of RyR activation, SR Ca
2+ 
release is greater. A large majority of cytoplasmic ATP is bound to Mg2+, only free ATP can 
bind to RyR2 (Fill & Copello, 2002; Rousseau, Smith, Henderson, & Meissner, 1986).  
 
Exposure to these physiological agents can alter RyR Po, thus SR Ca
2+ release and degree of 
shortening. This modulation of RyR has no long-lasting effects on inotropy (Fill & Copello, 
2002).  
 
 
1.2.9  Impaired regulation of Ca2+ handling in disease 
 
The regulation of Ca2+ handling mechanisms can become dysfunctional in disease. A major 
systolic dysfunction in cardiomyopathies is negative inotropy due to reduced SR Ca2+ 
content. Elevated diastolic SR Ca2+ leak is thought to decrease SR Ca2+ content in heart 
failure. This may therefore contribute to loss of contractility (Eisner et al., 2000). SR Ca2+ leak 
can also occur as a result of acidosis due to ischemia. While pH is not a physiological trigger 
of RyR2, acidosis can increase the sensitivity of RyR2 to Ca
2+ during relaxation, contributing to 
reduced diastolic SR Ca2+ content (Fabiato & Fabiato, 1978). 
 
At physiological concentrations ATP is usually in excess; however impaired metabolism in 
disease can reduce ATP levels. SERCA is an ATPase requiring which couples ATP hydrolysis to 
Ca2+ uptake. Low [ATP] can promote less efficient, uncoupled reactions, leading to a 
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reduction in rate of Ca2+ uptake. This also contributes to negative inotropy due to a 
reduction in SR Ca2+ Content (Feher, 1984; Takenaka et al., 1982).  
 
The loss of contractile force present in many cardiomyopathies is often still able to maintain 
a stroke volume due to increased end-diastolic volume (Jacob et al., 1992). This 
compensatory mechanism is however hindered by diastolic dysfunction such as loss of 
compliance (Maurer, Spevack, Burkhoff, & Kronzon, 2004). 
 
Ca2+ handling instability and delayed autoregulation can lead to the occurrence of alternans. 
Alternans are alternating short and large Ca2+ transients resulting from change in beat-to-
beat change in SR Ca2+ content (Eisner et al., 2000). Left ventricular alternans are associated 
with left ventricular dysfunction in cardiomyopathies, as well as in coronary artery disease 
and systemic hypertension (Nguyen, Cao, Tran, & Movahed, 2013). 
 
 
 
Figure 1-5. A diagram providing an overview of excitation-contraction coupling. The 
movement of Ca2+ has been indicated by red arrows (a) a ventricular action potential 
activates LTCC leading to a small Ca2+ influx. (b) the rise in local [Ca2+]i leads to SR Ca
2+ 
release via RyR. (c) the increase in global [Ca2+]i activates myofilaments initiating contraction. 
(d) the majority of cytoplasmic Ca2+ is taken up by SERCA to replenish SR Ca2+ content. (e) 
sarcolemmal proteins, primarily NCX, remove the remaining Ca2+, aiding relaxation. 
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1.3   Cytokines 
 
1.3.1   What are cytokines? 
 
Cytokines are small soluble peptides (<40 kDa) which act as cell signalling molecules 
mediating autocrine, paracrine or endocrine signalling. Cytokines also have an important 
role in modulation of the immune response, hematopoietic developmental pathways and 
inflammation (D. Chen, Assad-Kottner, Orrego, & Torre-Amione, 2008; Chousterman, 
Swirski, & Weber, 2017; Oppenheim, Matsushima, Yoshimura, Leonard, & Neta, 1989; Ozaki 
& Leonard, 2002). 
 
Cytokine release is stimulated by the presence of exogenous polysaccharides or bacterial 
endotoxins, causing levels to be raised in response to infection, however following recovery 
cytokines levels reduce to the basal level in health (Dinarello, 2007). The high potency of 
cytokines means that only low concentrations are required to mediate an effect (D. Chen et 
al., 2008). These effects can be amplified by simultaneous release of different cytokines 
working synergistically (Oppenheim et al., 1989). The function of different cytokines can 
overlap due to similarity of the binding motifs on some receptors, enabling these cytokines 
to share a single signalling pathway (Ozaki & Leonard, 2002). 
 
There are many different forms of cytokines, which include tumour necrosis factors, 
interleukins, growth factors, interferons and chemokines. The rate of production, release 
and the longevity of their effects differs between cytokines (Chousterman et al., 2017; 
Oppenheim et al., 1989). 
 
As the biochemical structure of cytokines differs, they are each able to bind to different 
receptors. The majority bind only to their own cell membrane receptors in order to activate 
specific cell signalling pathways (Dinarello, 2007; Oppenheim et al., 1989). Some cytokines 
are pleiotropic; able to activate multiple signalling pathways, and therefore able to carry out 
various roles. This pleiotropy can be due to either activation of multiple receptors or 
activation of receptors capable of activating multiple pathways (D. Chen et al., 2008; Ozaki & 
Leonard, 2002). 
48 
 
1.3.2  Role of cytokines in the immune response 
 
The primary role of cytokines is to protect the host, through preventing or fighting infection, 
by mediating an inflammatory or immune response. The expression of cytokines varies in 
response to different viral and bacterial infections, and some cytokines are present in the 
absence of infection. TNF-α and Interferon (IFN) -α, -β and -γ expression in the lungs are 
known to be protective against viral infections such as influenza, through preventing 
replication and viral load from increasing (Hoshino et al., 1983; Seo & Webster, 2002). IFN-γ 
also plays a role in prevention against bacterial infection (Sawai et al., 1999). 
 
Proinflammatory cytokines including TNF-α, IL-6, IL-1β and IFN-γ are known to produce 
intracellular and extracellular ROS on a time and dose dependent basis. Cytokine induced 
ROS generation can occur through the mitochondria electron transport chain or by 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (Nox2) (Agharazii et al., 
2015; D. Yang et al., 2007). ROS generation, particularly those derived from Nox2, can 
prevent infection and aid pathogen removal. ROS act through either direct oxidative damage 
to pathogens, activating other host immune responses or promotion of cell death pathways 
in microbes and infected host cells (Paiva & Bozza, 2014). 
 
In health cytokines are present in serum at much lower concentrations. Changes to basal 
serum cytokine concentrations occur with age, with many cytokines increasing in the elderly. 
With increased age, various interleukins increase in serum by ~10–40 fold, while TNF-α 
maintains a stable concentration in serum throughout the lifespan (Scheinert et al., 2015). 
 
 
1.3.3   The role of cytokines in inflammation and disease progression 
 
While cytokines can be beneficial in fighting infection, if serum cytokine concentrations 
remain high following recovery from infection, this can lead to autoimmune disease. TNF-α 
is the dominant cytokine present in autoimmune diseases (Dinarello, 2007). Some cytokines 
are associated with specific disease states. IL-4, IL-13, and IL-5 which all mediate the chronic 
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inflammatory response involved in various allergic diseases including asthma (Ngoc, Gold, 
Tzianabos, Weiss, & Celedon, 2005).  
 
Cytokines can also contribute to infectious disease pathogenesis. Duration of exposure can 
impact the overall effect a cytokine has on the body and whether it is negative or positive on 
health. IFN-γ initially prevents progression of stomach infection by Helicobacter pylori 
through decreasing the magnitude of colonisation. Prolonged exposure to IFN-γ has been 
shown to also contribute to the gastric inflammation and exacerbate symptoms (Sawai et al., 
1999). 
 
Many pleiotropic cytokines have both positive and negative effects, such as association with 
both regulation of host response and disease progression (Dinarello, 2007). Carswell et al. 
(1975) found that TNF-α is cytotoxic to tumour cells however more recently TNF-α was also 
found to promote cell growth. Similarly, proinflammatory cytokines including IL-6 are 
elevated in breast and pancreatic cancer, with the additional involvement of TNF-α and IL-1β 
in the latter. Increased IL-6 expression has been suggested to be involved in tumour 
progression, metastases and a poorer clinical outcome, although there is also evidence that 
IL-6 can mediate a tumour-suppressive host response (Farajzadeh Valilou, Keshavarz-Fathi, 
Silvestris, Argentiero, & Rezaei, 2018; Zhang & Adachi, 1999). Although cytokines are 
classified into pro- and anti-inflammatory, some cytokines, such as IL-6, have properties of 
both. IL-6 is primarily proinflammatory but can drive anti-inflammatory pathways by down-
regulation of both TNF-α and IL-1, and up-regulation of IL-1Ra (Thakur et al., 2002). 
 
It is not only proinflammatory cytokines which have this dual role in disease prevention and 
progression. The anti-inflammatory cytokine IL-10 has varying effects on tumour migration 
and is capable of both preventing angiogenesis and encouraging cell proliferation (L. Li et al., 
2017). Similarly, IL-2 has an important role in immunity, responsible for cytotoxic T-cell 
production,  however following organ or tissue transplantation IL-2 promotes graft-versus-
host disease (Dinarello, 2007). 
 
In order to mediate the inflammatory response, the proportions of proinflammatory or anti- 
inflammatory cytokines can change. When balanced each can neutralise the others’ effects, 
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whereas if the proportion of one outweighs the other, this determines the overall 
inflammatory response. If this response is excessive this can bring about dysfunction. 
Infection or injury initially drives proinflammatory cytokine production (Thakur et al., 2002) 
(A. Kumar, Kumar, Paladugu, Mensing, & Parrillo, 2007). The ratio of proinflammatory 
cytokines such as TNF-α and IL-6, to the anti-inflammatory IL-10 can determine the overall 
inflammatory response. Higher TNF-α and IL-6 relative to IL-10 can indicate an excessive 
inflammatory response in systemic inflammation. The compensatory increased release of 
anti-inflammatory cytokines however, can raise concentrations beyond that of 
proinflammatory cytokines. This can lead to anti-inflammatory response syndrome following 
systemic inflammation (Jerin et al., 2003; Mannick, Rodrick, & Lederer, 2001). In infection, IL-
1β levels increase, this cytokine is a very commonly involved in autoinflammatory disease. 
The ratio between the proinflammatory IL-1β and the competitive inhibitor IL-1Ra can 
determine whether a proinflammatory response is generated. The proportions of IL-1β to IL-
1Ra can indicate disease severity, with excess IL-1Ra reducing severity (Dinarello, 2007; 
Mannick et al., 2001; Thakur et al., 2002). 
 
The proportion of different individual cytokines expressed is important as imbalance – not 
solely between proinflammatory and anti-inflammatory cytokines, but also those with 
contrasting roles – can result in disease development. Oestrogen is known to regulate the 
expression of various proinflammatory cytokines to promote bone remodelling. TNF-α, IL-1β 
and IL-6 encourage bone resorption with a concentration dependant effect on loss of bone 
density. In the absence of oestrogen, the production of these cytokines is increased to 
beyond that of Interferon-γ (IFN-γ) and leukaemia inhibitory factor (LIF) involved in inhibition 
of bone resorption. In this case imbalance of cytokines leads to development of 
postmenopausal osteoporosis (Zheng et al., 1997). 
 
The accumulation of ROS due to increase in ROS production by proinflammatory cytokines or 
reduced expression of antioxidant enzymes, leads to oxidative stress which contributes to 
inflammation in disease. ROS can also modulate on some downstream signalling pathways 
which can lead to further complications in disease (Agharazii et al., 2015; D. Yang et al., 
2007). At high levels mitochondrial ROS can act on signalling pathways which further 
promote release of proinflammatory cytokines including TNF, IL-1β, IL-6 and IL-18, 
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amplifying the signal (Naik & Dixit, 2011). While ROS can be beneficial to fighting infection, 
some pathogens favour oxidative stress conditions (Paiva & Bozza, 2014). 
 
 
1.3.4  TNF-α and IL-1β are major regulators of inflammation 
 
Tumour necrosis factor-alpha (TNF-α) and Interleukin-1-beta (IL-1β) are proinflammatory 
cytokines which exert very similar effects on cells. They share important roles in both host 
response to an infectious stimulus and tissue repair following injury (Mann & Young, 1994; 
Oppenheim et al., 1989).  
 
 
1.3.4.1  Tumour necrosis factor-alpha 
 
TNF-α, also referred to as cachectin, was first identified by Carswell et al. (1975). TNF-α is 
sourced from macrophages, as well as non-immune cells such as endothelial cells and 
myocytes under some conditions. This release is induced by exposure to endotoxins and can 
mediate the cytotoxicity of activated macrophages. The protein structure of TNF-α is made 
up of 17 KDa monomers which unite to form a trimer (Blum & Miller, 2001; Eck & Sprang, 
1989). TNF-α primarily interacts with a cell through binding to transmembrane receptors 
including the 55 kDa TNF receptor-1 (TNFR1) and 75 kDa TNF receptor-2 (TNFR2) with 
different effects, but is also able to bind to other receptors (Idriss & Naismith, 2000; Kelly et 
al., 2010; Monden et al., 2007).  
 
 
1.3.4.2  Interleukin-1-beta 
 
IL-1β, also known as cataboline, is released from a variety of cells including macrophages 
and monocytes. The 31 kDa inactive IL-1β precursor becomes active in response to 
molecules released from dead cells and pathogens, such as endotoxins (Blum & Miller, 2001; 
Chaudhry et al., 2013; Lopez-Castejon & Brough, 2011). 
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IL-1β also has multiple receptors; the type I IL-1 receptor (IL-1RI) and the type II IL-1 receptor 
(IL-1RII). IL-1RI is found on the surface of multiple cells, however the effect of cytokine 
exposure is dependent upon the target cell. IL-1β binding to IL-1RI has been associated with 
stress and immune responses (Oppenheim et al., 1989; Subramaniam, Stansberg, & 
Cunningham, 2004). IL-1RI are not in abundance, however very few interactions per cell 
(<10) with either IL-1α or IL-1β are required to achieve a strong signal through simultaneous 
activation of multiple pathways, promoting inflammation. Competitive inhibition of IL-1α 
and IL-1β binding to the IL-1RI by the IL-1 receptor antagonist (IL-1Ra) prevents 
inflammation. IL-1RII, found predominantly on immune cells, provides a negative feedback 
mechanism through binding and neutralising IL-1β precursor. This inhibits the activation of 
pathways from IL-1RI binding (Chaudhry et al., 2013; Subramaniam et al., 2004). 
 
 
1.3.5  The role of cytokines in sepsis 
 
In response to infection, pathogen associated molecular patterns (PAMPs) and bacterial 
endotoxins present in serum or at the site of infection promote increased cytokine 
production. 
 
This cytokine recruitment is meant to help coordinate the immune response, and thus fight 
the infection. As infection and inflammation is systemic in sepsis, the cytokine response is 
overwhelming, this is known as a cytokine storm. At these concentrations, cytokines are 
harmful, initially promoting fever in patients and mediating direct organ dysfunction 
(Chaudhry et al., 2013; Markel et al., 2007). 
 
Circulation of both proinflammatory and anti-inflammatory cytokines increases in sepsis. The 
main proinflammatory cytokines increased include IL-6, IL-8, IL-12, IL-18, IFN-γ, TNF-α and IL-
1β. TNF-α and IL-1β responses are much greater in sepsis when compared to systemic 
inflammation resulting from a non-infection associated injury, both are associated with 
cardiac dysfunction in sepsis. Due to their ability to work synergistically, low concentrations 
are effective. Other proinflammatory cytokines present are responsible for recruitment of 
inflammatory cells, further promoting inflammation (Chaudhry et al., 2013; Jerin et al., 2003; 
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A. Kumar et al., 1996; Mera et al., 2011). Due to the excessive inflammation which occurs in 
sepsis, anti-inflammatory therapies targeting proinflammatory cytokines, particularly TNF-α 
and IL-1β, have been investigated as possible treatments. Anti-TNF-α has only been able to 
induce a modest reduction in the mortality of patients with sepsis. The results of combined 
anti-inflammatory therapies targeting both TNF-α and IL-1β activity is dependent on patient 
mortality risk, only effective in patients with a high risk of death (Eichacker et al., 2002; P. 
Qiu et al., 2013). 
 
IL-10 is an important anti-inflammatory cytokine elevated in septic serum (A. Kumar et al., 
1996). IL-10 is a known deactivator of cytokine synthesis, able to suppress production of 
proinflammatory cytokines including IL-1, IL-6, IL-8, IL-12 and TNF-α (Chaudhry et al., 2013; 
Mera et al., 2011). IL-4 and IL-13 release is also greater in sepsis (Fernandez et al., 2013; A. 
Kumar et al., 1996). IL-13 is able to inhibit cytokine expression and production including that 
of TNF-α. IL-4 and IL-13 have similar anti-inflammatory effects and the role of both unclear in 
sepsis as neither appears to be involved in host defence response against infection 
(Chaudhry et al., 2013). 
 
While the concentration of many cytokines is unchanged regardless of the stage and severity 
of sepsis, some relative cytokine concentrations can be used as indicators of sepsis severity 
and prognosis. A reduction in circulating IL-6 is an indicator of good prognosis, while high IL-
10 levels are associated with increased mortality (Chaudhry et al., 2013). There are 
conflicting reports on which stage of sepsis is indicated by high IL-10; Fernandez et al. (2013) 
found high IL-10 in patients with septic shock, while Mera et al. (2011) reported high levels 
of IL-10 in the serum of patients with less severe sepsis. Septic shock is also denoted by 
elevated levels of IL-6 and IL-13 (Fernandez et al., 2013). 
 
Severe sepsis presents with low IL-2 and high IL-8 in septic serum. The persistent high levels 
of certain cytokines such as IL-1β, IL-6, IL-8, IL-12, IFN-γ and IL-18 correlate with elevated risk 
of death. IL-8 is further elevated in non-survivors (Mera et al., 2011). This large elevation in 
IL-8 as an indicator of death was confirmed in a larger cohort of patients with post-surgical 
associated sepsis by Fernandez et al. (2013).  
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In some patients with sepsis, death occurs from secondary causes which are not associated 
with hyper-inflammation. This suggests that in some individuals, defective cytokine 
production follows the excessive inflammatory phase in severe sepsis. This may also occur as 
a result of excess anti-inflammatory cytokine production, leading to compensatory anti-
inflammatory response syndrome. The immunosuppression in these individuals may allow 
the initial infection causing sepsis to thrive and make the patient vulnerable to further 
infection from opportunistic pathogens (Boomer et al., 2011; Mannick et al., 2001). 
 
 
1.3.5.1  The role of cytokines in myocardial depression in sepsis 
 
Cytokines are known to be elevated in sepsis as discussed above, in section 1.3.5. This has 
been directly associated with myocardial depression. The diastolic and systolic features of 
myocardial depression were discussed in sections 1.1.6.1 and 1.1.6.2. An important aspect of 
myocardial depression is a reduced LVEF. In sepsis, this decrease in LVEF, and on occasion 
also reduced RVEF, is due to reduced myocardial contractility. This contributes to decreased 
cardiac output and increased end-diastolic volume (Court et al., 2002; Kimchi et al., 1984; 
Ognibene et al., 1988; Parker et al., 1984; Parrillo, 1989). As per section 1.1.8.2, TNF-α has 
been shown to reduce the ventricular ejection fraction in patients and animal models 
(Muller-Werdan et al., 1998; Vincent et al., 1992). TNF-α and IL-1β exposure has also been 
shown to induce an ultimate reduction in cardiac work and coronary flow. The latter would 
be expected with a reduced LVEF (Schulz et al., 1995). 
 
Impaired relaxation and loss of compliance has also been identified in many patients with 
septic shock (Bouhemad et al., 2008; Meierhenrich et al., 2008). These may also be 
associated with TNF-α and IL-1β exposure. The known cellular effects of these cytokines, 
particularly altered ECC, shall be discussed further in section 1.3.7. 
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1.3.6  Cytokines in heart failure 
 
Cytokines are released to aid recovery from myocardial injury, however they can also play an 
important role in the development and progression of heart failure due to the resulting 
inflammatory response (D. Chen et al., 2008; Gullestad et al., 2012; Monden et al., 2007). In 
both HF with both reduced and preserved EF the circulating concentrations of 
proinflammatory cytokines TNF-α, IL-1β and IL-6 are elevated (Gullestad et al., 2012). Heart 
failure with reduced EF can be induced by overexpression of these cytokines, as well as IL-2, 
can also induce biventricular dilatation. This cardiac depression can result in premature 
death (Blum & Miller, 2001; Bryant et al., 1998). 
 
TNF-α and IL-6 contribute to the development of chronic heart failure and acute 
decompensated heart failure with preserved EF. While TNF-α is generally high in stable heart 
failure patients, IL-6 is elevated further in acutely decompensated heart failure. TNF-α and 
IL-6 are therefore useful biomarkers for severity and outcome (Abernethy et al., 2018; D. 
Chen et al., 2008). 
 
Injury from myocardial infarction (MI) increases the risk heart failure development. ROS and 
danger-associated molecular patterns (DAMPs) are released due to ischemia-reperfusion 
injury and mechanical stress in MI. Post-MI, both ROS and DAMPs promote cytokine release 
including TNF-α, IL-1β and IL-6 in the myocardium (Gullestad et al., 2012; Monden et al., 
2007). 
 
Following a cardiac event such as MI, ischemia or another form of myocardial injury, TNF-α 
levels rise and bind to available soluble TNF receptors. The proportion of these receptors 
circulating changes in heart failure and can be used to determine prognosis (Gullestad et al., 
2012; Kelly et al., 2010; Monden et al., 2007). TNF-α binding to TNFR1 promotes cardiac 
remodelling, this is a mechanism by which the heart can adapt to decreased cardiac output, 
as is partially accomplished in HF with preserved EF. If this fails however, the ability to 
provide adequate cardiac output may decrease further, as in HF with reduced EF (Mann & 
Young, 1994; Monden et al., 2007). Different types of cardiac remodelling occur in HF, wall 
thickness is increased in HF with preserved EF, while apoptosis and fibrosis are up-regulated 
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in HF with reduced EF (Gullestad et al., 2012). Interaction with the TNFR1 also can be 
detrimental to recovery, inducing reversible contractile dysfunction and dilation, particularly 
in the left ventricle, associated with and time and TNF-α concentration dependant reduction 
in systolic Ca2+. This receptor also activates signalling pathways further elevating production 
of other proinflammatory cytokines (D. Chen et al., 2008; Kelly et al., 2010; Monden et al., 
2007; Yokoyama et al., 1993). This effect on ventricular dysfunction is lessened with TNF-α 
bound to TNFR2, encouraging improved myocardial function, decreased apoptosis and 
reduced damaging cardiac remodelling, aiding both survival and recovery (Kelly et al., 2010; 
Monden et al., 2007). 
 
Anti-inflammatory cytokines also have important roles in HF. IL-10 contributes to diastolic 
dysfunction in through promoting biventricular dilatation (Blum & Miller, 2001). The 
presence of transforming growth factor-β1 (TGF-β1) has both positive and negative effects 
on HF.  TGF-β1 can prevent or reduce the cardio-depressant effect of proinflammatory 
cytokines, including TNF-α and IL-1β, on a dose dependent basis. TGF-β can however also 
encourage fibrosis and ECM remodelling (Gullestad et al., 2012; A. Kumar et al., 2007). 
 
The dual function of proinflammatory cytokines in both supporting and worsening health, 
may suggest why there has been a mixed response to anti-cytokine treatments such as TNF-
α and IL-1β inhibitors in treating myocarditis and systemic inflammation (Eichacker et al., 
2002; Monden et al., 2007; P. Qiu et al., 2013). 
 
 
1.3.7  Role of cytokines in perturbed EC coupling 
 
Given that cytokines – especially TNF-α and IL-1β – are associated with negative inotropy 
and diastolic dysfunction in the whole heart, it is important to determine how these 
cytokines effect Ca2+ handling and contractility on a cellular level. 
 
While in sepsis cardiac dysfunction can occur in both ventricles, LV dysfunction is much 
greater than in the RV in myocardial depression. In response to endotoxin release from 
pathogens in sepsis, cytokine levels and cytokine receptor expression increases in the heart. 
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The distribution of cytokines and their receptors in tissues varies, as such the proportion of 
TNF-α release is greater in the RV (Markel et al., 2007; Oppenheim et al., 1989). Markel et al. 
(2007) demonstrated that the RV may be more resistant to TNFR1 signalling than the LV. The 
TNFR1 resistance and elevated TNF-α levels and TNFR2 expression promote TNFR2 
signalling, driving recovery through activation of protective signalling cascades (Monden et 
al., 2007). 
 
 
1.3.7.1  Global [Ca2+] and contractility 
 
Greensmith and Nirmalan (2013) studied the effect of TNF-α on rat ventricular myocytes. 
They found that 50 ng/ml TNF-α decreased Ca2+ transient amplitude by 31 % and 
contractility by 19 %. This provides a cellular basis for systolic dysfunction in myocardial 
depression in sepsis. A myocardial depressant effect has also been observed in rat 
ventricular myocytes which were exposed to serum containing elevated proinflammatory 
cytokines, including both TNF-α and IL-1β. The serum induced a 20 % decrease in Ca2+ 
transient amplitude resulting in reduced myocyte shortening (Fernandez-Sada et al., 2017). 
While the relative decrease in Ca2+ transient amplitude and contractility is not to the same 
magnitude as found by Greensmith and Nirmalan (2013), the serum used contained a lower 
concentration of TNF-α, alongside other components such as leptin. 
 
IL-1β is also proven to have a negative inotropic effect on rat ventricular myocytes. Following 
a 30 minute incubation with 10 ng/ml, IL-1β Ca2+ amplitude was reduced and contractility 
was depressed (Radin et al., 2008).  Leptin was also high in the serum used by Fernandez-
Sada et al. (2017), while leptin has a small negative inotropic effect on its own, it has been 
shown to interact with IL-1β preventing IL-1β induced myocardial depression (Radin et al., 
2008). 
 
TNF-α and IL-1β have been found to work synergistically in rat ventricular myocytes. With 
prolonged (3 hour) simultaneous application, TNF-α (0.05 ng/ml) and IL-1β (2 ng/ml) induce 
a 40 % decrease in Ca2+ transient amplitude and 46 % reduction is cell shortening (Duncan, 
Yang, Hopkins, Steele, & Harrison, 2010). 
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Less evidence has been identified which could provide a cellular basis for diastolic 
dysfunction in the heart. Both Greensmith and Nirmalan (2013) and Duncan et al. (2010) 
found no change to resting cell length, with TNF-α, or combined TNF-α and IL-1β treatment. 
 
 
1.3.7.2  SR Ca2+ content and CICR 
 
Negative inotropy can be caused by a reduction in Ca2+ influx. Both TNF-α application and 
prolonged (24 hour) IL-1β exposure leads to rapid inactivation of the LTCC and decreased in 
L-type Ca2+ current density, reducing Ca2+ influx (El Khoury, Mathieu, & Fiset, 2014; 
Greensmith & Nirmalan, 2013). The impact of IL-1β on LTCC was suggested to be a 
combination of ROS signalling and protein kinase C (PKC) activation (El Khoury et al., 2014). 
In both cases, the cytokine-mediated decrease in Ca2+ influx would also contribute to 
myocardial depression, through its impact on CICR.  
 
In work by Greensmith and Nirmalan (2013) the decrease in Ca2+ transient amplitude was 
attributed to a 14 % decrease in SR Ca2+ content. This is contrary to work by Jha et al. (1993) 
who reported that SR Ca2+ content was unaffected in dog hearts perfused with E.coli-related 
septic serum.  
 
There is also evidence that RyR Po may be altered with these cytokines, which would provide 
a possible mechanism for decreased SR Ca2+ content Spontaneous Ca2+ release from the SR 
has been identified in a rat model of sepsis (X. Zhu et al., 2005). In rat myocytes Duncan et al. 
(2010) demonstrated that this SR Ca2+ leak can be induced through synergistic treatment 
with TNF-α and IL-1β. These cytokines increase the frequency of Ca2+ sparks by more than 
four-fold. During electric stimulation, the distribution of Ca2+ release was uneven across the 
myocyte due to depolarisation by NCX-mediated Ca2+ removal. IL-1β also individually 
increases spontaneous Ca2+ release from the SR in mice ventricular myocytes (Monnerat et 
al., 2016). While this evidence supports that cytokines, particularly TNF-α and IL-1β, cause SR 
Ca2+ leak, another study by Jha et al. (1993) found that Ca2+ release from the SR was not 
impaired by exposure to septic serum. 
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Proinflammatory cytokine exposure, including to TNF-α and IL-1β, does not only induce 
myocardial depressant effects. The impaired Ca2+ handling can also be a precursor for 
ventricular arrhythmia in those with existing medical conditions, such as in patients with 
sepsis, where the prevalence of ventricular arrhythmias increases (Fernandez-Sada et al., 
2017; Shahreyar et al., 2018). Both TNF-α and IL-1β have been associated with increased 
frequency of spontaneous waves due to propagation of Ca2+ sparks and thus increases the 
likelihood of arrhythmia development (Duncan et al., 2010; Monnerat et al., 2016; Shahreyar 
et al., 2018). 
 
The effects of TNF-α and IL-1β on RyR Po shall be discussed and investigated further in 
chapter 5. 
 
 
1.3.7.3  Ca2+ removal mechanisms and relaxation 
 
Both Greensmith and Nirmalan (2013) and Duncan et al. (2010) found no recorded change in 
diastolic function, including rate of Ca2+ decay or rate of relaxation in response to application 
of TNF-α alone, or with IL-1β. This suggests that the combined Ca2+ removal mechanisms – 
SERCA and NCX – were unaffected by these cytokine treatments. These studies could 
therefore not yet provide a cellular basis to account for diastolic dysfunction also present in 
myocardial depression. 
 
Fernandez-Sada et al. (2017) did find diastolic dysfunction in the form of increased Ca2+ 
decay time and subsequent myocyte relaxation in response to septic serum. It is possible 
that another component of the serum besides TNF-α, possibly IL-1β, may be responsible for 
the increased relaxation time, this warrants further investigation. Radin et al. (2008) 
confirmed that IL-1β could reduce rate of Ca2+ removal and induce prolonged relaxation. 
Bouhemad et al. (2008) found that in ~41 % patients with septic shock, expression of the 
cytokines; TNF-α, IL-8 and IL-10, and the cardiac contractile regulatory protein TnI were 
elevated. This was associated with reversible diastolic dysfunction through impaired LV 
relaxation, as well as systolic dysfunction, especially in individuals where TnI expression had 
increased by >50 %. This may also allude to a possible mechanism for change in myofilament 
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sensitivity to Ca2+. While some studies have investigated the effects of these cytokines on 
myofilament sensitivity to Ca2+, this shall be discussed further in section 5.1.3. 
 
 
1.4  Main aims 
 
While current evidence supports that TNF-α and IL-1β contribute to myocardial depression 
through altered Ca2+ handling, the reported changes to Ca2+ handling are variable. Many of 
these studies have investigated the effects of intact septic serum or the combined effects of 
multiple cytokines on ventricular myocytes, the numerous cytokines or other components 
present make it difficult to distinguish the individual effects of TNF-α and IL-1β.  
 
Of the studies which have attempted to characterise the individual effects of these cytokines 
on intracellular Ca2+ handling, many have not used an integrative approach, for instance by 
not measuring the simultaneous effects of these cytokines on contractility. The majority of 
previous work has also been carried out in small mammal models, and as such may not be 
entirely representative of the condition in large mammals such as humans. This work aims to 
initially investigate whether the findings of Greensmith and Nirmalan (2013) are 
reproducible in a large mammal model. The effect of IL-1β on Ca2+ handling in large mammal 
left ventricular myocytes will also be investigated, as few studies have looked at the 
individual effects of IL-1β, in this way. 
 
The 1st beat increase in systolic Ca2+ amplitude with application of TNF-α previously 
acknowledged by Greensmith and Nirmalan (2013) will also be investigated further, 
alongside a more thorough, robust determination of the individual effects of both TNF-α and 
IL-1β on RyR Po. 
 
Whilst some work has explored the effects of these cytokines on myofilament sensitivity to 
Ca2+, once again many used small mammal models, and very few studied the effects of IL-1β 
alone. As such, the effects of both cytokines on myofilament sensitivity to Ca2+ shall be 
characterised in a large mammal model. A better understanding of the impact of elevated 
TNF-α and IL-1β in sepsis on all aspects of ECC in ventricular cardiac myocytes may aid 
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treatment of myocardial depression. This may also be preventative of further damage to 
other organs and systems. 
 
In heart failure, cytokines – including TNF-α – are also elevated and in some cases aspects of 
myocardial depression feature in heart failure patients. This study shall also investigate the 
effects of TNF-α in cells isolated from a large mammal heart failure model and a heart failure 
5 week recovery model, and whether the magnitude of these changes differs from the 
young, healthy model. This could potentially indicate whether heart failure patients, or those 
in recovery, are more or less susceptible to the myocardial depressant effects of TNF-α. The 
study may also reveal if the effects of TNF-α have already been saturated due to the prior 
effects on Ca2+ handling and contractility in heart failure and possible previous exposure to 
high TNF-α serum concentrations. 
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Chapter 2 
 
General methodology 
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2.1  Primary myocyte isolation and preparation 
 
2.1.1  Animals, tissue preparation and ethics 
 
Mid-myocardial left ventricular myocytes and tissue were isolated from young control sheep 
at approximately 18 months old and in good health at the University of Manchester. Other 
experimental ovine models used were a tachypaced induced heart failure model and a heart 
failure recovery model, in which tachypacy was ceased 5 weeks prior to sacrifice, to enable 
potential recovery to occur.  
 
All surgical procedures involved in the development of the heart failure and heart failure 
recovery models were carried out under analgesia (meloxicam, 0.5 mg/kg) and anaesthesia 
(isoflurane, 1-4 % in oxygen). The antibiotic (enrofloxacin 2.5 mg/kg) was also administered 
to prevent infection.  The surgical procedure involved implantation of a pacemaker in the 
right ventricle, this shall be discussed further in section 6.2.1. 
 
 
2.1.2  Ethics 
 
All procedures accord with the Animals (Scientific Procedures) Act, UK, 1986 and Directive 
2010/63/EU of the European Parliament (Home Office, 1986). Ethical approval was also 
sought from both the University of Salford ethical review board. All procedures were carried 
out at The University of Manchester and as such were also approved by The University of 
Manchester Welfare and Ethical Review Board. 
 
 
2.1.3  Isolation of sheep left ventricular myocytes 
 
Sheep were given heparin (10-20 ml) intravenously and then killed by lethal injection of 
sodium pentobarbitone (200 mg/kg). The administration of heparin was required to prevent 
formation of blood clots. Cardiothoracic incisions were made to gain access to the heart and 
enable rapid removal. The heart was then rinsed and briefly stored in Ca2+ free isolation 
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solution (see table 2-1 for components) to remove excess blood and prevent tissue 
deterioration. 
 
The ventricles were cut away from the rest of the heart to allow sole isolation of ventricular 
myocytes. The left ventricle was then cannulated via the coronary artery onto Langendorff 
apparatus, as shown in Fig 2-1. The tissue of the left ventricle was perfused with Ca2+ free 
isolation solution for 10 minutes removing blood from the tissue, and enabling control over 
components present during the initial heart isolation and subsequent digestion. This also 
serves to prevent clots and thus maximising the perfused region of the left ventricle. Flow 
rate of solution and pressure within tubing and circulatory vessels was regulated with a 
peristaltic pump (Fig 2-1). 
 
To facilitate cell disassociation from the tissue, collagenase type I (Worthington) (0.096-
0.108 mg/ml) and protease (Sigma) (~ 0.022 mg/ml) were then added to the perfusate in 
order to digest the collagen fibres and other extracellular matrix (ECM) proteins involved in 
cell adhesion. Enzyme concentration and perfusion times (typically within a range of 5-15 
minutes) were adjusted to optimise cell quality and yield. Tissue digestion was determined 
by several observations; increased tissue translucency and viscosity of perfusate. All 
solutions used were preheated to 37°C in a water bath, which is within the optimal 
temperature window for the digestive enzymes used.  
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Figure 2-1. Langendorff apparatus set up for myocyte isolation. (a) heat exchanger (b) cork 
sealing the coil within the heat exchanger. (c) peristaltic pump. (d) multi-way taps. (e) 
cannula. (f) cannulated sheep ventricle. (g) Ca2+ free isolation solution. (h) low Ca2+ taurine 
solution. (i) water bath. 
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Table 2-1 – Components of the Ca2+ free isolation 
solution 
Ingredients Concentration (mM) 
BDM 10 
NaCl 133 
HEPES 10 
Glucose 11.1 
BSA 7.5 
KCl 4 
MgSO4 1.2 
NaH2PO4 1.2 
The pH of was adjusted to 7.34 at room temperature 
(~22°C) through addition of either 1 M NaOH or 1 M 
HCl prior to volumizing. 
All components sourced from Sigma-Aldrich or Fisher 
 
 
Following digestion, the perfusate was switched to a low Ca2+ (0.1 mM) taurine (50 mM) 
containing solution for 20 minutes. This served as a wash to remove residual enzyme. As 
described in table 2-3, taurine supports restoration of contractile function with the 
reintroduction of Ca2+ and prevent Ca2+ overload. The digested area of the left ventricle was 
then dissected, and the epicardium and endocardium were removed. Remaining tissue was 
minced and agitated using a pasteur pipette in fresh taurine solution, then filtered through a 
net mesh (200 µm pores).  
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Table 2-2 – Components of the low Ca2+ taurine 
perfusion solution 
Ingredients Concentration (mM) 
BDM 10 
NaCl 108 
HEPES 10 
Glucose 11.1 
BSA 7.5 
KCl 4 
MgSO4 1.2 
NaH2PO4 1.2 
Taurine 50 
CaCl2 0.1 
The pH was adjusted to 7.34 at room temperature 
(~22°C) through addition of either 1 M NaOH or 1 M HCl 
prior to volumizing. 
All components sourced from Sigma-Aldrich or Fisher 
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Table 2-3 – Importance of solution components to cell survival during isolation 
Component Importance 
Ca2+ The absence of Ca2+ is known to weaken cell adhesion, 
promoting the release of myocytes during enzymatic 
digestion (Dolara, Agresti, Giotti, & Pasquini, 1973; Vendome 
et al., 2011; Yates & Dhalla, 1975). Ca2+ increases collagenase 
activity,  therefore in its absence there is a reduced the risk of 
over-digestion (Head & Yankeelov, 1976). Ca2+ must be 
reintroduced promptly following digestion, as prolonged Ca2+ 
free perfusion contributes to structural damage and loss of 
function (Yates & Dhalla, 1975). 
BDM Cardioprotective against the effects of hypoxia and ischemia. 
Inhibits contraction by ~82 %, delaying hyper-contracture 
during myocyte isolation (Zimmermann et al., 1996). 
Enhances the yield of viable, Ca2+ tolerant cells, prevents bleb 
formation and slow the rate of degradation (Kivisto et al., 
1995; Thum & Borlak, 2001). Not included in experimental 
solution due to its negative inotropic nature. 
Taurine Slows the rate of Ca2+ release from myocytes when perfused 
with Ca2+ free solution. Helps maintain osmotic pressure and 
prevents Ca2+ overload, promoting contractile recovery upon 
Ca2+ reperfusion (Hansen, Andersen, Birkedal, Cornett, & 
Wibrand, 2006; Suleiman, Rodrigo, & Chapman, 1992). 
BSA Prevents tissue damage through oedema during isolation, by 
maintaining colloid osmotic pressure (Suelter & DeLuca, 
1983). 
HEPES Used to buffer pH. This has a higher efficiency than other 
traditionally used bicarbonate buffers due to its reduced 
influence from fluctuations in carbon dioxide from 
metabolism (Baicu & Taylor, 2002; Good et al., 1966). 
Glucose Provides an energy source to enable metabolism, thus 
extending the survival of the isolated myocytes (Locke, 1895). 
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2.1.4  Myocyte storage and loading with Ca2+ indicators 
 
Freshly isolated cells were viewed at 40 x magnification using oil immersion. Good quality, 
viable cells were identified by their characteristic morphological features; a distinctive rod 
shape and striated structure. Dead or non-viable cells were identified by their round shape 
due to hyper-contracture (Kivisto et al., 1995). Cells were suspended in fresh solution, 
allowing them to be diluted or concentrated, dependent on the yield of viable cells. 
 
Prior to experimentation, cells were stored at room temperature and loaded in an 
intermediate solution, gradually elevating the Ca2+ concentration to that of the experimental 
solution in under to prevent Ca2+overload, which could result in cellular damage. In the 
majority of experiments the desired Ca2+ was 1.8 mM, and therefore cells were stored in a 
(50:50) taurine:Tyrodes solution (approximately 0.95 mM Ca2+).  
 
Preparation of the stock solution for the Ca2+ indicator, Fura-2, was carried out by a 
reconstituting 1 mg of desiccated Fura-2 in its cell-permeant acetoxymethyl (AM) ester form 
(Thermofisher) in pluronic F-127 (20 % solution in DMSO). The stock was stored in the dark 
at -20°C for use within the following month. 
 
An alloquot of cells suspended in the afore-mentioned taurine:Tyrodes 1:1 storage solution 
(3-4 ml) were loaded with Fura-2-AM (final concentration 0.1 mM) for 10 minutes. Loading 
was effectively stopped by addition of excess solution. These cells were left for at least ~25 
min to allow de-esterification of Fura-2. The attachment of AM ester to the Fura-2 
neutralises the indicators charge allowing intracellular loading through passive diffusion 
across the membrane. Esterases present in the cytoplasm cleave the AM esters by hydrolysis 
preventing the now charged, hydrophilic fluorophore from leaving the cell in its 
pentacarboxylate form. Loading was ceased by diluting the cells further, thus reducing the 
indicator concentration (Takahashi, Camacho, Lechleiter, & Herman, 1999). Unlike some 
other fluorphores Fura-2-AM is fluorescent prior to cleaving of the AM, as such cells were re-
suspended to remove residual Fura-2. Throughout and after loading, the vial of cells was 
surrounded by foil to prevent photobleaching from exposure to light. 
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2.2  General procedures and equipment 
 
2.2.1  Standard experimental solution 
 
Tyrode’s solution is an isotonic solution developed by Maurice Tyrode, following the 
adaption of Ringer’s solutions to the mammalian heart by Locke (1895). Unlike its 
predecessors, Tyrodes’s solution contains magnesium. In the standard experimental solution 
(table 2-4) and all other experimental solutions used in this study, MgCl2 concentration was 
kept constant as variability in magnesium concentration can impact Fura-2 emission 
intensity (Grynkiewicz, Poenie, & Tsien, 1985).  
 
 
Table 2-4 – Components of standard experimental solution 
(Normal Tyrode’s) 
Ingredients Concentration (mM) 
NaCl 140 
HEPES 10 
Glucose 10 
BSA 15 
KCl 4 
MgCl2 1 
CaCl2 1.8 
Probenecid (dissolved in 
NaOH) 
2 
The pH was adjusted to 7.34 at room temperature (~22°C) 
through addition of either 1 M NaOH or 1 M HCl prior to 
volumising 
All components sourced from Sigma-Aldrich, Fisher or Fluka 
 
 
Tyrode’s solution was stored for up to 5 days at 4 °C, without CaCl2 and glucose to reduce 
the risk of bacterial growth. Both were added on the day of use. While the solutions used in 
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myocyte isolation contained BSA to maintain colloid osmotic pressure (as described in table 
2-3), a higher concentration of BSA (0.1 %, 15 mM) was added to experimental solutions to 
serve an additional purpose. BSA adsorption to the inner surface of tubing, through either 
priming tubing with BSA or addition to carrier solutions, is a traditional and effective method 
of preventing non-specific interactions between the surface and other proteins in solution 
(Suelter & DeLuca, 1983).  
 
While Fura-2 in its penta-carboxylate form is unable to passively diffuse across the 
membrane, Fura-2 is an organic anion, and thus efflux can be carried out via organic anion 
transporters. The rate of indicator secretion of from the cell is slower at temperatures below 
37 °C. While loaded cells were stored at room temperature (~22 °C) prior to use, during 
experiments solutions are heated to 37 °C in order to remain physiologically relevant.  
Through a similar mechanism the indicator can also accumulate in intracellular 
compartments such as vesicles and organelles, with the potential to lead to cytotoxicity. 
Both Fura-2 efflux and accumulation can disrupt the fluorescent signal.  A known inhibitor of 
organic anion transport is probenecid (Di Virgilio, Steinberg, & Silverstein, 1989). Due to the 
low solubility of probenecid, it was first dissolved in a small volume NaOH. pH adjustment 
was carried out after probenecid was added to the standard experimental (Tyrode’s) 
solution due to the alkaline nature of NaOH. As cells were loaded in taurine:Tyrode’s 
solution 1:1, ~1 mM probenecid was present, this was advantageous as probenecid prevents 
clearance of Fura-2 from the cell. The de-esterification process and intracellular Ca2+ 
concentration, both at rest and when field stimulated, are unaffected by the presence of 
probenecid (Di Virgilio, Steinberg, Swanson, & Silverstein, 1988). 
 
 
2.2.2   Preparation of cytokine solutions  
 
Human, recombinant TNF-α and IL-1β (both obtained from Sigma-Aldrich) were 
reconstituted in 0.1 % BSA in phosphate-buffered saline (PBS) and stored in aliquots with a 
stock concentration of 100 µg/ml, at -20 °C. The BSA was added to prevent cytokine 
adsorption to tubing, which would otherwise result in a decreased final concentration 
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reaching the cell. This is especially important given the low concentrations being used of 
both TNF-α and IL-1β in experiments (50 ng/ml). 
 
 
2.2.3  Pre-experimental preparations 
 
Following the loading protocol, cells were allowed to settle in a cell bath for ~10 minutes. 
Cells were viewed again, using an epi-fluorescent inverted microscope under x 40 
magnification. Immersion oil was used to improve resolution. The previously described 
characteristic appearance of viable myocytes was used to select cells for experimentation. 
Those with a granulated appearance, evidence of a disrupted membrane, or cytoskeletal 
damage such as blebbing, were avoided. 
 
Through perfusion of the cell bath with experimental control solution and field stimulation, 
it was possible to determine whether contractile function had returned. This was especially 
important given their previous exposure to BDM. The flow through the bath also aided 
clearance of debris and dead cells. Some cells began oscillating with the reintroduction to 
Ca2+ at physiological concentrations; these cells were treated as non-viable due to their low 
tolerance to Ca2+. 
 
Once a viable cell had been identified, it was positioned into the centre of the window with 
aid of the eyepiece and the imaging provided by an Ion Optix MyoCam-S CCD camera. Blinds 
were used to isolate the single cell from nearby cells and debris, to ensure the signal 
recorded belonged solely to that cell. 
 
 
2.2.4  Control of perfusion 
 
In order for experiments to be physiologically relevant, temperature of all solutions were 
kept at 37°C. To mitigate bubble formation solutions were preheated using BubbleStop and 
the inline heating element, ThermoClampTM-1 (AutoMate Scientific). This controlled 
temperature of solutions to within 1 °C of 37 °C during experiments.  
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A ValveLink system (AutoMate Scientific) was used to control perfusion by enabling 
switching between solutions. Flow rate was controlled by (1) reservoir height and (2) the 
solution level in the reservoir. To ensure rapid solution switching the perfusion pencil was 
placed in close proximity to the cell of interest using a 3-dimensional axis mechanical 
micromanipulator (Narishige). Solution in the cell bath was removed a peristaltic pump, 
outflow rate was adjusted to match the rate of solution inflow to maintain a stable bath 
level.  
 
 
2.2.5  Measurement of intracellular calcium 
 
2.2.5.1  The fluorophores 
 
Fura-2 is a dual excitation indicator with maximum absorption peaks at 335 and 363 nm for 
maximum and minimum bound Ca2+ respectively. When bound to Ca2+ and excited at either 
wavelength Fura-2 emits at 510 nm, described as blue emission (Takahashi et al., 1999). 
Through measurement of the 510 nm emitted light in response to the both excitation 
wavelengths, two traces can be formed from, with a positive and negative response to 
increased Ca2+ respectively. The ratio between these signals is unaffected by any loss of 
signal due to reduced indicator concentration or photobleaching, unlike other non-
ratiometric fluorophores, such as Fluo-3. When using Fura-2 it is therefore possible to 
estimate intracellular Ca2+ concentration from these wavelength measurements. In addition 
to being a ratiometric indicator, Fura-2 also has a high emission intensity (Grynkiewicz et al., 
1985). 
 
 
2.2.5.2  Apparatus configuration 
 
As the equipment measures relative changes in [Ca2+], it was important to limit light from 
other sources, as such the microscope was concealed in a large case with a blackout curtain 
covering the front, and additional lights were switched off during an experiment to reduce 
the noise in the emission signal. 
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LED light sources excited the cell at both 340 and 380 nm consecutively, alternating at a 
frequency of 200 Hz regulated by Multistream Pro (Cairn). These wavelengths are routinely 
used for excitation of Fura-2. The microscope configuration and beam-path are shown in Fig 
2-2. Band-pass (BP) excitation filters for 340 and 380 nm respectively were placed in front of 
each of these LEDs. A 370 nm long-pass (LP) dichroic mirror allowed the 380 nm light beam 
to pass through, while deflecting the 340 nm light beam, causing beams to converge. 425 nm 
and 500 nm LP dichroic mirrors were used to redirect the converged 340 nm and 380 nm 
beams through the objective lens, whilst also eliminating the influence of any light from 
higher wavelengths. Once the cell had been excited at both 340 nm and 380 nm, emitted 
light at 510 nm, passed back through the objective lens and through the 500 nm LP dichroic 
mirror. A series of standard mirrors then deflect the emitted light. Blinds were used to 
isolate the cell in the field of view, preventing emitted light from the surrounding cells and 
solution from being processed. A final 600 nm LP dichroic mirror directs this into the photo 
multiplier tube (PMT). The PMT both detects and amplifies the emitted fluorescent signal. 
The emitted light from the 340 nm and 380 nm excitation waves length was separated into 2 
traces through IonWizard fluorescent acquisition (Ion Optix) software.  
 
A camera (Myocam) was used to allow the cell to be viewed in real-time, thus aiding with 
placement of the blinds and measurement of contractility (which shall be discussed further 
in section 2.2.6). To prevent this from interfering with the beam bath of the emitted light, 
white light from the microscope passed through a 700 nm LP filter, before reaching the cell. 
This then passed though the objective lens, converging with the emitted 510 nm light, and 
was redirected by the same 500 nm LP dichroic mirror and standard mirrors. As the light 
from the microscope light was now sole >700 nm, it was able to pass through the final 600 
nm LP dichroic mirror, separating the light from the emitted light and allowing its detection 
by the camera. 
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Figure 2-2. Epi-fluorescent microscope apparatus configuration. (a) 600 nm LP dichroic 
mirror. (b) 700 nm LP filter. (c) objective lens. (d) 340 nm BP excitation filter. (e) 380 nm BP 
excitation filter. (f) 370 nm LP dichroic mirror. (g) 500 nm LP dichroic mirror. (h) 425 nm LP 
dichroic mirror. (i) standard mirrors. 
 
 
2.2.5.3  Standard settings 
 
The emitted light signal was optimised in two ways. The gain determines magnitude of the 
signal amplification by the PMT, this could be adjusted however was kept fairly consistent as 
with increase in gain also amplifying background noise. Alternatively, the intensity of each 
excitation wavelength was adjusted on a cell-by-cell basis, using the dual optoled power 
supply (Cairn). This was a common adjustment as the uptake of indicator varied between 
cells. While increasing the excitation intensity will increase the light signal emitted, in excess 
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it will lead to photobleaching and loss of signal. Photobleaching occurs with all indicators 
and is proportional to light intensity and length of exposure. 
 
 
2.2.6  Measurement of contractility 
 
Changes to sarcomere length were measured as a parameter of contractility via video 
detection using an Ion Optix MyoCam-S high speed digital camera with a charge-coupled 
device (CCD). This data was acquired using the real-time by the SarcLen Sarcomere Length 
Acquisition Module (Ion Optix) integrated with the IonWizard 6.5 system. The myocyte was 
positioned to the centre of the video display and aligned so that the striations fell vertically. 
If necessary, image gain and offset could be altered to increase contrast to view striations 
clearly. A box was manually placed around a series of striations, or sarcomeres (minimum of 
7), on the screen. This outlined region determined where sarcomere length was measured 
from and this produced a density trace. As further sarcomeres entered the identified region 
of interest during contraction, to reduce the impact of inconsistency at the region edges the 
central sarcomeres contributed more to the sarcomere length estimate. The peak produced 
in the density trace was used to indicate sarcomere length as sarcomeres per pixel, which 
was automatically converted to pixels per sarcomere by the software. A lower boundary 
power spectrum bar could be used to eliminate noise prior to the peak.  
 
 
2.2.7  Field stimulation of ventricular myocytes 
 
Cells were stimulated using a DS2A constant voltage isolate stimulator (Digitimer ltd). The 
voltage and polarity were controlled by a Constant Voltage Isolated Stimulator (model DS2A, 
Only the minimum voltage required to produce excitation was used; typically between 40 – 
70 V, with a pulse width of 10 ms. A Train/delay generator (model DG2A, Digitimer ltd) was 
used to control the frequency at which cells were paced. The standard pacing frequency 
used was 0.5 Hz (unless otherwise stated); the pacing frequency was adjusted for specialised 
experiments. 
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2.3  Data analysis 
 
2.3.1  Measurement of diastolic and systolic Ca2+ 
 
To create a representative Ca2+ transient of steady state and limit the influence of any noise 
in the signal, 5 Ca2+ transients at steady state were averaged to produce a mean Ca2+ 
transient. Once exported from IonWizard (Ion Optix) software, analysis of mean Ca2+ 
transient was carried out using Ca Multi; a excel based program developed and described by 
Greensmith (2014). Following each experiment, the cell was moved out of the imaging 
window to record background signal from the surrounding medium. A trace region from this 
‘no cell’ (F0) state was also exported and input into the Ca Multi program. Both the 340 and 
380 nm ‘no cell’ signals were averaged, and the resulting value was subtracted from the 
remaining fluorescent traces respectively. The ratio between the 340 and 380 nm 
wavelengths was calculated 340/380, indicating proportional change in [Ca2+]i (Grynkiewicz 
et al., 1985). Cursors controlled via scroll bars were used to define the resting and peak 
fluorescent signal, from this the Ca2+ amplitude could be calculated (Greensmith, 2014). 
 
 
2.3.2  Measurement of sarcomere shortening 
 
In order to measure diastolic and systolic contractility, the corresponding 5 sarcomere 
sweeps at each steady state were averaged and exported in the same manner as described 
for the fluorescent data in section 2.3.1. Resting sarcomere length and peak shortening were 
measured using the Ca Multi program (Greensmith, 2014), which when combined allowed 
measurement of the amplitude of contraction (or systolic sarcomere shortening). This 
required used of cursors to identify the maximum or minimum sarcomere lengths, 
respectively, and a negative deflection was used given that the sarcomere signal moves in 
the opposite direction to the Ca2+ signal. 
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2.3.3  Measurement of rate of sarcomere relaxation and shortening  
 
The rates of sarcomere relaxation and shortening were determined by the time taken to 50 
% of the total incline or decline in sarcomere length respectively. This is otherwise referred 
to as the 50 % decay time. This was calculated through use of the excel-based program ‘APD 
single 2010 v2’. This also required manual indication of the maximum or minimum 
sarcomere lengths, using cursors. 
 
 
2.3.4  Measurement of rate of Ca2+ removal 
 
Rate of Ca2+ removal was measured based on the single exponential rate constant (RC) of 
decay of the representative mean Ca2+ transient. The RC of a mean Ca2+ transient at steady 
state was termed ksys, referring to systolic Ca
2+ removal and thus the total rate of Ca2+ 
removal from the sarcoplasm via all mechanisms combined. As caffeine effectively inhibits 
SERCA, Ca2+ decay (kcaff) following caffeine application is primarily due to removal by NCX. 
Through subtracting kcaff from ksys, the rate of SR Ca
2+ uptake and thus SERCA activity (kSERCA) 
can be measured. The 90-10 % of Ca2+ decay was measured – as described in respect to rate 
of relaxation in section 2.3.3 – as an alternative way of measuring the rate of change in the 
fluorescent signal and thus rate of Ca2+ removal. 
 
 
2.3.5  Statistics 
 
Following data extraction and primary analysis, raw data was compiled into an Excel 
(Microsoft) spreadsheet. For each parameter recorded, data was also normalised against 
that of the control steady state.  Data were statistically analysed using SigmaPlot 12.5 (Systat 
Software Inc). The statistical tests used were dependent on the experiment. In the majority 
of experiments, a one-way ANOVA was used to compare the parameters at steady state 
during the control period, with cytokine treatment and during washout. A one-way ANOVA 
was also used to allow comparisons between the experimental models. In the experiments 
involving induced Ca2+ waves, measurements were taken from set time points, as such a 
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one-way repeated measures ANOVA was used to test significance. As per chapter 5, in order 
to compare the effects different Ca2+ concentrations on sarcomere length in untreated and 
cytokine treated cells, a two-way ANOVA was used. Any additional statistical tests used will 
be stated in their respective chapters. The ‘n’ provided refers to the total number of 
experiments carried out, however these cells were isolated from multiple animals. The 
number of animals used will also be provided in the figure legends. 
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Chapter 3 
 
The effects of TNF-α and IL-1β on Ca2+ handling and 
contractility in sheep left ventricular myocytes 
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3.1   Introduction 
 
As previously discussed in section 1.1.8.2, it is commonly accepted that the proinflammatory 
cytokines TNF-α and IL-1β are myocardial depressant substances. Both are known to have 
elevated serum concentrations in inflammatory conditions including sepsis (Muller-Werdan 
et al., 1998; Odeh, 1993; Radin et al., 2008; Vincent et al., 1992). However, the cellular basis 
of how TNF-α and IL-1β induce myocardial depression is not fully understood. Much 
evidence suggests they act by altering intracellular Ca2+ handling (as described in section 
1.3.7), though here too, the precise mechanisms remain unclear. 
 
Many previous studies have investigated the synergistic effect of both TNF-α and IL-1β  
(Duncan et al., 2010; Schulz et al., 1995), or the effect of septic serum containing TNF-α and 
IL-1β in addition to other cytokines (Fernandez-Sada et al., 2017; Jha et al., 1993). Common 
observations included loss of left ventricular contractile force and – in whole heart studies – 
reduced cardiac output (Jha et al., 1993; Schulz et al., 1995; Vincent et al., 1992). The effect 
on SR Ca2+ content is unclear, as Jha et al. (1993) recorded no change with septic serum, 
whilst Duncan et al. (2010) found evidence of increased diastolic SR Ca2+ release with 
combined TNF-α and IL-1β treatment. 
 
While these previous studies have contributed to the understanding of the overall effect of 
cytokines in sepsis, they have been unable to determine the individual impact of TNF-α and 
IL-1β. Of those studies that have investigated the individual effects of these cytokines, many 
have not taken an integrative cellular approach. For example, many have only looked at 
certain aspects of ECC in isolation. While highly reductionist, this does not take into account 
the fact that ECC is a dynamic process and highly dependent on the interaction of all sub-
cellular mechanisms (El Khoury et al., 2014; Trafford, Diaz, O'Neill, & Eisner, 2002). 
 
Some limited studies have used an integrative approach to study the effect of TNF-α and IL-
1β on Ca2+ and contractility dynamics simultaneously. Greensmith and Nirmalan (2013) 
performed this analysis for TNF-α and Radin et al. (2008) for IL-1β. Studies such as these 
have considerably advanced our understanding of the cellular basis of cytokine induced 
myocardial depression. For example, Greensmith and Nirmalan (2013) demonstrated that 
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TNF-α decreased SR Ca2+ content, leading to reduced systolic Ca2+ thence contractility. 
Interestingly, no alterations to diastolic dysfunction were observed. Radin et al. (2008) found 
that IL-1β also decreased cell shortening due to a reduction in systolic Ca2+. While the study 
did not the effect of IL-1β on SR Ca2+ content, they demonstrated that IL-1β reduced the rate 
of Ca2+ removal and cell relaxation. However, both studies suffer the limitation that a small 
mammal model (rat) was used. This is important as large mammal models better represent 
the human condition and it is currently unknown whether in these models, these 
observations are reproducible. Sheep hearts are very comparable model to humans, due to 
their similar heart rates; 60-120 bpm in sheep and ~72 bpm in humans. Previously used 
models, particularly rodents, have a faster heart rate and as such have a much shorter 
ventricular action potential duration. Sheep and humans also have a similar proportion of 
Ca2+ handling proteins and rely on both SERCA and NCX activity for Ca2+ removal, unlike 
rodents which are more reliant on SERCA alone (Milani-Nejad & Janssen, 2014). 
Furthermore, certain key components of ECC were not studied; namely the RyR and 
myofilament sensitivity to Ca2+, and so it is unclear how they are affected by TNF-α and IL-
1β. 
 
Though the effect of TNF-α and IL-1β on the ryanodine receptor and myofilament sensitivity 
to Ca2+ will be addressed specifically in chapter 4 and 5 respectively, it should be pointed out 
that in rat, Greensmith and Nirmalan (2013) observed a transient potentiation of systolic 
Ca2+ upon application of TNF-α. While not definitive, this may be indicative of RyR 
potentiation (Greensmith, Galli, Trafford, & Eisner, 2014). However, (1) Greensmith and 
Nirmalan (2013) did not thoroughly investigate this phenomenon (2) as this is the first 
reported observation of the phenomenon it is not known if it occurs in sheep. 
 
 
3.1.1   What is a pathologically relevant cytokine concentration? 
 
Previous studies have used a wide range of concentrations when investigating the effects of 
TNF-α and IL-1β on single myocytes or whole heart function (Amadou, Nawrocki, Best-
Belpomme, Pavoine, & Pecker, 2002; Cailleret et al., 2004; Combes et al., 2002; Duncan et 
al., 2010; El Khoury et al., 2014; Greensmith & Nirmalan, 2013; Ing, Zang, Dzau, Webster, & 
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Bishopric, 1999; Kaur, Sharma, Dhingra, & Singal, 2006; Liu, Zhou, & Kennedy, 1999; Maass, 
White, & Horton, 2002; McTiernan et al., 1997; Y. Qiu, Liao, & Zhang, 2009; Rozanski & Witt, 
1994; Schreur & Liu, 1997; Schulz et al., 1995; Skayian & Kreydiyyeh, 2006; Stamm et al., 
2001; Sugishita et al., 1999; Tatsumi et al., 2000; Tsujino et al., 1994; Yokoyama et al., 1993). 
Mean concentrations used were 17 ± 3 ng/ml TNF-α (n=23) and 14 ± 7 ng/ml IL-1β (n=19), 
over a range of 0.1-50 ng/ml and 0.1-100 ng/ml respectively. 
 
In previous data (Nirmalan et al, unpublished), plasma and intra-cardiac cytokine 
concentrations were measured in patients with sepsis. The latter revealed median levels of 
102 pg/ml TNF-α and 48 pg/ml IL-1β at the coronary sinus, although ranges were wide; 22-
1060 pg/ml and 20-420 pg/ml for TNF-α and IL-1β respectively. This does not reflect the local 
cytokine concentrations, which at the site of production – for example leukocytes in the 
heart (Neumann et al., 1995) – would be assumed to be much higher. The 50 ng/ml 
concentration of used for TNF-α and IL-1β in this study allowed the fundamental and 
individual effects of each cytokine to be determined. 
 
 
3.1.2  Aims 
 
(1) Separately characterise the effects if TNF-α and IL-1β in a sheep using an integrative 
approach 
(2) Establish if the effects of TNF-α and IL-1β in sheep are limited to systole 
(3) Ascertain whether, in sheep, there exists a temporary potentiation of systolic Ca2+ 
following application of TNF-α and IL-1β. 
 
 
3.2   Methods 
 
Left ventricular myocytes were isolated from young control sheep (aged approximately 18 
months) and paced at 0.5 Hz using field stimulation (see section 2.2.7). Cells were perfused 
with a control solution (see section 2.2.1) until a steady state was reached at which point 50 
ng/ml TNF-α or IL-1β were applied individually and changes to Ca2+ and contractility were 
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tracked to steady state. Subsequently, the reversibility of the effects of these cytokines was 
tested by switching back to control solution. The relative change to SR Ca2+ content was 
estimated by the amplitude of 10 mM caffeine-evoked Ca2+ transient (see section 2.3.4). 
 
Unless stated as otherwise, data shown represents mean ± standard error for steady state 
control, cytokine then wash for a given parameter. All data for each cell were normalised to 
each cells’ own control value, as this study measures fluorescence and not Ca2+ directly, 
normalisation allows relative change to be measured. There is a large variation in the quality 
of cells obtained from enzymatic digestion, normalisation also allows for baseline changes in 
the day-to-day quality of cells. 
 
Data were analysed using custom written software (Greensmith, 2014) as per (section 2.3). 
Statistical significance (p<0.05) was tested using one-way analysis of variance (ANOVA) 
(parametric data) or ANOVA on ranks (non-parametric data). Individual comparisons 
between groups were tested using Dunn's, Holm-Sidak or Tukey post-hoc tests as 
appropriate. 
 
 
3.3   Results 
 
3.3.1   The effect of 50 ng/ml TNF-α on intracellular Ca2+ levels and contractility 
 
The specimen records of Fig 3-1A and 3-1C demonstrate the effect of TNF-α on intracellular 
Ca2+ levels. The effect of TNF-α on systolic Ca2+ was rapid and sustained. On average, in the 
steady state, TNF-α irreversibly reduced Ca2+ transient amplitude by 16.79 ± 3.16 % (n=28, 
p<0.05) (Fig 3-2A). On average, diastolic Ca2+ decreased by 4.35 ± 1.67 % (n=28, p<0.05) (Fig 
3-2C). 
 
The effects of TNF-α on contractility are shown in the specimen records of Fig 3-1B and 3-1D. 
TNF-α caused a mean decrease in sarcomere amplitude of contraction by 20.31 ± 7.58 % 
(n=24, p<0.05) (Fig 3-2B), and a mean decrease in resting sarcomere length by 0.46 ± 0.1 % 
(n=24, p<0.05) was found (Fig 3-2D). With the exception of the effect on sarcomere 
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shortening which recovered to control levels (n=17, p>0.05), no other measured parameters 
reversed during washout. 
 
The specimen record of Fig 3-1E is an example of the effect of TNF-α on rate of contractility 
and relaxation. TNF-α application did not change the rate of sarcomere shortening (n=22, p = 
0.056) (Fig 3-2E) or the rate of relaxation (n=23, p>0.05) (Fig 3-2F). Following washout, the 
rate of sarcomere relaxation increased, as the 50 % decay time decreased by 18.92 ± 7.11 % 
(n=17, p<0.05). 
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Figure 3-1. Specimen records of the effect of TNF-α on cytoplasmic Ca2+ and contractility in 
left ventricular myocytes from young control sheep. (A) specimen record showing Ca2+ 
transients. (B) specimen record showing sarcomere shortening. (C) specimen mean Ca2+ 
transients for the periods highlighted in A.  (D) specimen mean sarcomere shortening traces 
for the periods highlighted in B. (E) specimen sarcomere shortening traces for the periods 
highlighted in B, with normalised diastolic and systolic levels. 
87 
 
 
 
Figure 3-2. The effects of TNF-α on cytoplasmic Ca2+ and contractility in left ventricular 
myocytes from young control sheep, and washout (n = 28 cells from 10 animals). (A) mean 
Ca2+ transient amplitude. (B) mean sarcomere shortening. (C) mean diastolic Ca2+. (D) mean 
resting sarcomere length. (E) mean 50 % sarcomere shortening time. (F) mean 50 % 
sarcomere relaxation time. * indicates p <0.05, NS denotes non-significance (p >0.05), SS = 
steady state. 
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3.3.2   The effect of 50 ng/ml IL-1β on intracellular Ca2+ levels and contractility 
 
As demonstrated in the specimen traces of Fig 3-3A and 3-3C, IL-1β alters intracellular Ca2+ 
dynamics. The effect on systolic Ca2+ was rapid and sustained with IL-1β producing a mean 
decrease in Ca2+ transient amplitude by 23.63 ± 6.61 % (n=26, p<0.05), which did not reverse 
upon washout (Fig 3-4A).  
 
The specimen records of 8B and 8D show an example of the effect of IL-1β on cell 
contractility. The magnitude of change to sarcomere shortening was unchanged by IL-1β 
(n=24, p>0.05), however following washout shortening increased on average by 146.01 ± 
59.32 % (n=17, p<0.05) (Fig 3-4B). Whilst IL-1β did not alter diastolic Ca2+ (n=25, p = 0.739) 
(Fig 3-4C), resting sarcomere length was irreversibly decreased by 0.76 ± 0.2 % (n=24, 
p<0.05) (Fig 3-4D).  
 
An example of the effect of IL-1β on rate of contractility and relaxation is demonstrated in 
the specimen figure of Fig 3-3E. The mean rate of sarcomere shortening (n=24, p>0.05) (Fig 
3-4E) and relaxation (n=24, p>0.05) (Fig 3-4F) were not affected by IL-1β application. 
Following washout, the rate of both sarcomere shortening and relaxation increases, as the 
50 % time taken for each decreased by 28.54 ± 10.16 % (n=17, p<0.05) and 50.46 ± 3.84 % 
(n=17, p<0.05). 
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Figure 3-3. Specimen records of the effect of IL-1β on cytoplasmic Ca2+ and contractility in 
left ventricular myocytes. (A) specimen record showing Ca2+ transients. (B) specimen record 
showing sarcomere shortening. (C) specimen mean Ca2+ transients for the periods 
highlighted in A. (D) specimen mean sarcomere shortening traces for the periods highlighted 
in B. (E) specimen sarcomere shortening traces for the periods highlighted in B, with 
normalised diastolic and systolic levels. 
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Figure 3-4. The effects of IL-1β on cytoplasmic Ca2+ and contractility in left ventricular 
myocytes, and washout (n= 29 cells from 9 animals). (A) mean Ca2+ transient amplitude. (B) 
mean sarcomere shortening. (C) mean diastolic Ca2+. (D) mean resting sarcomere length. (E) 
mean 50 % sarcomere shortening time. (F) mean 50 % sarcomere relaxation time. * indicates 
p <0.05, NS denotes non-significance (p >0.05), SS = steady state. 
 
 
3.3.3   The effect of TNF-α and IL-1β on SR Ca2+ content 
 
As demonstrated by Fig 3-5, 50 ng/ml TNF-α and IL-1β decreased the caffeine evoked Ca2+ 
transient amplitude by 27.32 ± 3.41 % (n=20, p<0.05) and 41.39 ± 3.43 % (n=22, p<0.05) 
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respectively from control. This decrease in caffeine evoked Ca2+ amplitude was maintained 
during washout of both TNF-α (n=6, p<0.05) and IL-1β (n=18, p<0.05). 
 
 
 
Figure 3-5. 10 mM caffeine evoked Ca2+ transient amplitudes in TNF-α (n= 20 cells from 7 
animals) and IL-1β (n= 22 cells from 9 animals) treated cells. (A and B) specimen records for 
caffeine evoked Ca2+ transient following control, cytokine and wash steady states, for TNF-α 
and IL-1β respectively. (C) mean caffeine evoked Ca2+ transients in TNF-α treated cells. (D) 
mean caffeine evoked Ca2+ transients in IL-1β treated cells. * indicates p <0.05, NS denotes 
non-significance (p >0.05), SS = steady state. 
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3.3.4   The effect of TNF-α and IL-1β on the major Ca2+ removal mechanisms 
 
The specimen record of Fig 3-6A shows an example of the effect of TNF-α on the decay 
phase of the systolic Ca2+ transient. Data have been normalised to permit direct 
comparability. On average, the rate constant of this decay phase (ksys) was unaltered by TNF-
α (n=26, p = 0.170) (Fig 3-6C). However, due to concerns over variation in the profile of the 
Ca2+ transient, the rate of systolic Ca2+ decay was also measured using 90 - 10 % decay time 
which was also unaffected by TNF-α (n=27, p = 0.242) (Fig 3-6D). 
 
The specimen record of Fig 3-6B demonstrates the effect of TNF-α on the decay phase of the 
caffeine evoked Ca2+ transient. Data have been normalised to permit direct comparability.   
TNF-α did not affect the rate constant of decay of the caffeine evoked Ca2+ transient (kcaff) 
(n=12, p = 0.122) (Fig 3-6E). kSERCA was derived by subtraction of kcaff from ksys (see section 
2.3.4) which was also unaltered by TNF-α (n=11, p>0.05) (Fig 3-6F). However, during 
washout kSERCA increased by 91.67 ± 26.29 % (n=3, p<0.05). 
 
Similar analysis was performed for of IL-1β and can be seen in the specimen records of Fig 3-
7A and 3-7B. With IL-1β, ksys increased by 24.04 ± 6.5 % (n= 26, p<0.05), increasing further to 
80.54 ± 18.12 % (n= 21, p<0.05) greater than control following washout (Fig 3-7C). 90 - 10 % 
decay time of the Ca2+ transient (n=26, p>0.05) was unaltered by IL-1β, however washout 
produced an 11.88 ± 9.41 % decrease (n=21, p<0.05), and thus elevated rate of systolic Ca2+ 
removal following washout (Fig 3-7D).  
 
On average IL-1β increased kcaff by 29.47 ± 10.55 % (n= 19, p<0.05) which was maintained 
during washout (n= 16, p<0.05) (Fig 3-7E). While IL-1β application did not alter the kSERCA 
(n=19, p>0.05), following washout, kSERCA increased by 78.26 ± 17.67 % (n=16, p<0.05) (Fig 3-
7F). 
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Figure 3-6. The effect of 50 ng/ml TNF-α on rate of Ca2+ removal (n = 26 cells from 10 
animals). (A) specimen trace of Ca2+ transients at control, TNF-α and washout steady state, 
with normalised diastolic and systolic levels. (B) specimen trace of caffeine-evoked Ca2+ 
transients at control, TNF-α and washout steady state, with normalised diastolic and systolic 
levels. (C) mean normalised ksys. (D) mean normalised 90-10 % decay time of the Ca
2+ 
transient. (E) mean normalised kcaff. (F) mean normalised kSERCA. * indicates p <0.05, NS 
denotes non-significance (p >0.05), SS = steady state. 
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Figure 3-7. The effect of 50 ng/ml IL-1β on rate of Ca2+ removal (n = 26 cells from 9 animals) 
(A) specimen trace of Ca2+ transients at control, IL-1β and washout steady state, with 
normalised diastolic and systolic levels. (B) specimen trace of caffeine-evoked Ca2+ transients 
at control, IL-1β and washout steady state, with normalised diastolic and systolic levels.  (C) 
mean normalised ksys. (D) mean normalised 90-10 % decay time of the Ca
2+ transient. (E) 
mean normalised kcaff. (F) mean normalised kSERCA. * indicates p <0.05, NS denotes non-
significance (p >0.05), SS = steady state. 
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3.3.5   The early effect of 50 ng/ml TNF-α and IL-1β on systolic Ca2+ 
 
Preceding the decrease of systolic Ca2+ to a lower steady state (Fig 3-1 to 3-3 above), in 
certain cells both cytokines produced an early, short-lived potentiation of the Ca2+ transient 
amplitude lasting 1-3 beats. Potentiation was defined as a greater than 10 % increase of 
systolic compared to control. Potentiation was observed in 71 % of cells exposed to TNF-α 
and 52 % of cells exposed to IL-1β. As such, cells were sub-grouped into responders (those 
with an early potentiation – see Fig 3-8A and 3-8D for examples) and non-responders (those 
without – see Fig 3-9A and 3-9D for examples). 
 
In responders, on average TNF-α increased the amplitude of the first beat by 57.75 ± 10.23 % 
(n=20, p<0.05) (Fig 3-8B). This was accompanied by a mean increase in sarcomere shortening 
by 348.3 ± 128.73 % (n=15, p<0.05) (Fig 3-8C). For both Ca2+ transient amplitude and 
sarcomere shortening, this initial potentiation was temporary. Cells responding to IL-1β 
showed a similar pattern. on average IL-1β increased the Ca2+ amplitude of the 1st beat by 
51.72 ± 12.61 % (n=15, p<0.05) (Fig 3-8E). This was accompanied by an increase in 1st beat 
sarcomere amplitude of contraction by 215.25 ± 46.42 % (n=14, p<0.05) (Fig 3-8F). For both 
Ca2+ transient amplitude and sarcomere shortening, this initial potentiation was temporary. 
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Figure 3-8. The effect of 50 ng/ml TNF-α (n = 20 cells from 7 animals) and IL-1β (n = 15 cells 
from 8 animals) on the 1st beat Ca2+ transient amplitude and contractility of cells showing 
signs of RyR potentiation (A) specimen record showing Ca2+ transients, immediately prior to 
[black], during [dark red] and following [red] 1st beat application of TNF-α. (B) mean 
normalised Ca2+ transient amplitude with 1st beat application of TNF-α. (C) mean normalised 
sarcomere shortening with 1st beat application of TNF-α. (D) specimen record showing Ca2+ 
transients with1st beat application of IL-1β, as labelled in A. (E) mean normalised Ca2+ 
transient amplitude with 1st beat application of IL-1β. (F) mean normalised sarcomere 
shortening with 1st beat application of IL-1β. * indicates p <0.05, NS denotes non-
significance (p >0.05), SS = steady state. 
 
 
In TNF-α non-responders, the 1st beat Ca2+ transient amplitude (n=8, p>0.05) did not differ 
from control, however Ca2+ transient amplitude had reduced by 29.09 ± 7.52 % (n=7, p<0.05) 
once steady state had been reached in TNF-α (Fig 3-9B). The 1st beat magnitude of 
sarcomere shortening was unchanged (n=7, p>0.05) with TNF-α, while a 15.77 ± 5.97 % (n=7, 
p<0.05) reduction was found at steady state (Fig 3-9C). 
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In IL-1β non-responders treated cells, a mean decrease in Ca2+ transient amplitude by 24.07 
± 5.22 % (n=14, p<0.05) was found. Ca2+ transient amplitude decreased further to 47.7 ± 4.45 
% (n=12, p<0.05) of control at steady state (Fig 3-9E). The 1st beat magnitude of sarcomere 
shortening increased by 112.81 ± 76.27 % (n=13, p<0.05) with IL-1β (Fig 3-9F). Sarcomere 
shortening was restored to control levels at IL-1β steady state (n=11, p<0.05). 
 
 
Figure 3-9. The effect of 50 ng/ml TNF-α (n = 8 cells from 6 animals) and IL-1β (n = 14 cells 
from 7 animals) on the 1st beat Ca2+ transient amplitude and contractility of cells without 
signs of RyR potentiation (A) specimen record showing Ca2+ transients, immediately prior to 
[black], during [dark red] and following [red] 1st beat application of TNF-α. (B) mean 
normalised Ca2+ transient amplitude with 1st beat application of TNF-α. (C) mean normalised 
sarcomere shortening with 1st beat application of TNF-α. (D) specimen record showing Ca2+ 
transients with 1st beat application of IL-1β, as labelled in A. (E) mean normalised Ca2+ 
transient amplitude with 1st beat application of IL-1β. (F) mean normalised sarcomere 
shortening with 1st beat application of IL-1β. * indicates p <0.05, NS denotes non-
significance (p >0.05), SS = steady state. 
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To determine whether the observed phenomenon was influenced by switching between the 
lines, the experiment was repeated using control solution. A small, initial increase in Ca2+ 
transient amplitude by 8.12 ± 2.7 % (n=10, p<0.05) was identified following switching of the 
lines (Fig 3-10). 
 
 
 
Figure 3-10. The effect of switching lines between control solutions on 1st beat and steady 
state Ca2+ amplitude (n = 10 cells from 3 animals). (A) specimen record showing Ca2+ 
transients, immediately prior to [black], during [dark red] and following [red] switching to a 
different control solution line (B) mean normalised Ca2+ transient amplitude. * indicates p 
<0.05, NS denotes non-significance (p >0.05), SS = steady state. 
 
 
3.4   Discussion 
 
3.4.1 Does acute exposure to 50 ng/ml TNF-α and IL-1β alter Ca2+ handling and 
contractility in a large mammal model? 
 
TNF-α irreversibly reduced Ca2+ transient amplitude by 16.79 ± 3.16 % (Fig 3-2A), this 
corresponded with a decrease in sarcomere shortening by 20.31 ± 7.58 % (Fig 3-2B). This was 
to be expected as there is generally a positive relationship between [Ca2+]i and cell 
shortening, as Ca2+ is required to bind to myofilaments to initiate contraction. As the same 
TNF-α concentration (50 ng/ml) was used by Greensmith and Nirmalan (2013) in rat 
myocytes, inducing similar reductions in both Ca2+ transient amplitude and contractility, this 
work confirms that the effect on systolic dysfunction is the same in a large mammal model. 
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As demonstrated in the specimens of Fig 3-1A and 3-1B, the onset of the depressive effect 
on both systolic Ca2+ and shortening observed was rapid, after only ~3 beats. This also agrees 
with the findings of Greensmith and Nirmalan (2013) which recorded both an initial and 
sustained reduction in systolic Ca2+ in rat myocytes. 
 
 IL-1β also irreversibly decreases Ca2+ transient amplitude by 23.63 ± 6.61 % (Fig 3-4A). 
Despite this reduction in Ca2+ transient amplitude, IL-1β had no significant effect on 
sarcomere shortening (Fig 3-4B). Given that the change with washout was large (a 146.01 ± 
59.32 % increase), this may have masked any smaller changes to shortening with the 
cytokine alone.  
 
Contrary to previous studies, including work by Greensmith and Nirmalan (2013) and Duncan 
et al. (2010), there was evidence of diastolic dysfunction with both TNF-α and IL-1β. TNF-α 
induced irreversible decreases in both diastolic Ca2+ by 4.35 ± 1.67 % and resting cell length 
by 0.46 ± 0.1 % (Fig 3-2C and 3-2D). IL-1β application was shown in Fig 3-4D, to induce a 
reduction in resting cell length by 0.76 ± 0.2 %, whilst no change to diastolic Ca2+ was 
recorded (Fig 3-4C). Given the magnitude of change to resting cell length with IL-1β, it is 
likely that and any change to diastolic Ca2+ would also be small. Therefore, the method used 
may not have been sensitive enough to detect a change. 
 
No changes were recorded to the rate of relaxation with TNF-α (Fig 3-2F). As demonstrated 
in the specimen shown in Fig 3-1E, during washout 50 % time of sarcomere relaxation were 
decreased by 18.92 ± 7.11 %.  The 91.67 ± 26.29 % increase in kSERCA also found during TNF-α 
washout (Fig 3-6F), could account for the increased rate of sarcomere relaxation due to an 
elevated rate of SR Ca2+ uptake.  
 
IL-1β did not affect the rate of relaxation (Fig 3-4F). This contradicts the increased rate of 
relaxation found by Radin et al. (2008) with IL-1β in rat. As the exposure time in this study 
was shorter, it is possible that an effect on relaxation had yet to become significant, that 
with prolonged exposure a change to relaxation may be detected. As shown in the specimen 
of Fig 3-3E, during washout 50 % time of sarcomere relaxation were decreased by 50.46 ± 
3.84 %, this coincides with 80.54 ± 54 %, 29.47 ± 10.55 % and 78.26 ± 17.67 % increases in 
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ksys, kcaff and kSERCA respectively, while 90 – 10 % decay time of the Ca
2+ transient decreased 
by 11.88 ± 9.41 % (Fig 3-7). All these measurements indicate an increase in rate of Ca2+ 
removal from control and cytokine steady state, which could account for the increased rate 
of sarcomere relaxation. 
 
 
3.4.2  How do both 50 ng/ml TNF-α and IL-1β reduce Ca2+ transient amplitude? 
 
The amplitude of systolic Ca2+ is dependent on many factors. In terms of inotropic control, 
there are two primary regulators (1) the amount of Ca2+ contained in the SR and (2) the 
amplitude of the on ICaL (see section 1.2.8.2). Of the two, SR Ca
2+ content is the more 
influential (Bers, 2002; Eisner, 2018). As such, in order to provide the basis of a pathological 
change to inotropy, it is logical to begin by ascertaining if SR Ca2+ is altered. 
 
In young control sheep, TNF-α reduced SR Ca2+ content to 72.68 % of control (see Fig 3-5A 
and 3-5C). As the relationship between SR Ca2+ content and Ca2+ transient amplitude is cubic 
(Trafford, Diaz, Sibbring, & Eisner, 2000), it is possible to calculate the expected reduction in   
Ca2+ transient amplitude. As (0.7268)3 = 0.3839, Ca2+ amplitude would be expected to 
decrease to 38.39 % of control, when in fact it only decreased to 83.21 %. IL-1β produced a 
41.39 % reduction in SR Ca2+ content to 53.61 % of control (see Fig 3-5B and 3-5D). Given 
that (0.5361)3 = 0.1541, therefore an 84.59 % decrease in Ca2+ transient amplitude to 15.41 
% of control would be predicted, however IL-1β only reduced Ca2+ transient amplitude to 
76.37 % of control.  
 
Some caution must be used when interpreting the precise relationship and so apparent 
attenuated decrease of systolic Ca2+. SR Ca2+ content was estimated using the amplitude of 
the caffeine-evoked Ca2+ transient, which can be independently affected by intracellular Ca2+ 
buffering. As the effects of TNF-α and IL-1β on Ca2+ buffering are unknown, it cannot be 
ruled out that such an effect may independently affect the amplitude of the caffeine evoked 
Ca2+ transient in these experiments (Trafford, Diaz, & Eisner, 1999). The decrease observed is 
considerable (27 and 41 % by TNF-α and IL-1β respectively), and therefore it is highly unlikely 
that altered Ca2+ buffering could account for this alone. It is much more likely that the 
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majority of this change is due a considerably reduced release of SR Ca2+ content resulting 
from a depletion of SR Ca2+ (J. W. Bassani et al., 1995). As such, at least qualitatively, the 
decrease of systolic Ca2+ produced by both cytokines can be explained by a decrease of SR 
Ca2+. This is corroborated by the fact that in rat Greensmith and Nirmalan (2013) observed a 
decrease of SR Ca2+ when measured quantitively by integration of caffeine-evoked sodium 
currents – a method that measures total rather than only free Ca2+ and so is not affected by 
altered Ca2+ buffering (Varro, Negretti, Hester, & Eisner, 1993). 
 
As previously mentioned ICaL is also known to regulate Ca
2+ transient amplitude. While this 
study was unable to investigate the effect of TNF-α and IL-1β on ICaL, previous work by 
Greensmith and Nirmalan (2013) found that in response to application of 50 ng/ml TNF-α in 
rat ventricular myocytes peak ICaL reduced by 11 %. This is a minor effect and given that the 
ICaL and resultant Ca influx are fundamentally similar in both rat (Greensmith & Nirmalan, 
2013) and young sheep (Dibb et al., 2004) it is unlikely that an effect on ICaL would contribute 
to the reduction in Ca2+ transient amplitude. For completeness, in future work it may be 
useful to characterise the effects of both cytokines on ICaL in a large mammal model. 
 
 
3.4.3 How do TNF-α and IL-1β alter SR Ca2+ content? Are the Ca2+ removal 
mechanisms affected?  
 
SR Ca2+ content can be influenced by change to SERCA activity and change to RyR Po. Rapid 
SERCA activity increases Ca2+ uptake resulting in increased SR Ca2+ content, while a decrease 
in SR Ca2+ content – as was identified in response to both cytokines – can be contributed to 
by reduced Ca2+ uptake as a result of deceased SERCA activity. Equally, RyR regulates Ca2+ 
release from the SR and thus can alter SR Ca2+ content (Bers, 2002).  
 
At steady state, TNF-α did not alter the rate of intracellular calcium removal. ksys, kcaff and 
kSERCA (and 90 - 10 % decay time) were all unchanged by TNF-α (Fig 3-6), suggesting NCX, and 
crucially, SERCA, are unaffected by TNF-α exposure. As such, it appears that an effect on 
SERCA, or indeed NCX is not responsible for the decrease of SR Ca2+ content. The fact that 
kSERCA increased following TNF-α washout is surprising as this implies that here, SERCA 
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activity may be increased. Why this is the case, needs to be investigated further, however for 
all things being equal this ought to coincide with a modest increase of SR Ca2+ content (Bode 
et al., 2011). However, during washout, the decrease of SR Ca2+ produced by TNF-α was 
maintained adding further support to the suggestion that the decrease in SR Ca2+ content by 
TNF-α is not associated with change to the rate of SERCA-mediated Ca2+ removal. In other 
words, even if SERCA is increased during washout, the maintained reduction of SR Ca2+ (Fig 
3-5) suggests that either (1) the effect of TNF-α on SERCA is uncoupled from that on SR and 
(2) something else must be responsible for the depletion of SR Ca2+.  
 
IL-1β increased the rate of intracellular Ca2+ removal (ksys) which resulted from an increase of 
kcaff and ultimately an increase of kSERCA. This suggests that the activity of NCX and SERCA are 
both increased by IL-1β. Again, this is an interesting phenomenon and the mechanism 
underlying this ought to be investigate further. However, in respect to SR Ca2+, the effects of 
IL-1β may be more complex than those of TNF-α. For all things being equal, an increase of 
NCX activity could contribute to decreased SR Ca2+ (Shannon, Pogwizd, & Bers, 2003). 
Conversely, an increase in SERCA activity would increase SR Ca2+. It may be therefore, that 
the effect of IL-1β on NCX is greater than that on SERCA thus contributing to a net decrease 
of SR Ca2+ content. However, given the relative contribution of NCX and SERCA to net Ca2+ 
removal (R. A. Bassani et al., 1992), and that that magnitude of effect on kSERCA and kcaff is 
similar it is likely that as with TNF-α, another mechanism is primarily responsible for 
decreasing SR Ca2+. 
 
What is clear from both sets of data is SERCA activity is not reduced by either of the 
cytokines. To the contrary, most data suggests that SERCA activity is actually increased. This 
strongly suggests that something other than an effect on SERCA is responsible for the 
decrease of SR Ca2+ content.  
 
One possible mechanism by which both TNF-α and IL-1β could reduce SR Ca2+ content is if 
they were to potentiate the RyR. 
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3.4.4  TNF-α and IL-1β produce and temporary potentiation of systolic Ca2+ – Could 
RyR sensitivity be increased? 
 
SR Ca2+ is also influenced by RyR Po. When RyR Po is increased, so does diastolic SR Ca
2+ leak 
leading to a reduced SR Ca2+ content (Belevych et al., 2007; Shannon et al., 2003). Luminal 
Ca2+ can also impact the RyR, as such reduced SR Ca2+ content would be expected to 
decrease RyR Po (Ching et al., 2000). 
 
A proportion of cytokine treated cells presented with an early potentiation of the Ca2+ 
transient and subsequent shortening in response to both cytokines (Fig 3-8). This agrees with 
findings in  the work of Greensmith and Nirmalan (2013) which acknowledged a 1st beat 
increase in Ca2+ transient amplitude in response to 50 ng/ml TNF-α in rat, but did not 
investigate further. The corresponding effects of these cytokines on shortening indicate that 
this early potentiation is a true physiological phenomenon, not a fluorescent artefact. 
 
The effect of change to RyR Po can cause only a brief change to Ca
2+ transient amplitude 
(Trafford et al., 2000), therefore this initial 1-3 beat increase in Ca2+ amplitude is evidence to 
suggest increase in Ca2+ release from the SR through potentiation of the RyR. RyR regulates 
Ca2+ release from the SR, therefore this may account for the decrease in SR Ca2+ content 
during exposure, especially if, like caffeine (Greensmith et al., 2014), this Ca2+ release drives 
Ca2+ extrusion via NCX.  
 
With both cytokines, there were also a proportion of cells which did not present with this 
initial increase in Ca2+ transient amplitude (Fig 3-9). The 24.07 % decrease in 1st beat Ca2+ 
transient amplitude with IL-1β corresponds with the 23.63 % mean decrease identified at 
steady state, as shown in Fig 3-4A. This suggests that in this subgroup RyR potentiation may 
occur far more quickly, thus the final effect of IL-1β on systolic Ca2+ is rapid. Although ICaL 
was not measured in this study, it is also possible that, in this sub-group of non-responders, 
these cytokines may be having a greater effect on LTCC, leading to decreased ICaL, than that 
on RyR Po.  
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While this temporary potentiation of systolic Ca2+ is indicative of increased RyR sensitivity, it 
is not definitive. As such chapter 4 will investigate this further. 
 
 
3.4.5 Do TNF-α and IL-1β alter the relationship between cytoplasmic Ca2+ and 
sarcomere shortening? 
 
TNF-α induced simultaneous decrease in both diastolic Ca2+ and resting sarcomere length by 
4.35 ± 1.67 % and 0.46 ± 0.1 % respectively (Fig 3-2C and 3-2D), maintained following 
washout, indicates an increase in myofilament sensitivity to Ca2+. After TNF-α washout, 
however the 16.79 ± 3.16 % decrease in Ca2+ transient amplitude was sustained, while 
sarcomere shortening was unchanged (Fig 3-2A and 3-2B). This could be used to further 
suggest increased myofilament sensitivity following washout, however it may also suggest 
that TNF-α reduced myofilament sensitivity, which was recovered with washout. 
 
A potential change to myofilament sensitivity is also evident in IL-1β treated cells. Resting 
sarcomere length decreased by 0.76 ± 0.2 % while diastolic Ca2+ was unchanged, during both 
IL-1β application and washout (Fig 3-4C and 3-4D), and Ca2+ transient amplitude was 
decreased by 23.63 ± 6.61 % despite sarcomere shortening remaining unchanged, both of 
which could suggest increased sensitivity to Ca2+. With washout, the effect on Ca2+ transient 
amplitude was maintained, however a 146.01 ± 59.32 % increase in sarcomere shortening 
occurred (Fig 3-4A and 3-4B). As with TNF-α, this could support reduced sensitivity to Ca2+, 
recovered following IL-1β washout, or a direct increase in sensitivity to Ca2+ with washout. 
 
This is evidence that some change to myofilament sensitivity may be occurring with TNF-α 
and IL-1β, however whether myofilament sensitivity is increased or decreased with exposure 
to these cytokines is still uncertain. This does, however, provide further cause to investigate 
the effects of both cytokines of myofilament sensitivity to Ca2+. In addition, evidence 
supports that both cytokines may potentiate the RyR. The effects of TNF-α and IL-1β on RyR 
Po and myofilament sensitivity to Ca
2+ will be explored further in subsequent chapters. 
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Chapter 4 
 
The effects of 50 ng/ml TNF-α and IL-1β on cardiac 
intracellular calcium waves 
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4.1   Introduction 
 
4.1.1  Background to the effect of cytokines on RyR  
 
Though the reduction in SR Ca2+ content by TNF-α and IL-1β identified in section 3.3.3, does 
not appear to be a consequence of SERCA inhibition, this may be the result of an increase in 
diastolic SR Ca2+ leak from the SR due to increased RyR Po. SR Ca
2+ leak is spontaneous 
release Ca2+ release from the SR via the RyR. Increased RyR Po contributes to an increase in 
net diastolic Ca2+ leak from the SR. Increased leak leads to a reduction in SR Ca2+ content 
(Eisner, Kashimura, O'Neill, Venetucci, & Trafford, 2009).  
 
Previous findings suggest there may be a role for increased SR Ca2+ release in sepsis. X. Zhu 
et al. (2005) found evidence of increased SR Ca2+ leak in a cecal ligation and puncture (CLP) 
model of sepsis, as Ca2+ spark frequency increased on time-dependent basis, indicating an 
effect on RyR Po. Other studies suggest that this effect on RyR Po may be due to the 
increased presence of proinflammatory cytokines in septic serum. In rat ventricular 
myocytes treated with TNF-α and IL-1β (0.05 and 2 ng/ml) for 3 hours, the frequency and 
duration of Ca2+ sparks increased, as did wave frequency when the cells were also exposed 
to high Ca2+ levels (Duncan et al., 2010). Similar effects on spontaneous Ca2+ release events – 
Ca2+ sparks and waves – were identified in atrial myocytes following 2 hour exposure to 0.05 
ng/ml TNF-α (Zuo et al., 2018). 
 
TNF-α is also elevated in other inflammatory conditions of the heart, such as in reperfusion 
injury following ischemia and post–myocardial infarction (Fauconnier et al., 2011; Y. Yang et 
al., 2014). Increased ROS production, particularly NO, promoted by TNF-α (10 ng/ml) 
treatment was associated with increased S-nitrosylation on the RyR, contributing to RyR Po 
modulation (Fauconnier et al., 2011). The high levels of TNF-α in a post-myocardial infarction 
heart failure model have been associated with a reduced affinity of CaM binding to RyR (Y. 
Yang et al., 2014). RyR Po is known to increase with less CaM binding (Balshaw, Xu, 
Yamaguchi, Pasek, & Meissner, 2001). 
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Although few studies have investigated the effect of IL-1β alone on RyR activity, IL-1β has 
been associated with arrhythmia, which can occur as a result of increased diastolic SR Ca2+ 
leak. IL-1β (10 ng/ml) promotes CaMKII oxidation and phosphorylation in cardiac strips from 
a diabetic model. CaMKII is a known modulator of RyR suggesting an indirect effect of IL-1β 
on RyR Po (Monnerat et al., 2016). 
  
However, previous studies suffer similar limitations to those described in chapter 3. Multiple 
experimental approaches were used; therefore, the effects of these cytokines were difficult 
to assimilate into a unified model. Furthermore, the previously described studies above 
investigating the effect of these cytokines on cardiac RyR, were all carried out in small 
mammal models; either rat  (Duncan et al., 2010; Fauconnier et al., 2011; Y. Yang et al., 
2014) or mice (Monnerat et al., 2016; Zuo et al., 2018), as opposed to in a large mammal 
model. This is important as there are differences in the binding affinities of RyR and their 
spatial density in different mammal species, which could affect overall activity (Bers, 1991). 
 
In addition, these studies investigated effects on RyR and its modulators after prolonged (> 1 
hour) exposure to one or both cytokines. Given that experiments of Fig 3-8 showed 1st beat 
potentiation of the Ca2+ transient (refer to section 3.3.5), implying that an effect on RyR 
activity may be more immediate than previously thought. 
 
Given these limitations combined, there is a clear need to further investigate the effect of 
TNF-α and IL-1β on RyR function. 
 
 
4.1.2  What are intracellular Ca2+ waves? 
 
Ca2+ waves are multiple spontaneous diastolic Ca2+ release events from the SR which 
propagate across the myocyte to generate further Ca2+ release events. These Ca2+ release 
events are therefore also not uniformly distributed across the cell as would be expected in 
Ca2+ transient. The probability that a Ca2+ wave will occur is dependent on both the rate of 
SR Ca2+ loading and SR Ca2+ threshold, the latter of which is determined by RyR Po. As such 
both increased SR Ca2+ uptake and increased RyR Po can contribute to wave generation. 
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Increased RyR Po generally cannot induce waves alone, however it can modulate the 
threshold for waves. If RyR Po is increased the threshold would be reduced and therefore a 
small increase in SR Ca2+ content could evoke Ca2+ waves (Stokke et al., 2011; Venetucci, 
Trafford, & Eisner, 2007). If increased RyR Po reduces the threshold beyond that of SR Ca
2+ 
content, this will cause waves, as found in some ventricular arrhythmias and sudden cardiac 
death (Jiang et al., 2005). Equally if RyR Po were to be reduced, the threshold for Ca
2+ waves 
would become increased, therefore a large increase in SR Ca2+ content would be required to 
trigger Ca2+ release events and thus Ca2+ waves (Venetucci, Trafford, Diaz, O'Neill, & Eisner, 
2006). 
 
 
4.1.3  Experimental production of waves  
 
Production of Ca2+ waves under experimental conditions can be carried out through either 
the RyR potentiated, increased SR Ca2+ content or a combination of both (Stokke et al., 2011; 
Venetucci et al., 2007). As this series of experiment was designed to measure the effect of 
TNF-α and IL-1β on RyR Po through change to the SR Ca
2+ threshold for waves, potentiation 
of the RyR independently in order to evoke waves would interfere with the results in 
response to both cytokines. Overloading the SR is therefore the most appropriate method of 
causing Ca2+ waves in this experiment. 
 
There are multiple was of increasing SR Ca2+ content to meet the threshold and thus induce 
Ca2+ overload. A β-agonist could be used to increase SR Ca2+ loading, leading to the 
production of waves, however β-adrenergic stimulation is also known to impact RyR-
mediated Ca2+ release in response to Ca2+ influx via the LTCC (Maxwell, Domeier, & Blatter, 
2013; Zhou et al., 2009). Ouabain is a known Na+-K+ ATPase inhibitor causing increased [Na]i, 
this in turn drives Ca2+ influx via reverse-phase NCX activity. The resulting elevation in [Ca2+]i 
enhances SR Ca2+ loading, thus increasing SR Ca2+ content (Nishio et al., 2004). Increased 
[Ca2+]o is able to steepen [Ca
2+] gradients, facilitating non-specific Ca2+ influx and SR uptake, 
as well as SR Ca2+ leak (Bovo, Mazurek, Blatter, & Zima, 2011). A combination of both 
ouabain and high [Ca2+]o could be used to further drive reverse-phase NCX activity and SR 
Ca2+ loading, ensuring production of waves for the given purpose of these experiments. 
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4.1.4  Aims 
 
The aim of this experiment was to investigate the effects of TNF-α and IL-1β on (1) Ca2+ wave 
dynamics in a large mammal model and (2) any change to SR Ca2+ threshold for waves. This 
was in order to determine whether either cytokine had an effect on RyR potentiation. 
 
 
4.2   Methods 
 
4.2.1   Wave facilitation 
 
As described in section 2.1.4 left ventricular myocytes from young control sheep were 
loaded with the ratiometric Ca2+ indicator Fura-2. The standard experimental solution given 
in section 2.2.1 was modified to include 5 mM extracellular Ca2+ and 0.3 mM Ouabain and so 
evoke spontaneous Ca2+ waves. These concentrations were optimised (see Fig 4-1) to 
produce a basal wave frequency of approximately 21 waves per minute. This meant that 
wave frequency was high enough to provide the required sensitivity to detect an effect if 
one was to occur but low enough to ensure each wave was a distinct event. 
 
During a given experiment once wave frequency was stable, TNF-α and IL-1β were each 
applied individually at 50 ng/ml for 5 minutes prior to a 2 minute wash period.  
 
 
4.2.2   Quantification of SR Ca2+ threshold for waves 
 
In a similar protocol to that detailed in section 2.3.4, 20 mM caffeine was applied during a 
wave to indirectly measure SR Ca2+ content immediately prior to the wave. This determined 
the SR Ca2+ content required to reach the threshold causing a Ca2+ wave and therefore can 
be used to indicate the SR Ca2+ threshold for waves. The SR Ca2+ threshold indicates RyR Po, 
and increased RyR Po would be expected to reduce the threshold, while a decreased RyR Po 
would be expected to raise the threshold (Stokke et al., 2011; Venetucci et al., 2007). 
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Caffeine potentiates the RyR, leading to Ca2+ release from the SR, as such it alters the SR 
threshold. This also contributes to a decrease in SR Ca2+ content to below the threshold, 
abolishing Ca2+ waves (Greensmith et al., 2014). To prevent caffeine impacting results 
through this independent effect on RyR and SR threshold, caffeine could only be applied at 
the end of an experiment. Some experiments were carried out solely on control waves, with 
caffeine application once a steady state had been reached. Of cells which received a cytokine 
treatment, after 5 minutes exposure, either caffeine was applied – thus the experiment was 
concluded – or the caffeine application followed a 2 minute washout period. 
 
 
4.2.3  Analysis of Ca2+ waves 
 
IonWizard files were exported as text files enabling them to be imported into Clampfit. 
Clampfit – while not designed for this specific purpose – has sophisticated event detection 
algorithms which are highly suitable for analysis of Ca2+ waves. The baseline of the Ca2+ 
signal was manually corrected using Clampfit, to allow measurement of Ca2+ wave amplitude 
and frequency.  
 
A first marker was placed to indicate the baseline. As Ca2+ fluorescence moves in the positive 
direction during waves, only peaks moving in a positive direction were detected. A second 
marker just above the baseline and associated noise to indicate a threshold and by which 
only points that exceed beyond – ideally waves – would be detected. To further exclude any 
false peaks from being detected noise rejection generally initially set to ~50 ms. The noise 
rejection threshold did however often need to be altered in either direction, dependent on 
the volume of noise in the trace, while ensuring all true waves were detected. Using Clampfit 
event detection, the peak height of each wave was then automatically identified allowing 
the measurement of Ca2+ wave amplitude and instantaneous frequency, based on the time 
points at which these peaks occurred. If any signal interference remained despite 
implementation of these thresholds, noise effecting Ca2+ wave amp could be manually 
rejected and flagged as an incorrect amplitude value, therefore not interfering with results. 
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10 s averages were taken at the end of each 1 minute exposed to cytokine, and from the end 
of each 30 s interval during the washout period. Mean values were normalised to control. 
Data were analysed using a one-way repeated measures ANOVA.  
 
 
4.3   Results 
 
4.3.1  Optimisation of inducing waves in sheep myocytes 
 
 While other studies have implemented a similar method of evoking Ca2+ waves with ouabain 
and high [Ca2+]o, the sensitivity of Na
+/K+- ATPase to ouabain varies between species, in 
particular large and small mammals (Blanco & Mercer, 1998). It was therefore important to 
reoptimize the method for use in sheep myocytes. 
 
In control, a steady state wave frequency and amplitude was desired, in which there were 
gaps between waves greater than 1 second and Ca2+ wave amplitude was reasonably 
consistent. This was to allow any to change to frequency following the application of either 
cytokine. To determine how best to obtain this control wave frequency, a variety of ouabain 
and Ca2+ concentrations were tested. 
 
The specimen record of Fig 4-1 shows the process by which the ouabain and Ca2+ 
concentration was optimised to provide a suitable basal wave frequency. As demonstrated 
by Fig 4-1A in most cases 0.1 mM ouabain and 5 mM Ca2+ did not provide sufficient SR Ca2+ 
overload to produce Ca2+ waves.  As per Fig 4-1B Increasing [Ca2+]o to 10 mM Ca
2+, did 
produce Ca2+ waves. However, those waves were not of consistent amplitude, presumably 
because wave frequency was so high that complete recovery between a given wave wasn’t 
permitted, as such and as per Fig 4-1C, it was found that modulating ouabain concentration 
had a more subtle effect on frequency. After several iterations it was found that 0.3 mM 
ouabain and 5 mM Ca2+ could reliably evoke Ca2+ waves at the desired frequency (Fig 4-1D). 
Though Fig 4-1D provides a typical example, the baseline wave frequency did vary 
considerably between cells, but under no circumstance was wave frequency so high that the 
data could be not be used. 
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Figure 4-1. Specimen Ca2+ traces of cells exposed to different ouabain and Ca2+ 
concentrations. (A) 0.1 mM ouabain and 5 mM Ca2+. (B) 0.1 mM ouabain and 10 mM Ca2+. 
(C) 0.5 mM ouabain and 5 mM Ca2+. (D) 0.3 mM ouabain and 5 mM Ca2+. 
 
 
4.3.2  The effect of 50 ng/ml TNF-α on intracellular Ca2+ wave amplitude and 
frequency 
 
The specimen records of Fig 4-2 show an example of the time-dependent effect of TNF-α on 
Ca2+ wave amplitude and frequency. Fig 4-2A and 4-2B show typical original Ca2+ and 
sarcomere length records respectively. A time-dependent decrease in Ca2+ wave amplitude is 
clear and corresponds with a respective decrease in sarcomere shortening. Fig 4-2D provides 
example individual Ca2+ waves from the end of control, TNF-α and wash. As the effect on 
frequency isn’t as obvious, Fig 4-2C provides the instantaneous frequency over the time 
course of the same experiment, again, a progressive increase is apparent.  Fig 4-3 and Table 
4-1 show the mean time-dependent decrease of Ca2+ wave amplitude and increase in 
frequency produced by TNF-α. On average, after 5 minutes of TNF-α exposure wave 
frequency was increased by 38.22 ± 8.11 % (n=22, p <0.001) whereas amplitude was 
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decreased by 46.13 ± 5.75 % (n=22, p <0.001). Neither the effect on frequency or amplitude 
reversed during the duration of the wash period. 
 
 
Table 4-1: The effect of 50 ng/ml TNF-α on normalised Ca2+ wave amplitude and 
instantaneous wave frequency over time and with washout 
Time (min) Normalised Ca2+ amplitude 
(AU) 
Normalised instantaneous 
frequency 
(AU) 
Control 1 ± 0 1 ± 0 
1 0.85 ± 0.04 1.08 ± 0.05 
2 0.79 ± 0.05 1.16 ± 0.04 
3 0.73 ± 0.05 1.28 ± 0.05 
4 0.58 ± 0.04 1.4 ± 0.08 
5 0.54 ± 0.06 1.38 ± 0.08 
Wash (2 min) 0.45 ± 0.07 1.42 ± 0.15 
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Figure 4-2. A specimen record of the effect of 50 ng/ml TNF-α *red+ and washout *blue+ wave 
dynamics, with averaged regions indicated.  (A) specimen record showing Ca2+ waves. (B) 
specimen record showing sarcomere shortening. (C) specimen record showing change in the 
instantaneous frequency of Ca2+ waves (D) individual specimen waves from a control steady 
state period [black], 5 minutes of TNF-α exposure *red+ and a 2 minute washout [blue]. The 
coloured lines above indicate the 10 s periods which were sampled and averaged, these 
were normalised to the control steady state indicated with the black line above. 
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Figure 4-3. The effects of TNF-α [red] on Ca2+ wave dynamics in left ventricular myocytes 
from young control sheep over 5 minutes, and during a 2 minute washout [blue] (n = 33 cells 
from 10 animals). (A) mean Ca2+ wave amplitude. (B) mean wave frequency. 10 s periods 
were averaged at the end of each minute of cytokine application and each 30 s during 
washout. * indicates p <0.05, NS denotes non-significance (p >0.05). 
 
 
4.3.3 The effect of 50 ng/ml IL-1β on intracellular Ca2+ wave amplitude and 
frequency 
 
The specimen records of Fig 4-4 show an example of the time-dependent effect of IL-1β on 
Ca2+ wave amplitude and frequency. Fig 4-4A and 4-4B show typical original Ca2+ and 
sarcomere length records respectively. A time-dependent decrease in Ca2+ wave amplitude is 
clear and corresponds with a respective decrease in sarcomere shortening. Fig 4-4D provides 
example individual Ca2+ waves from the end of control, TNF-α and wash. As the effect on 
frequency is not as obvious, Fig 4-4C provides the instantaneous frequency over the time 
course of the same experiment, with an obvious progressive increase.  Fig 4-5 and Table 4-2 
show the mean time-dependent decrease of Ca2+ wave amplitude and frequency produced 
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by IL-1β. On average, after 5 minutes of IL-1β exposure the wave frequency was increased by 
28.35 ± 11.35 % (n=32, p <0.001), whereas amplitude was decreased by 34.42 ± 6.82 % 
(n=32, p <0.001). As with TNF-α. neither the effect on frequency or amplitude reversed 
during the duration of the washout period. 
 
 
Table 4-2: The effect of 50 ng/ml IL-1β on normalised Ca2+ wave amplitude and 
instantaneous wave frequency over time and with washout 
Time (min) Normalised Ca2+ amplitude 
(AU) 
Normalised instantaneous 
frequency 
(AU) 
Control 1 ± 0 1 ± 0 
1 0.88 ± 0.05 1.07 ± 0.03 
2 0.81 ± 0.06 1.14 ± 0.05 
3 0.78 ± 0.06 1.13 ± 0.05 
4 0.70 ± 0.06 1.16 ± 0.06 
5 0.66 ± 0.07 1.28 ± 0.11 
Wash (2 min) 0.59 ± 0.08 1.51 ± 0.13 
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Figure 4-4. A specimen record of the effect of 50 ng/ml IL-1β *red+ and washout *blue+ wave 
dynamics, with averaged regions indicated.  (A) specimen record showing Ca2+ waves. (B) 
specimen record showing sarcomere shortening. (C) specimen record showing change in the 
instantaneous frequency of Ca2+ waves (D) individual specimen waves from a control steady 
state period [black], 5 minutes of IL-1β exposure *red+ and a 2 minute washout [blue]. The 
coloured lines above indicate the 10 s periods which were sampled and averaged, these 
were normalised to the control steady state indicated with the black line above. 
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Figure 4-5. The effects of IL-1β [red] on Ca2+ wave dynamics in left ventricular myocytes from 
young control sheep over 5 minutes, and during a 2 minute washout [blue] (n = 39 cells from 
7 animals). (A) mean Ca2+ wave amplitude. (B) mean wave frequency. 10 s periods were 
averaged at the end of each minute of cytokine application and each 30 s during washout. * 
indicates p <0.05, NS denotes non-significance (p >0.05). 
 
 
4.3.4  The effect of TNF-α and IL-1β on SR Ca2+ content threshold for waves 
 
The specimen records of Fig 4-6A and 4-6B show examples of the effect of TNF-α and IL-1β 
respectively on the amplitude of caffeine-evoked SR Ca2+ release. It is important to note that 
caffeine was applied during the onset of a Ca2+ wave and thus infers the SR Ca2+ threshold 
for that wave. With TNF-α on average (Fig 4-6C) caffeine-evoked Ca2+ wave amplitude 
decreased by 49.16 % (control; 1.66 ± 0.2 (n=12), TNF-α; 0.85 ± 0.11 (n=5) F340/F380, p = 
0.021). Following washout this change was maintained (control; 1.66 ± 0.2 (n=12), washout; 
0.77 ± 0.13 (n=6) F340/F380, p = 0.818). 
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On average (Fig 4-6D), with IL-1β the caffeine-evoked Ca2+ wave amplitude decreased by 
52.94 % (control; 1.66 ± 0.2 (n=12), IL-1β; 0.78 ± 0.13 (n=13) F340/F380, p = 0.005). This 
caffeine-evoked Ca2+ transient amplitude was partially recovered with washout, which is not 
significantly different from both control (control; 1.66 ± 0.2 (n=12), washout; 1.29 ± 0.28 
(n=8), F340/F380, p = 0.218) and following 5 minutes of IL-1β exposure (IL-1β; 0.78 ± 0.13 
(n=13), washout; 1.29 ± 0.28 (n=8), F340/F380, p = 0.167). 
 
 
 
 
 
 
 
120 
 
 
 
Figure 4-6. The effects of TNF-α and IL-1β on the SR Ca2+ threshold for waves. (A) specimen 
trace of caffeine application mid-wave in control conditions [black], with TNF-α *red+ and 
wash [blue]. (B) specimen trace of caffeine application mid-wave in control conditions 
[black], with IL-1β *red+ and wash *blue+.  (C) mean caffeine-evoked Ca amplitude with TNF-
α. (D) mean caffeine-evoked Ca2+ amplitude with IL-1β. * indicates p <0.05, NS denotes non-
significance (p >0.05). (control, n = 12 cells from 4 animals; TNF-α, n = 5 cells from 3 animals; 
IL-1β, n = 13 cells from 5 animals; TNF-α washout, n = 6 cells from 4 animals; IL-1β washout, 
n = 8 cells from 5 animals). 
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4.4   Discussion 
 
4.4.1  Does 50 ng/ml TNF-α and IL-1β potentiate the RyR? 
 
Both TNF-α and IL-1β decreased mean Ca2+ wave amplitude and increased mean wave 
frequency (Fig 4-3 and 4-5). As decreased SR Ca2+ threshold occurs when a lower SR Ca2+ 
content is required before SR Ca2+ release, the SR Ca2+ content is lower and thus amplitude 
of Ca2+ released with each wave will also be reduced. Waves also occur more frequently 
when the threshold is reduced as rate of SR Ca2+ uptake is unchanged and a lower SR Ca2+ 
content threshold for waves can be met more promptly. The changes to both parameters 
therefore indicated a decrease in SR Ca2+ threshold for waves.  
 
This was confirmed by the caffeine-evoked Ca2+ wave amplitude when applied mid-wave 
provided the SR Ca2+ content at the time of the wave, at the end of cytokine exposure this 
was reduced by 49.16 % and 52.94 % (Fig 4-6) with TNF-α and IL-1β respectively. As these 
waves occurred at lower SR Ca2+ contents, this further supports that both cytokines 
decreased SR Ca2+ threshold for waves. The SR Ca2+ threshold for waves is primarily 
determined by RyR Po. The decrease in SR Ca
2+ threshold, therefore suggests RyR Po was 
elevated. 
 
It should be noted that for a wave to occur SR Ca2+ content must be increased to that 
threshold; a concept that is important to understand the basis of certain arrhythmias 
(Venetucci et al., 2007). As the primary focus of these experiments were to measure SR Ca2+ 
threshold and therefore RyR Po, not SR Ca
2+ content, the experiment conditions provided 
initially forced SR Ca2+ content to meet the threshold. The above data supports that TNF-α 
and IL-1β decreased the SR Ca2+ threshold for waves in sheep myocytes, suggesting that both 
cytokines increase RyR Po. 
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4.4.2 What is the underlying mechanism of increased RyR Po with TNF-α and 
IL-1β? 
 
RyR Po can be Ca
2+ dependent – with elevated SR Ca2+ or [Ca2+]i contributing to elevated RyR 
Po (Diaz, Trafford, O'Neill, & Eisner, 1997) – or Ca
2+ independent. An example of a Ca2+ 
independent change to RyR Po is caffeine, which potentiates the RyR (Greensmith et al., 
2014). 
 
In section 3.3.3, both cytokines were shown to reduce SR Ca2+ content. A reduction in SR 
Ca2+ content would be expected to decrease RyR Po (Stokke et al., 2011) and thus increase 
the threshold for waves (Diaz et al., 1997). An increase in diastolic [Ca2+]i could also elevate 
RyR Po, however the experiments of sections 3.3.1 and 3.3.2 revealed that neither cytokine 
increased diastolic [Ca2+]i , but rather TNF-α caused a decrease in diastolic [Ca
2+]i and IL-1β 
had no effect. Given that changes to SR and cytoplasmic Ca2+ produced by TNF-α and IL-1β, if 
anything would decrease RyR Po, it appears that effects of both cytokines must therefore 
increase RyR Po directly as opposed to a Ca
2+ dependent effect.  
 
There are multiple other Ca2+ independent mechanisms of change to RyR Po. TNF-α and IL-1β 
can both elevate mitochondrial ROS and activate ROS procuring enzymes such as NADPH 
oxidase (Nox) and xanthine oxidase. Acute cytokine exposure can lead to generation of ROS 
in a dose dependent and transient manner (Brandes, Weissmann, & Schroder, 2014; X. Chen 
et al., 2008; Fauconnier et al., 2011; D. Yang et al., 2007). Nox2 in particular is found in the 
sarcolemma, therefore sharing a close proximity to RyR, allowing local rises in ROS (Brandes 
et al., 2014). 
 
Elevated NO production can also result from TNF-α and IL-1β exposure. With IL-1β, this rise 
in NO can occur due to activation of a myocardial L-arginine NO-pathway. The effects of TNF-
α on negative inotropy have been attributed to NO production (Evans, Lewis, & Shah, 1993; 
Fauconnier et al., 2011; Finkel et al., 1992). 
 
ROS and NO are capable of activating signalling pathways and proteins such as 
Ca2+/calmodulin(CaM)-dependent protein kinase II (CaMKII) and CaM respectively, to 
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indirectly modulate RyR Po, which if increased can contribute to SR Ca
2+ leak (Ho et al., 2014; 
Okabe, Tsujimoto, & Kobayashi, 2000; Y. Yang et al., 2014). For instance, superoxide can 
initiate a signalling pathway involving CaM, Whilst CaM can both activate and inactivate RyR, 
dependent on concentration (Sigalas, Bent, Kitmitto, O'Neill, & Sitsapesan, 2009), CaM 
binding generally modulates Ca2+ release from the SR through reducing RyR Po, acting as an 
inhibitor (Balshaw et al., 2001; Okabe et al., 2000). Low concentrations of superoxide can 
increase RyR Po, while much higher concentrations (μM) can prevent CaM from inhibiting 
RyR entirely (Okabe et al., 2000). The resulting low CaM–RyR binding affinity can lead to 
severe ventricular arrhythmia (Y. Yang et al., 2014).  
 
NO can drive CaMKII oxidation, contributing to increased CaMKII-dependent 
phosphorylation of RyR. RyR phosphorylation increases RyR Po and thus Ca
2+ spark frequency 
(Ho et al., 2014; Stokke et al., 2011). Prolonged (24 hour) IL-1β and (2 hour) TNF-α exposure 
have both been shown to promote CaMKII oxidation and phosphorylation of RyR in mice. 
This has been associated with arrhythmia (Monnerat et al., 2016; Zuo et al., 2018). 
 
Duncan et al. (2010) found that combined application of both TNF-α and IL-1β had no effect 
on RyR potentiation in rat ventricular myocytes following permeabilisation. This suggests 
that a secondary mediator is involved in the effect on RyR which is able to accumulate in 
intact cells and required to do so for modulation to occur. Potential mediators could be ROS 
or NO, which can accumulate locally to RyR.  
 
ROS and NO can also act directly on RyR, to modulate RyR Po. Redox modifies the disulphide 
bonds between cysteine molecules. RyR contains many of these groups and therefore are 
sensitive to redox modification altering RyR Po. ROS induced oxidation can increase the 
sensitivity of RyR to Ca2+ (Y. Yang et al., 2014; Zima & Blatter, 2006; Zissimopoulos & Lai, 
2006). As such ROS, including superoxide and H2O2, can increase RyR Po promoting Ca
2+ 
release from the SR (Kaneko, Matsumoto, Hayashi, Kobayashi, & Yamazaki, 1994; Zima & 
Blatter, 2006). 
 
NO is also capable of directly modulating cardiac RyR via covalent S-nitrosylation of reactive 
thiol residues within the RyR protein. The resulting conformational change increases RyR Po 
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and as such the occurrence of spontaneous Ca2+ release events (Lim, Venetucci, Eisner, & 
Casadei, 2008).  
 
In rat, TNF-α produced an increase in NO production altering RyR S-nitrosylation, known to 
increase RyR Po and thus diastolic Ca
2+ efflux from the SR (Fauconnier et al., 2011). Whilst 
NO-mediated S-nitrosylation increases RyR Po, NO can also decrease RyR Po when the level of 
PKA activation is high (Lim et al., 2008). This may be due to an overshadowing effect of PKA, 
which decreases Ca2+ release events (Valdivia et al., 1995). 
 
Given the fairly fast effect on wave dynamics – with decreases in Ca2+ wave amplitude after 
only 1 and 2 minutes with TNF-α and IL-1β respectively – and the potentiation of the Ca2+ 
transient observed in section 3.X, the effect on RyR must be rapid. Local increases in ROS can 
NO occur rapidly, whereas pathways modifying RyR through phosphorylation are slow, 
taking a place over a number of minutes (Yoshida et al., 1992). The direct effects of ROS and 
NO are therefore the more likely mechanisms by which these cytokines could increase RyR 
Po in sheep myocytes. The involvement of CaM and CaMKII in RyR modification cannot be 
entirely ruled out, especially due to the time-dependency of the effect. 
 
 
4.4.3 Could the TNF-α and IL-1β induced increase in RyR Po contribute to decrease 
of SR Ca2+? 
 
Change to RyR Po alters the magnitude of spontaneous SR Ca
2+ release; this therefore 
regulates SR Ca2+ content. Elevated RyR Po increases SR Ca
2+ leak and would be expected to 
reduce diastolic SR Ca2+ content. Caffeine – known to potentiate the RyR – has 
demonstrated that increased RyR Po can decrease SR Ca
2+ content. This reduction in SR Ca2+ 
content is known the then reduce the frequency of Ca2+ release events (Venetucci et al., 
2007). 
 
In the case of both cytokines, increased RyR Po provides a cellular mechanism for diastolic SR 
Ca2+ leak and the subsequent decrease in SR Ca2+ content previously measured in section 
3.3.3. Other studies which demonstrated reduced Ca2+ transient amplitude and SR Ca2+ 
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content in response to TNF-α and IL-1β, such as Greensmith and Nirmalan (2013) and 
Duncan et al. (2010) can also be attributed to RyR potentiation. Whilst the method used in 
this study can indicate change to RyR Po, it cannot be used to quantify the extent of RyR Po. 
Further experiments using confocal microscopy to measure the rate of Ca2+ sparks could be 
carried out to determine whether the elevation in RyR Po with TNF-α and IL-1β can account 
entirely for the observed decrease in SR Ca2+ content. What is certain is that the increase in 
RyR Po would contribute to reduced SR Ca
2+ content. 
 
 
4.4.4 The time-dependency and relative potency of the effect of TNF-α and IL-1β on 
RyR Po 
 
Over the 5 minute exposure periods with both cytokines, the effects on both Ca2+ wave 
amplitude and frequency changed on a time-dependent. This may indicate a level of time-
dependency of the effect of TNF-α and IL-1β on RyR Po. Whether or not these parameters 
would eventually reach a stable point beyond the 5 minute exposure time is undetermined. 
As the CLP-induced sepsis rat model studied by X. Zhu et al. (2005) also found a progressive 
increase in spontaneous Ca2+ release events over a 48 hour testing period, which – although 
cytokine concentrations were not measured assuming both cytokines were present in the 
septic serum – would suggest that the effects on RyR Po are in fact time-dependent over a 
much longer time period. 
 
This work also suggests that the changes in Ca2+ wave amplitude and frequency with TNF-α 
are more immediate than with IL-1β. At 1 minute in TNF-α, Ca2+ wave amplitude had reduced 
by 14.54 ± 3.8 %, whilst with IL-1β, Ca2+ wave amplitude was only significant decreased after 
2 minutes of exposure by 19.07 ± 6.11 %. Similarly, while both cytokines increased wave 
frequency, this effect was only measured after 5 minutes exposure to IL-1β with a 28.35 ± 
11.35 % increase in instant frequency. The equivalent increase in frequency (27.68 ± 4.97 %) 
was recorded at 3 minutes with TNF-α. This evidence suggests that the effect of IL-1β on RyR 
Po is more latent and to a lesser extent than with TNF-α. It is possible that these cytokines 
alter RyR Po through different mechanisms. 
 
126 
 
4.4.5  Are the effects of 50 ng/ml TNF-α and IL-1β on the RyR Po reversible? 
 
The TNF-α induced decrease in Ca2+ wave amplitude and increase in wave frequency were 
maintained with washout (Fig 4-3) and the effect of TNF-α on the SR Ca2+ threshold for 
waves was irreversible (Fig 4-6), suggesting RyR Po did not recover to control levels or 
increase further during washout. This is supported by Fauconnier et al. (2011)  who also 
found that RyR Po was increased in response to ischemic reperfusion injury induced in rat, 
associated with elevated TNF-α levels. They found that the effect on RyR function was 
maintained a day later, once TNF-α levels had fallen. 
 
During IL-1β washout, the reduction in Ca2+ wave amplitude and increase in wave frequency 
were maintained (Fig 4-5). The effect on the SR Ca2+ threshold for waves, however, appears 
to be partially recovered with washout, as the mean caffeine-evoked Ca2+ wave amplitude is 
between and not significant from both the control state and after IL-1β (Fig 4-6). IL-1β could 
act by a different mechanism with a higher reversibility. It is equally possible that the effect 
of IL-1β on the SR Ca2+ threshold for waves could have been completely reversed with a 
longer washout.  
 
In summary, TNF-α and IL-1β decreased the SR Ca2+ threshold for waves, and therefore 
increased RyR Po on a time dependent basis, with TNF-α acting more rapidly than IL-1β. The 
effect of TNF-α on RyR Po was irreversible, whereas the effect caused by IL-1β showed signs 
of reversibility, with which complete reversibility may have been possible over a longer time 
period. Possible mechanisms for the effect of both cytokines include CaM and CaMKII-
mediated phosphorylation of RyR and direct S-nitrosylation of RyR via NO. All these 
mechanisms can be promoted by elevated ROS and NO production as a result of increased 
cytokines, including TNF-α and IL-1β. Redox modification and S-nitrosylation appear to be 
the more likely mechanisms due to the speed of the effect observed, however the time-
dependency could also suggest that there could be multiple mechanisms at play contributing 
to the overall effect on SR Ca2+ leak. 
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Chapter 5 
 
The effects of 50 ng/ml TNF-α and IL-1β on myofilament 
sensitivity to Ca2+ 
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5.1   Introduction 
 
The previous experiments described in chapter 3 suggested that TNF-α and IL-1β may alter 
myofilament sensitivity, however the precise nature of this effect was not clear. Certain 
observations suggested that myofilament sensitivity may be increased by both cytokines 
while others implied a decrease. There remained a clear need to investigate the effect of 
both cytokines on myofilament sensitivity more thoroughly. 
 
 
5.1.1  Myofilament sensitivity 
 
As described in section 1.2.8.1, the relationship between [Ca2+]i and sarcomere shortening is 
sigmoidal. This relationship can shift in either direction, indicating an increase (left shift) or 
decrease (right shift) in myofilament sensitivity to Ca2+. Myofilament sensitivity to Ca2+ 
determines the force of contracture at a given [Ca2+]i . Changes to myofilament sensitivity 
can occur as a result of altered rate of cross bridge cycling and the strength of cross bridges 
formed. A common target for alteration to myofilament sensitivity is TnC (Moss et al., 2004). 
 
Myofilament sensitivity to Ca2+ is a powerful modulator of inotropy. If myofilament 
sensitivity is increased, a lower [Ca2+]i is required for myofilament activation, positively 
effecting inotropy. Equally, with reduced myofilament sensitivity, myofilaments required 
higher [Ca2+]i for activation, and so contractility at a given [Ca
2+]i is reduced. 
 
An example of a compound which can modulate inotropy in this way is Levosimendan. At 
low concentrations Levosimendan binds with a high affinity to TnC accelerating the rate of 
cross bridge formation (Haikala, Levijoki, & Linden, 1995). This has a positive effect on 
inotropy, increasing the force of contraction without elevating [Ca2+]i (Toller & Stranz, 2006). 
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5.1.2  Myofilament sensitivity in inflammatory disease 
 
Decreased cardiac myofilament sensitivity has been identified in various models of sepsis 
and endotoxemia, including CLP and endotoxin injection. It is thought this phenomenon is 
mediated by NO and increased levels of PKA mediated phosphorylation of myofilament 
associated proteins (Y. Li, Ge, Peng, & Chen, 2013; Sips et al., 2013; Tavernier, Garrigue, 
Boulle, Vallet, & Adnet, 1998; Tavernier et al., 2001; Wu, Tang, & Liu, 2001). It is worth 
noting that these studies were carried out in a small mammal models, as such it is unknown 
whether the relationship between Ca2+ and contractility may be altered in a larger model. 
Also, whether the effect on myofilament sensitivity is directly associated with cytokines is 
undetermined. 
 
In other conditions associated with inflammation in the heart, including end stage heart 
failure and post-myocardial infarction, myofilament Ca2+ sensitivity was increased. Reduced 
PKA mediated phosphorylation due to impaired β-adrenergic stimulation pathways was 
implicated (van der Velden, 2011; Venkataraman et al., 2013). As elevated proinflammatory 
cytokines would be expected in all the above-mentioned inflammatory heart conditions, 
whether they produce a positive or negative change to myofilament sensitivity, if any, is 
unknown. 
 
 
5.1.3  The effects of cytokines on myofilament sensitivity 
 
Previous work suggests cytokines can alter myofilament sensitivity, though work specifically 
related to cardiac muscle, and both TNF-α and IL-1β are limited. Furthermore, findings 
remain controversial.  
 
In skeletal muscle, relatively high concentrations (500 ng/ml) TNF-α reduced myofilament 
calcium sensitivity which was shown to contribute to decreased contractile function in mice. 
It was theorised that ROS and NO may be involved (Reid, Lannergren, & Westerblad, 2002). 
However, in guinea-pig smooth muscle TNF-α increased  the sensitivity of myofilaments to 
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Ca2+, through phosphorylation of the myosin light chain (Parris, Cobban, Littlejohn, 
MacEwan, & Nixon, 1999). 
 
Very few studies have measured the effect of cytokines applied directly to isolated 
ventricular myocytes. Here too exists considerable controversy.  Goldhaber et al. (1996) 
found that relatively very high concentrations of TNF-α (10000 U/ml) could decrease the Ca2+ 
sensitivity of myofilaments in rabbit ventricular myocytes and attributed this to an effect on 
NO production. In those experiments, the effect on myofilament sensitivity was delayed (20 
minutes) which is interesting given that the experiments of chapter 3 suggest that any effect 
on myofilament sensitivity appears to occur over much shorter periods (< 5 minutes). 
Whereas in rat ventricular myocytes, Duncan, Hopkins, and Harrison (2007) demonstrated 
no effect on myofilament sensitivity with TNF-α and IL-1β exposures lasting over an hour. 
 
Overall, evidence supports the hypothesis that cytokines alter myofilament sensitivity, and 
this may account for impaired cardiac function in sepsis and other inflammatory heart 
diseases. While sepsis is associated with decreased myofilament Ca2+ sensitivity, the specific 
effects of TNF-α and IL-1β on myofilament sensitivity and whether these changes have a 
negative or positive inotropic effect remains unclear. 
 
 
5.1.4  Aims 
 
(1) Determine the effect of TNF-α and IL-1β exposure on myofilament sensitivity to Ca2+ 
 
 
5.2  Methods 
 
In order to measure an effect on myofilament sensitivity to Ca2+, a parameter of contractility 
must be correlated with one of intracellular Ca2+. Modulation of [Ca2+]i allows [Ca
2+]i to 
become the independent variable. There are a number of ways to independently modulate 
[Ca2+]i, however they generally fall into one of two approaches; inducing physiological 
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changes to [Ca2+]i – for example altering pacing frequency – or directly altering [Ca
2+]i 
through membrane permeabilisation. In this study, both approaches were used. 
 
 
5.2.1  Modulation of intracellular calcium levels by change of pacing frequency 
 
A standard pacing change protocol was applied to three groups of cells; untreated (exposed 
only to control solution, as detailed in section 2.2.1), 50 ng/ml TNF-α treated and 50 ng/ml 
IL-1β treated. The pacing protocol is demonstrated in Fig 5-1. Once a healthy pacing cell had 
been identified at 0.5 Hz, the stimulation frequency was then reduced to 0.1 Hz. Stimulation 
frequency was increased in a stepwise manner – through 0.5 Hz, 1 Hz and 2 Hz – to 3 Hz, and 
allowed to reach a new steady state at each frequency.  
 
In cytokine-treated experiments, either TNF-α or IL-1β were applied through superfusion, as 
opposed to prior incubation. As such, in order to first confirm that a selected cell had basic 
contractile function, this was administered following a period of pacing at 0.5 Hz in control 
solution. Once a new steady state had formed with the cytokine, the pacing protocol 
continued. 
 
An average of the final 5 Ca2+ beats were taken and analysed as per the protocol described in 
section 2.3. Mean values were normalised to control. The data from each cell was plotted 
both as diastolic Ca2+ against resting sarcomere length, and as the sarcomere length : 
diastolic Ca2+  against frequency. The relationship between end diastolic Ca2+ and sarcomere 
length were used to measure changes to myofilament sensitivity to Ca2+, for the purpose of 
this experiment, as these parameters had the most stability (Wisloff et al., 2001). In both 
cases, the relationship between the two parameters was quantified using regression 
analysis. As the nature of the change was unclear, we used both single exponential, f = 
y0+a*exp(-b*x), and linear regression, f = y0+a*x. The values of the b and y0 coefficients 
were studied from the exponential and linear regressions respectively. Means were 
compared using a one-way ANOVA. When testing the effect of frequency on diastolic Ca2+ 
and shortening in control cells, the one-way ANOVA was followed by a Dunn’s post-hoc test.  
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Figure 5-1. A diagram demonstrating the change in stimulation frequency of the time course 
of the experiment; highlighting the period over which the pacing cell was in control solution 
[black] and the period for which a cytokine treatment (if any) was applied [red]. 
 
 
5.2.2  Modulation of intracellular Ca2+ using permeabilisation.  
 
Cells were permeabilised by superfusion with 20 μg / ml saponin in a Ca2+ free variation of 
the control solution described in section 2.2.1, for 60 – 90 s. The starting exposure time at 
the beginning of an experimental day was ~70 s, this exposure time was adapted throughout 
the day based on the success of the permeabilisation achieved in the previous experiment. 
This allowed for any variation in the initial membrane integrity following the isolation 
protocol and any further deterioration throughout the day.  
 
Once permeabilised, resting sarcomere length was left to stabilise in a 0 Ca2+ control 
solution. In 50 ng/ml TNF-α and IL-1β treated cells, the cell was exposed for >100 seconds 
even if a steady state was reached prior to this, to allow time for any effect on myofilament 
sensitivity to Ca2+ to occur. 100 s was chosen as the minimum exposure period to each 
cytokine prior to an increase in [Ca2+], as this fell within the range of exposure times used in 
the experiments of chapter 3, in which a possible effect on myofilament sensitivity had been 
indicated. 
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In case the effect on myofilament sensitivity with these cytokines was time-dependent, the 
cell was exposed to each elevation in [Ca2+] – 50 nM, 150 nM and 200 nM Ca2+ – for 
approximately 100 s. The experiment was ended early if the cell began to wave and data 
from that cell at the highest concentration tested could only be used if a steady state had 
been reached prior to the 1st wave. The resting sarcomere length during the last 10 s at each 
[Ca2+] was measured using custom software (Greensmith, Eisner, & Nirmalan, 2010). If this 
10 s period was unstable or in a constant state of decline, a point which best represented 
the sarcomere length over this period was measured. Mean sarcomere lengths measured at 
each [Ca2+] were normalised to that measured in 0 Ca2+. Data were analysed using a two-way 
ANOVA and subsequent individual comparisons were carried out through a Holm-Sidak post-
hoc test. 
 
Cells which survived exposure to 200 nM Ca2+ (at pH 7.34, as with all previous control 
solutions), were exposed to 100 s each to two further pH solutions. This resulted in a total of 
3 pH control solutions – at pH 7.1, pH 7.34 and pH 7.6 – with a fixed Ca2+ concentration of 
200 nM. The additional pH control solutions did not contain cytokines. This was designed as 
an supplementary control to determine whether the permeabilisation protocol was 
successful at allowing external application of Ca2+ to directly alter [Ca2+]i and the resultant 
sarcomere shortening, as pH is known to alter myofilament sensitivity to Ca2+ (Orchard & 
Kentish, 1990). 
 
 
5.3   Results 
 
5.3.1 The effect of rate induced change to intracellular Ca2+ on sarcomere length in 
the presence of TNF-α and IL-1β 
 
The absolute levels of systolic and diastolic intracellular Ca2+ and so force, are known to be 
dependent on stimulation frequency. The precise force (calcium)-frequency relationship is 
species dependent. In the majority of species including healthy humans, increased frequency 
is associated with a positive effect on both systolic and diastolic [Ca2+]i and so sarcomere 
shortening (Bers, 2000; Gattoni et al., 2016; Varian & Janssen, 2007). For the purpose of this 
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experiment however, the nature of this relationship is not important. Rather, altering pacing 
frequency simply provides a physiological way to alter [Ca2+]i levels in intact and fully 
functional cells and so provides a way to probe the relationship between [Ca2+]i levels and 
sarcomere length. 
 
The specimen records of Fig 5-2, 5-3 and 5-4 show examples of the effect of stimulation 
frequency on Ca2+ dynamics in untreated, TNF-α treated and IL-1β treated cells respectively. 
For each cell and at each frequency end diastolic Ca2+ and sarcomere length was measured. 
The mean normalised data from this analysis can be seen in Fig 5-5. It is clear from Fig 5-5A 
that the relationship between diastolic Ca2+ and sarcomere length is not altered by TNF-α or 
IL-1β. Whilst an exponential relationship would be expected, at lower frequencies this can 
appear linear (Varian & Janssen, 2007). As per section 5.2.1 the relationship was quantified 
using both linear and single exponential regression analysis on a cell by cell basis. On 
average, the slope of linear regression was unchanged between untreated cells (n=17) and 
those treated with TNF-α (n=10) and IL-1β (n=12) (p = 0.658) (Fig 5-5B). The mean rate 
constant of single exponential analysis was also unaffected in untreated (n=16), TNF-α (n=9) 
and IL-1β (n=12) treated cells (p = 0.571) (Fig 5-5C). This suggests that neither were altered 
by either cytokine.  
 
The nature of the relationship between Ca2+ and sarcomere length carried between cells 
were not consistently described by linear or exponential regression, hence both methods 
were required. As such regression analysis was also performed on the relationship between 
rate and the ratio of end diastolic sarcomere length : Ca2+. This too was unaffected by either 
cytokine, as no change was revealed between untreated (n=14), cells and those treated with 
TNF-α (n=9) and IL-1β (n=12) (p = 0.238) (Fig 5-6). 
 
The specimen records of Fig 5-2A show examples of the effect of stimulation frequency on 
Ca2+ dynamics in untreated control cells. In control cells, on average stimulation frequency 
increased diastolic Ca2+ by 24.73 ± 6.43 % (n=19, p <0.05) and 51.92 ± 11.53 % (n=12, p 
<0.05) (Fig 5-2C) and 2 Hz and 3 Hz respectively. The lower stimulation frequencies – 0.1 Hz 
(n=22, p >0.05) and 1 Hz (n=19, p >0.05) – had no effect on diastolic Ca2+ levels. 
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The specimen records of Fig 5-2B show examples of the effect of stimulation frequency on 
contractility in untreated control cells. Increase in stimulation frequency decreases resting 
sarcomere length. When compared to that of 0.1 Hz, in control cells sarcomere length 
decreased by 0.71 ± 0.15 % (n=21, p <0.05), 1.55 ± 0.29 % (n=19, p <0.05), 3.08 ± 0.43 % 
(n=19, p <0.05), 5.14 ± 0.51 % (n=12, p <0.05) with 0.5 Hz, 1 Hz, 2 Hz and 3 Hz respectively 
(Fig 5-2D). 
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Figure 5-2. The influence of pacing frequency on Ca2+ dynamics and contractility in untreated 
control cells (n = 22 cells from 5 animals). (A) specimen record of change to systolic Ca2+ with 
change in frequency. (B) specimen record of change to contractility with change in 
frequency. (C) Mean diastolic [Ca2+] at different pacing frequencies. (D) and resting 
sarcomere length at different pacing frequencies. * indicates p <0.05, NS denotes non-
significance (p >0.05). 
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Figure 5-3.  The influence of pacing frequency on Ca2+ dynamics and contractility in TNF-α 
treated cells. (A) specimen record of change to systolic Ca2+ with change in frequency. (B) 
specimen record of change to contractility with change in frequency.  
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Figure 5-4.  The influence of pacing frequency on Ca2+ dynamics and contractility in IL-1β 
treated cells. (A) specimen record of change to systolic Ca2+ with change in frequency. (B) 
specimen record of change to contractility with change in frequency.  
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Figure 5-5. Mean data showing the relationship between resting sarcomere length and 
diastolic [Ca2+] in untreated [black] (n = 22 cells from 5 animals), TNF-α treated *red+ (n = 13 
cells from 4 animals), and IL-1β treated *blue+ (n = 12 cells from 4 animals) cells. (A) mean 
normalised resting sarcomere length plotted against mean normalised diastolic [Ca2+]. (B) 
Mean rate constant of the curve relationship between resting sarcomere length and diastolic 
[Ca2+]. (C) Mean change in diastolic [Ca2+] with change in resting sarcomere length. * 
indicates p <0.05, NS denotes non-significance (p >0.05). 
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Figure 5-6. Mean data showing the relationship between the ratio of resting sarcomere 
length and diastolic [Ca2+], and frequency in untreated [black], TNF-α treated *red+, and IL-1β 
treated [blue] cells. (A) mean normalised resting sarcomere length ; diastolic [Ca2+] against 
frequency. (B) mean rate constant of the curve relationship between the resting sarcomere 
length : diastolic [Ca2+] and frequency. * indicates p <0.05, NS denotes non-significance (p 
>0.05). 
 
 
5.3.2  The effect of TNF-α and IL-1β on the relationship between *Ca2+]i and resting 
sarcomere length in permeabilised cells 
 
Through the permeabilisation of myocytes it is possible to directly alter intracellular Ca2+ by 
introducing the cells to solutions of defined [Ca2+]. This provides a more direct method of 
controlling intracellular calcium and so measures any change in myofilament sensitivity to 
Ca2+. The range of [Ca2+] in experimental solutions must be much lower than described in 
section 2.2.1 as the membrane and ion channels within no longer act as a selective barrier. 
Rather, internal Ca2+ will simply equilibrate with external. Though this manoeuvre alters cell 
function considerably, it has been used by others to isolate and specifically measure change 
to myofilament sensitivity to Ca2+ (Parris et al., 1999; Wisloff et al., 2001).  
 
Fig 5-7A shows the result of this manoeuvre in untreated cells. A clear, response of 
sarcomere length to the range of calcium concentrations used is apparent. This 
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demonstrates that (1) the permeabilisation protocol is working, as without direct 
equilibration, such small changes of Ca2+ would not produce an effect and (2) the magnitude 
of sarcomere length change is great enough to provide sufficient sensitivity to detect an 
effect by cytokines if one were to exist. 
 
The specimen record of Fig 5-7A, B and C show examples of the change of sarcomere length 
in response to change of [Ca2+]i in untreated, TNF-α and IL-1β exposed cells. Fig 5-8 shows 
the mean relationship between [Ca2+]i and sarcomere length and results of a two-way 
ANOVA. These data demonstrate two points. (1) sarcomere shortening in response to 
increased [Ca2+]i is preserved in the presence of both cytokines. Although, (2) compared to 
control, that response is blunted by both TNF-α (n=17, p = 0.003) and IL-1β (n=21, p<0.001). 
In other words, in the presences of TNF-α and IL-1β the degree of shortening produced by 
any given [Ca2+]i over the experimental range used is less. This is highlighted by the 
sarcomere length response to the highest concentration of Ca2+ used. In control cells, 200 
nM Ca2+ produced a 2.25 ± 1.1 % (n=8) decrease in sarcomere length relative to 0 Ca2+. In the 
presences of TNF-α and IL-1β, the same concentration of Ca2+ only produced a 0.64 ± 0.24 % 
(n=6) and 0.43 ± 0.13 % (n=6) decrease respectively. There was no difference in the 
magnitude of blunted response between cytokines (p = 0.546). 
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Figure 5-7. Specimen records demonstrating the change in resting sarcomere length in 
permeabilised cells with increasing [Ca2+]. The bars above indicated the time period over 
which an average was taken. (A) in untreated control cells. (B) in 50 ng/ml TNF-α treated 
cells. (C) in 50 ng/ml IL-1β treated cells 
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Figure 5-8. Mean resting sarcomere length at different [Ca2+] in untreated control cells 
[black] (n = 17 cells from 5 animals), TNF-α treated cells [red] (n = 17 cells from 5 animals) 
and IL-1β treated cells *blue+ (n = 21 cells from 7 animals). A two-way ANOVA revealed 
significance in the sarcomere length response with each [Ca2+] [above], and the significance 
of the effect between untreated, TNF-α treated and IL-1β treated cells *right+. * indicates p 
<0.05, NS denotes non-significance (p >0.05). 
 
 
5.3.3  Effects of acidity on myofilament sensitivity to Ca2+ with TNF-α and IL-1β 
 
pH is known to alter myofilament sensitivity to Ca2+, while retaining the sigmoidal 
relationship between [Ca2+] and contractile force. pH interacts with troponin, altering the 
affinity of TnC for Ca2+ and its relationship with TnI. Acidosis reduces Ca2+ sensitivity, while 
increased pH increases Ca2+ sensitivity (Orchard & Kentish, 1990). Wisloff et al. (2001) used 
pH as a positive control in experiments measuring change to myofilament sensitivity to Ca2+ 
in permeabilised cells. In this study, we changed pH for two reasons. (1) In untreated cells, 
the change of pH served as a positive control to demonstrate we could detect a change to 
myofilament sensitivity to Ca2+ if one exists. (2) In treated cells, to determine if pH produced 
any further change myofilament sensitivity to Ca2+.  It was thought that the latter 
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experiments may provide addition support the experiments of section 5.3.2 and would 
highlight whether any myofilament sensitivity to Ca2+ reserve remained or if the effect had 
been saturated. 
 
In untreated control cells, myofilament sensitivity to Ca2+ decreased with increased acidity, 
resulting in reduced shortening at a given [Ca2+]i of 200 nM (Fig 5-9). With IL-1β, at any given 
pH the degree of shortening was reduced in comparison to control. However, the 
relationship between myofilament sensitivity to Ca2+ and pH appears to be at least partially 
lost. This is highlighted by the observation that similar magnitudes of shortening occur at 
each pH, with 0.48 ± 0.23 % (n=4), 0.43 ± 0.13 % (n=6), and 0.6 ± 0.27 % (n=3) reductions in 
sarcomere length from control at pH 7.1, 7.34 and 7.6 respectively.  
 
With TNF-α, at pH 7.34, the change to sarcomere length is similar to that of IL-1β, decreasing 
by 0.64 ± 0.24 % (n=6). At pH 7.1 and 7.6 sarcomere shortening with TNF-α is increased in 
relation to control, with 3.53 ± 3.08 % (n=6) and 4.19 ± 2.97 % (n=6) decreases in resting 
sarcomere length at the set [Ca2+], however the relationship between myofilament 
sensitivity to Ca2+ and pH is maintained. 
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Figure 5-9. The mean resting sarcomere length at different acidities in untreated control cells 
[black] (n = 8 cells from 4 animals), TNF-α treated cells *red+ (n = 6 cells from 5 animals) and 
IL-1β treated cells [blue] (n = 6 cells from 3 animals). 
 
 
5.4   Discussion 
 
5.4.1   Do TNF-α and IL-1β reduce myofilament sensitivity to Ca2+? 
 
Two experiments were used in an attempt to answer this question, both of which measured 
the relationship between change to sarcomere length with change to [Ca2+]i physiologically. 
The first experiment modulated [Ca2+]i physiologically using change to stimulation frequency. 
In the second experiment, permeabilisation of the cell membrane allowed [Ca2+]i to be 
directly modulated through change in the [Ca2+] of solutions. In both cases, the resulting 
change to sarcomere length was measured. 
 
 
5.4.1.1  Is the sarcomere length response to physiologically modulated [Ca2+]i altered 
by TNF-α and IL-1β? 
 
As introduced in 5.3.1, a change in stimulation frequency is known to alter [Ca2+]i
 (Bers, 
2000). Wisloff et al. (2001), Sips et al. (2013) and Reid et al. (2002) have used rate to produce 
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a change in Ca2+, and so measure changes to myofilament sensitivity. As per Fig 5-2 and as 
expected, in sheep increasing pacing frequency increased diastolic [Ca2+]i resulting in 
decreased resting sarcomere length. As such, we were able to compare the effects of both 
cytokines on the relationship between Ca2+ and sarcomere length. 
 
According to Fig 5-5 and 5-6, it appears that neither TNF-α and IL-1β alter the relationship 
between Ca2+ increased by pacing frequency and sarcomere length. This observation alone 
suggests that neither TNF-α and IL-1β alter myofilament sensitivity.  
 
As shown in Fig 5-2C, although 2 Hz and 3 Hz were able to increase diastolic Ca2+ 
considerably in the untreated sheep myocytes – by 24.73 ± 6.43 % and 51.92 ± 11.53 % 
respectively – the remaining lower frequencies were unable to alter diastolic Ca2+. Similarly, 
while the entire rate spectrum tested was able to cause a significant decrease in sarcomere 
length, the magnitude of these changes ranged between 0.71 ± 0.15 % and 5.14 ± 0.51 % (Fig 
5-2D). Given that the change to sarcomere length is so small over this range, the pacing 
frequency range used in this study to physiologically alter [Ca2+]i may have been too narrow 
to provide sufficient sensitivity to detect an effect of either cytokine tested, should one exist. 
In rabbit – a small mammal model known to have a positive force-frequency relationship 
(Bers, 2000) – Varian and Janssen (2007) solely found significant changes in diastolic [Ca2+]i, 
at the higher frequencies tested (2 Hz and 3 Hz), this correlates with the findings in sheep 
(Fig 5-2C). It therefore is not surprising that over the range of frequencies used, the 
relationship between diastolic Ca2+ and sarcomere length appeared more linear. Similarly, in 
an endotoxin–administered model of sepsis, a decrease in diastolic Ca2+ and Ca2+ amplitude 
were found at 4 Hz, indicating a reduction in  myofilament sensitivity to Ca2+ (Sips et al., 
2013). In skeletal muscle fibres, Reid et al. (2002) 500 ng/ml TNF-α, a concentration 10 fold 
higher than used in this study, was shown not to affect contractile force at 1 and 10 Hz.  
 
In comparison to the range of stimulation frequencies used in this study (0.1-3 Hz), Wisloff et 
al. (2001), Sips et al. (2013) and Reid et al. (2002) carried out tests over a much wider range 
of frequencies; 0.1-10 Hz, 1-4 Hz and 1-150 Hz.  Whilst higher frequencies, such as 4 Hz and 5 
Hz, were attempted in the sheep ventricular myocytes used in this study, the myocytes 
would not tolerate higher frequencies or could not maintain a steady state, therefore it was 
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not possible to reach or exceed a higher pacing frequency such as 10 Hz. A factor which may 
have contributed to the sheep myocytes inability to reach higher pacing frequencies, was 
the use of field stimulation as appose to patch clamping as a method of pacing cells. In 
addition, smaller mammal models, such as rat and mouse, are more tolerant to higher 
pacing frequencies, as their hearts naturally beat at a faster frequency than sheep. 
 
There are disadvantages however, to using small mammal models in this experiment; their 
relationship between stimulation frequency and [Ca2+]i, and thus contractility, is biphasic. At 
lower stimulation frequencies – 0.5-1 Hz in rat and 1-2 Hz in mice – the force-frequency 
relationship is negative (Endoh, 2004; Gattoni et al., 2016). In sheep, there was a positive 
relationship between stimulation frequency and diastolic [Ca2+]i, and therefore resting cell 
length (Fig 5-2), this is therefore more clinically relevant to human studies (Bers, 2000; 
Gattoni et al., 2016). 
 
Although other studies, such as Wisloff et al. (2001), have used this physiological method of 
adjusting [Ca2+]i through change to stimulation frequency, in order to determine an effect on 
myofilament sensitivity to Ca2+. More recent work by Varian and Janssen (2007) has 
indicated that, within the tested frequency range of 1-4 Hz, stimulation frequency can cause 
a decrease myofilament sensitivity to Ca2+ in rabbit. It is uncertain whether the effect of 
frequency on myofilament sensitivity to Ca2+ also exists in other species, however given that 
this would impact results, it may not necessarily be the most robust way to measure 
myofilament sensitivity. 
 
Given the limitations in both the method and the rate spectrum achieved in a large mammal 
model, the changes of Ca2+ and sarcomere length produced by this range of frequencies may 
have been too small to reveal an effect on myofilament sensitivity to Ca2+. As such, a more 
direct way of changing [Ca2+]i was required.  
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5.4.1.2  Is the sarcomere length response to directly modulated [Ca2+]i altered by 
TNF-α and IL-1β? 
 
Both 50 ng/ml TNF-α and IL-1β individually decreased the extent of sarcomere shortening 
with stepwise increases in [Ca2+] when compared to untreated cells. At the highest 
concentration tested (200 nM Ca2+) resting sarcomere length decreased by 2.25 ± 1.1 %, 0.64 
± 0.24 % and 0.43 ± 0.13 % in untreated, TNF-α treated and IL-1β treated cells respectively 
(Fig 5-8). This indicates a 71.56 % and 80.89 % reduction in the Ca2+ sensitivity of 
myofilament to with TNF-α and IL-1β. As there was no significant difference between the 
relationship between [Ca2+] and sarcomere length with TNF-α and IL-1β (p = 0.546), it is clear 
that both cytokines cause a similar effect on myofilament sensitivity to Ca2+.  
 
Despite the use of a 10 fold lower TNF-α concentration in this study, the effect of TNF-α was 
similar to that observed in mice skeletal muscle (Reid et al., 2002). This study also provides 
evidence that the decrease in myofilament sensitivity with TNF-α found by Goldhaber et al. 
(1996) in rabbit ventricular myocytes, is also a mechanism of decreased contractility in a 
large mammal model. Unlike the work of Goldhaber et al. (1996) however, which only 
identified an effect of Ca2+ sensitivity following ~20 minutes exposure to TNF-α, this study 
found evidence of decreased Ca2+ sensitivity over a much shorter time base (<10 mins). 
 
The findings of this study also contradict that of Duncan et al. (2007), who found no change 
to myofilament sensitivity with prolonged TNF-α and IL-1β exposure in rat ventricular 
myocytes. As this study has identified that both TNF-α and IL-1β decrease Ca2+ sensitivity an 
overall larger decrease in Ca2+ sensitivity would be expected when both cytokines were 
administered together. Another possible explanation for the lack of an effect of these 
cytokines on myofilament sensitivity, may be a difference in activity in rat or an interaction 
between the cytokines which prevents an effect on myofilament sensitivity. Duncan et al. 
(2007) did however state that their method for detecting change to myofilament sensitivity 
may not have been sensitive enough to reveal a change, due to wide variation in the cells 
inotropic state initially. 
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5.4.2 How rapid are the effects of TNF-α and IL-1β on myofilament sensitivity to 
Ca2+? – What is a possible mechanism for this change? 
 
In endotoxemia, a condition associated with sepsis in which proinflammatory cytokines such 
as TNF-α and IL-1β would be expected to be elevated, there has been a reported time-
dependent decrease in myofilament sensitivity to Ca2+ (Tavernier et al., 1998). Reid et al. 
(2002) later found that TNF-α could alter Ca2+ sensitivity on a time-dependent basis. This 
effect was gradual, with a ~4 % decrease in contractile force each hour.  
 
Given the time allowed for steady state to be reach in 0 Ca2+ and the ~100 s exposure times 
in each [Ca2+] used in this study, the overall cytokine exposure lasted for approximately 7-10 
minutes. The length of exposure was much therefore much shorter than that used by Reid et 
al. (2002). At 200 nM Ca2+ – the final concentration introduced – the magnitude of 
sarcomere shortening had already been blunted with TNF-α. TNF-α caused a 0.64 ± 0.24 % 
decrease in sarcomere length, in comparison to the much larger 2.25 ± 1.1 % decrease in 
untreated cells. The effect on change to Ca2+ sensitivity therefore appears more rapid that 
suggested by Reid et al. (2002). A similar effect was observed in IL-1β treated cells where 
sarcomere shortening had also been blunted within the time course of the experiment, with 
only a 0.43 ± 0.13 % decrease in sarcomere shortening. 
 
Previous work by Tavernier et al. (2001) indicated that increased phosphorylation, possibly 
by PKA, was the mechanism of decreased myofilament sensitivity to Ca2+ in a model of 
endotoxemia. PKA-mediates phosphorylation of cardiac myosin–binding protein C, this 
increases the rate of cross bridge detachment, therefore decreasing myofilament sensitivity 
(P. P. Chen, Patel, Rybakova, Walker, & Moss, 2010). TnI can also undergo phosphorylation 
via PKA, further contributing to decreased myofilament sensitivity to a smaller extent (M. 
Kumar et al., 2015). Wu et al. (2001) found that phosphorylation of TnI occurred in the 
earlier stages of sepsis – 9 hours following CLP – whereas during later phases, 
phosphorylation of myosin–binding protein C was predominant. Phosphorylation of these 
proteins can also be carried out by PKC. Phosphorylation is time-dependant, however 
phosphorylation of these proteins with PKA and PKC can increase over minutes (~2 min) 
exposure (Noland et al., 1995). This would be within the time course of this study, as >100 s 
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exposure to either cytokine was allowed prior to the first increase in [Ca2+], in order to allow 
a steady state to be reached in 0 Ca2+. Phosphorylation of these myofilament associated 
proteins could therefore be a possible mechanism of decreased myofilament sensitivity to 
Ca2+ with TNF-α and IL-1β.  
 
Another possible mechanism of altered myofilament sensitivity to Ca2+ involves the direct 
effect of elevated NO and ROS production. In acute inflammation of the heart, NO and ROS 
have both been associated with reduced myofilament sensitivity to Ca2+ and impaired 
relaxation (Y. Li et al., 2013). In sepsis, S-nitrosylation of myofilament associated proteins is 
considered to be responsible for the decrease in myofilament sensitivity to Ca2+ (Sips et al., 
2013). Excessive NO production can however limit ROS production and as such lead to 
increased myofilament sensitivity to Ca2+ (Ichinose et al., 2007). 
 
 
5.4.3 Do the effects of TNF-α and IL-1β on myofilament sensitivity to Ca2+ alter with 
change to pH? 
 
The expected relationship between pH and myofilament sensitivity to Ca2+ was found in 
untreated control cells, supporting that the permeabilisation method was effective and 
enabling control of intracellular [Ca2+] and pH, and thus as a way of determining change to 
myofilament sensitivity. 
 
When compared to the untreated cells, IL-1β reduced the change in sarcomere shortening 
achieved at all pH levels, at the given [Ca2+]i of 200 nM. This supports the message of section 
5.4.1.2 in that the decrease in myofilament sensitivity to Ca2+ with increased acidity is 
enhanced with IL-1β. IL-1β is therefore capable of reducing myofilament sensitivity to Ca2+ in 
sheep ventricular myocytes. With IL-1β, the degree of Ca2+ sensitivity also appeared to be 
less affected by increased acidity, resulting in a similar degree of shortening in all pH 
solutions used. This indicates that the pH dependency is partially lost in the presence of IL-
1β. This loss of pH dependency suggests that the effect on myofilament sensitivity to Ca2+ 
caused by IL-1β is much greater than that of pH, and therefore IL-1β has already saturated 
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the effect on myofilament sensitivity to Ca2+, resulting in no further influence by change in 
pH. 
 
For economy reasons, TNF-α and IL-1β were left out of the pH solutions, with the exception 
of pH 7.34, which was the final solution used in the concentration curve above. This was 
carried out under the assumption that the effect of assumption that the effect of these 
cytokines on myofilament sensitivity would not readily wash out. As this experiment was 
measuring diastolic changes to sarcomere length, the assumption that the effect of TNF-α on 
myofilament sensitivity to Ca2+ would not readily reverse were based on the diastolic 
changes with TNF-α, shown in chapter 3. As per Fig 3-2C and 3-2D, the changes to both 
diastolic Ca2+ and resting sarcomere length with TNF-α were maintained with washout. 
 
Over the pH range used, TNF-α appeared to cause an increase in myofilament sensitivity to 
Ca2+. Sarcomere shortening was reduced when exposed to the pH 7.34 solution which did 
contain TNF-α – like IL-1β – indicating a reduction in Ca2+ sensitivity. The pH 7.1 and 7.6 
solutions did not contain cytokines, and as such, mimics a washout step. The absence of 
cytokine from these solutions did not appear to affect the response to IL-1β, suggesting that 
the effect of IL-1β on myofilament sensitivity to Ca2+ was maintained following washout. 
With TNF-α washout, the effect on myofilament sensitivity to Ca2+ is shown to be far more 
readily reversible, restored to similar levels as untreated cells. This suggests that the effect 
of the cytokine is greater than that of pH following removal of TNF-α, and also that TNF-α 
has a higher reversibility than IL-1β. 
 
A previous study by Goldhaber et al. (1996) investigated the possibility that TNF-α could 
alter myofilament sensitivity through a cytokine-induced change in pH. They found that 
change in pH was not the mechanism behind the TNF-α induced reduction of myofilament 
sensitivity in rabbit ventricular myocytes. This study further confirms the lack of involvement 
of pH, as both cytokines were demonstrated to have a much larger effect on myofilament 
sensitivity than pH. 
 
Both TNF-α and IL-1β data supports a general reduction in myofilament sensitivity to Ca2+, in 
which TNF-α had a higher level of reversibility. 
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5.4.4 Can the change to myofilament sensitivity to Ca2+ observed account for the 
changes to inotropy? 
 
Other exogenous substances have been discovered with the ability to modulate myofilament 
sensitivity and alter inotropy. One such example is blebbistatin; a known Ca2+ desensitiser, 
which inhibits myosin-II ATPase to uncouple myofilament cross bridges in a dose dependent 
manner. In rat cardiac myocytes, Farman et al. (2008) found that 1 hour exposure to 0.5 μM 
blebbistatin almost completely abolished sarcomere shortening with no effect on Ca2+ 
transient amplitude. Blebbistatin can therefore be used as an example of how a Ca2+ 
desensitizer can reduce inotropy. 
 
As per chapter 3, 50 ng/ml TNF-α reduced sarcomere shortening by 20.31 ± 7.58 % (Fig 3-
2B), while IL-1β did not affect sarcomere shortening (Fig 3-4B). The effects with these 
cytokines on contractility are therefore weaker than the comparatively great levels of 
contractile inhibition with blebbistatin (Farman et al., 2008). As per section 5.3.2, both 
cytokines reduce myofilament sensitivity to Ca2+, however as higher [Ca2+] (150 nM and 200 
nM) were able to cause a degree of sarcomere shortening (Fig 5-8), the ability of TNF-α and 
IL-1β to decrease in myofilament sensitivity is not as strong as that on blebbistatin. The 
reduced myofilament could contribute to loss of contractility, especially with the observed 
loss of contractility with TNF-α.  
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Chapter 6 
 
The effect of TNF-α on Ca2+ handling and contractility in left 
ventricular myocytes from sheep with induced heart failure 
and those allowed to recover 
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6.1  Introduction 
 
As was introduced in section 1.1.7, in heart failure, contractility is impaired, particularly in 
the left ventricle. This often leads to reduced fractional shortening and, as a result, reduces 
ejection fraction to less than 40 %. Cardiac output is therefore not easily maintained in heart 
failure, leading to hypoperfusion (Briston et al., 2011; Kemp & Conte, 2012; Mullens et al., 
2008). As the heart cannot eject the same volume of blood, end-diastolic volume increases, 
as does end-systolic volume (Briston et al., 2011; Kemp & Conte, 2012). 
 
Low cardiac output can promote cardiac remodelling. This helps the heart to maintain 
cardiac output and prevent hypoperfusion, but though increased cardiac workload. Resulting 
symptoms include dyspnea (laboured breathing) and tachycardia (Kemp & Conte, 2012). Due 
to the blunted force frequency relationship in the failing heart, tachycardia could worsen 
heart failure with a negative effect on inotropy (Lou, Janardhan, & Efimov, 2012; Mullens et 
al., 2008). 
 
 
6.1.1   Altered Ca2+ handling in heart failure 
 
This study is not attempting to characterise altered ECC in heart failure, as this has already 
been investigated using a robust and integrative approach (Briston et al., 2011). 
Alternatively, this study will explore the response of cells isolation from a heart failure model 
to TNF-α. It is therefore important to first understand perturbed Ca2+ handling in heart 
failure.  
 
The Ca2+ transient amplitude decreased is reduced in heart failure, leading to reduced 
contractility. Whilst some studies have reported that SR Ca2+ content is reduced in heart 
failure (Lou et al., 2012; Phillips et al., 1998), Briston et al. (2011) reported that change to SR 
Ca2+ content may not be the primary cause of reduced Ca2+ release, rather decreased ICaL 
could lead to reduced CICR by RyR. Equally, while RyR levels remain unchanged in heart 
failure, decreased fractional release via RyR means that ICaL must be higher (Briston et al., 
2011; Lou et al., 2012; Phillips et al., 1998). Impaired Ca2+ uptake by SERCA has been 
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implicated in the reduction to SR Ca2+ content (Lou et al., 2012). In heart failure resulting 
from ischemia, SERCA can be down-regulated, however in other forms and models of heart 
failure SERCA protein levels are unaffected (Briston et al., 2011; Lou et al., 2012).  
 
There is conflicting evidence over whether PLN levels change in heart failure, with reports of 
down-regulated PLN in some cases of heart failure (Lou et al., 2012; Phillips et al., 1998). 
Down-regulation of PLN reduces the inhibition of SERCA, and therefore may be a 
compensatory mechanism to improve SR Ca2+ loading. There is however a reduced ability to 
modulate SR Ca2+ content with lower PLN, as such beat to beat variation in SR Ca2+ release 
and the resulting contractility, can lead to the occurrence of alternans (Phillips et al., 1998).  
 
Decreased phosphorylation of PLN has also been reported in heart failure, contributing to 
reduced SR Ca2+ uptake by SERCA. The lower rate of Ca2+ removal contributes slower 
relaxation. It is thought than these effects on PLN and SERCA activity are mediated by levels 
of PKA and CaMKII. In some cases of heart failure, increased involvement of NCX in Ca2+ 
removal, results in overall rate of Ca2+ removal being unaffected, but lower diastolic Ca2+. 
Heart failure cells are also less responsive to β-adrenergic stimulation (Briston et al., 2011; 
Lou et al., 2012; Phillips et al., 1998). 
 
 
6.1.2  Cytokines in heart failure 
 
TNF-α are increased in congestive heart failure and continue to increase with elevation in 
disease severity (Aukrust et al., 1999; Torre-Amione et al., 1996). Circulating plasma 
concentrations of TNF-α have been measured within a range of 0.5 – 32 pg/ml TNF-α in 
plasma in congestive heart failure by Testa et al. (1996) and 1.95-64 pg/ml by Torre-Amione 
et al. (1996). Other proinflammatory cytokines, including IL-1β and IL-6, become elevated in 
more advanced heart failure and anti-inflammatory cytokine levels can also be abnormal. 
Regardless of the cause of congestive heart failure, the cytokines present are similar 
(Aukrust et al., 1999; Testa et al., 1996; Torre-Amione et al., 1996). TNF-α has been 
associated with cardiac remodelling and left ventricular dysfunction, including depressed 
contractile function. In a heart failure model of mice where TNF-α production was up-
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regulated, down-regulation of both SERCA and PLN occurred (Feldman et al., 2000; Torre-
Amione et al., 1996) 
 
Increased levels of soluble TNF-α receptors have been measured in association with heart 
failure, especially type 2 (p75) TNF-α receptors in more advanced heart failure. Soluble TNF-
α receptors essentially competitively inhibit the effects of TNF-α as less is available to bind to 
membrane bound receptors capable of evoking a response. This could potentially reduce the 
effect of TNF-α in heart failure cells (Aukrust et al., 1999; Testa et al., 1996). 
 
 
6.1.3  Recovery from heart failure 
 
In some heart failure patients, treatment can improve and even, in some cases, fully restore 
cardiac function and reverse remodelling. In these individuals, mortality is lower than heart 
failure patients on a whole, however still elevated in comparison to healthy individuals 
(Nijst, Martens, & Mullens, 2017). It is therefore interesting to know whether such 
individuals remain susceptible to the effects of TNF-α, given that it is expected they would 
have already been exposed to elevated TNF-α previously in heart failure (Testa et al., 1996). 
 
Many of the treatments used with heart failure are pharmaceutical, however cardiac 
resynchronization therapy (CRT) has also been shown to effectively improve cardiac 
function. CRT involves implantation of a pacemaker (sometimes accompanied by a 
defibrillator) to modify the pacing of the heart; to coordinate the pacing and thus 
contraction of the different myocardial chambers (Nijst et al., 2017). 
 
Case studies involving heart failure patients treated with CRT, identified that improvements 
to myocardial function occurred which prolonged survival and reduced hospitalization. 
Following 3-4 months CRT, left ventricular ejection fraction have increased, allowing 
improved cardiac output. Left ventricular end-systolic volume and end-diastolic volume were 
both reduced, indicating decreased myocardial dilation. The proteins often down regulated 
in heart failure – SERCA, NCX, PLN, β1-adrenergic receptor – were up-regulated following 
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CRT treatment and restored to similar proportions as in health (Cleland et al., 2005; Mullens 
et al., 2008). 
 
The heart failure recovery model used in this study mimics the effect on the heart once the 
factor causing heart failure – in this instance tachycardia – is removed. A similar canine 
model of congestive heart failure found that once tachypacing ceased, body weight, heart 
rate, respiratory rate and reduced ejection fraction were restored to their previous levels 
after a week. Myocardial dilation also recovered ~4 weeks following ceased tachycardia 
(Howard, Stopps, Moe, Gotlieb, & Armstrong, 1988). The model used in this study may bear 
some comparison with improved heart failure patients, especially those treated with CRT. 
 
As above, cytokines are elevated in heart failure and involved in its pathogenesis. It is 
therefore fair to assume that both the heart failure model and recovery model cells have 
already been previously exposed to high levels of TNF-α. 
 
This study will determine whether the effects of TNF-α on ECC in cells isolated from the 
heart failure and recovery models are similar to those in young control sheep. It is possible 
that the effects of TNF-α on the various measured parameters of ECC will become saturated 
in these experimental models or that the magnitude of the effects of TNF-α could be 
exacerbated, given that Ca2+ handling and contractility is already impaired in heart failure. As 
such, this could provide evidence as to whether patients with heart failure or in recovery 
would be as susceptible to the effects of TNF-α in the heart as healthy individuals. 
 
 
6.1.4  Aims 
 
(a) Determine the effects of 50 ng/ml TNF-α on left ventricular myocytes isolated from a 
tachypaced sheep model of heart failure 
(b) Determine the effects of 50 ng/ml TNF-α on left ventricular myocytes isolated from an 
uncharacterised tachypaced sheep model of heart failure, allowed to recover for 5 weeks 
(c) Investigate possible differences in the response to TNF-α, if any, between cells from these 
experimental models and that of a young control model. 
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6.2  Methods 
 
6.2.1   Generation of the experimental models 
 
The sheep used to generate both experimental models were age matched to that of the 
young control sheep used in the previous experiments (~18 months old). Heart failure was 
induced using tachypacing. Sheep were subjected to transvenous right ventricular 
tachypacing using a pacing lead – positioned at the right ventricular apex – and attached to a 
Medtronic Thera cardiac pacemaker, positioned in the cervical subcutaneous pocket. 
Following implantation of the pacemaker, ~10 days were allowed prior to pacemaker 
activation and thus onset of the tachypacing protocol, to enable animals to recover from the 
surgical procedure.  
 
Hearts were paced at 210 beats per minute. The tachypacing protocol spanned over 
approximately 50 days, until the sheep presented with symptoms of heart failure, including 
lethargy, cachexia (weakness and muscle wasting) and dyspnoea. Echocardiography was 
carried out of conscious, unsedated animals, enabling alterations in fractional shortening to 
be assessed in vivo; this was used to determine end-stage heart failure. The animals were 
sacrificed once end-stage heart failure had been determined. Similar methods have been 
described and used by Briston et al. (2011), Dibb et al. (2009), Clarke et al. (2015) and Horn 
et al. (2012). 
 
In order to confirm whether cells isolated from tachypaced sheep exhibited a heart failure-
like phenotype, the raw kcaff values following control steady state (Fig 6-6B) were compared 
to that from young control animals (Fig 3-6B).   kcaff was chosen because NCX activity is 
known to be decreased in heart failure, due to reduced NCX expression (Clarke et al, 2015). 
Furthermore, kcaff is unaffected by dye loading or calibration. kcaff was 28.81 % lower in cells 
from the tachypaced heart failure model than that of the young sheep control model (p = 
0.009, unpaired t-test, young control sheep, 1.35 ± 0.13 F340/F380, n = 15; heart failure model, 
0.96 ± 0.08 F340/F380, n = 26). Given that kcaff is significantly lower in the cells from the 
tachypaced model, this confirms that they were phenotypically heart failure in nature. 
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For the recovery heart failure model, the protocol was carried out as described above, 
however once severe heart failure had been induced, tachypacing was ceased. Animals were 
sacrificed following a period of 5 weeks, which allowed for recovery to occur if possible. 
While a similar canine model of heart failure and recovery has been studied by Howard et al. 
(1988) to determine changes to whole heart function in vivo, this model is currently 
uncharacterised on a cellular level. 
 
All procedures carried out to generate these experimental models were done so in 
collaboration with the Trafford research group at the University of Manchester.  
 
 
6.2.2  Experimental procedure 
 
Cell isolation was carried out as described in section 2.1, from 2 experimental ovine models; 
tachypaced induced heart failure and following 5 weeks recovery. Data was recorded using 
Ionwizard software and measurements were taken as described in section 2.2. As per 
section 2.3.4, application of 10 mM caffeine was used to estimate SR Ca2+ content. 
 
 
6.2.3  Analysis 
 
As per section 2.3, the final 5 sweeps were averaged and values were normalised to control. 
Differences between control, TNF-α and wash state were compared using a one-way 
ANOVA. The normalised changes to each parameter with TNF-α and washout in both 
experimental models and the young control model used were also compared using a one-
way ANOVA. Post-hoc tests were used to provide additional individual comparisons between 
the sub-groups. 
 
In the figures comparing the data from the young control, heart failure and recovery sheep 
models, the data presented represents the normalised mean of a given parameter following 
TNF-α exposure or washout. All data for each cell were normalised to each cells’ own control 
steady state value meaning all changes shown are relative. As previously described, 
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normalisation is useful given that this study is interested in the relative change to Ca2+, as 
opposed to the absolute Ca2+ concentration.  
 
 
6.3  Results 
 
6.3.1 The effects of 50 ng/ml TNF-α on intracellular Ca2+ levels and contractility in 
heart failure sheep 
 
The specimen records of Fig 6-1A and 6-1C show an example of the effect of TNF-α on Ca2+ 
dynamics in a heart failure model. On average, Ca2+ transient amplitude decreased by 21.08 
± 3.66 % with TNF-α (n=34, p <0.05) (Fig 6-2A). Mean diastolic Ca2+ decreased by 3.19 ± 1.89 
% with TNF-α (n=34, p <0.05) (Fig 6-2C). Both changes to diastolic Ca2+ (n=32, p <0.05) and 
Ca2+ transient amplitude (n=32, p <0.05) were maintained during washout. 
 
The specimen records of Fig 6-1B and 6-1D shows an example of the effect of TNF-α on 
contractility in a heart failure model. The mean resting sarcomere length decreased by 0.8 ± 
0.2 % with TNF-α (n=25, p <0.05), which was maintained following washout (n=24, p <0.05) 
(Fig 6-2B). Sarcomere shortening unaffected by TNF-α application or washout (n=24, p = 
0.052) (Fig 6-2D). 
 
The specimen record of Fig 6-1E shows an example of the effect of TNF-α on rate of 
sarcomere shortening and relaxation in a heart failure model. Neither the rate of sarcomere 
shortening (n=20, p = 0.457) (Fig 6-2E), nor rate of sarcomere relaxation (n=21, p = 0.100) 
(Fig 6-2F) was affected by either TNF-α or washout. 
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Figure 6-1. Specimen records of the effect of TNF-α on cytoplasmic Ca2+ and contractility in 
left ventricular myocytes from a sheep heart failure model. (A) specimen record showing 
Ca2+ transients. (B) specimen record showing sarcomere shortening. (C) specimen mean Ca2+ 
transients for the periods highlighted in A.  (D) specimen mean sarcomere shortening traces 
for the periods highlighted in B. (E) specimen sarcomere shortening traces for the periods 
highlighted in B, with normalised diastolic and systolic levels. 
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Figure 6-2. The effects of TNF-α and washout on cytoplasmic Ca2+ and contractility in left 
ventricular myocytes from a sheep heart failure model (n = 34 cells from 12 animals). (A) 
mean Ca2+ transient amplitude. (B) mean sarcomere shortening. (C) mean diastolic Ca2+. (D) 
mean resting sarcomere length. (E) mean 50 % sarcomere shortening time. (F) mean 50 % 
sarcomere relaxation time. * indicates p <0.05, NS denotes non-significance (p >0.05), SS = 
steady state. 
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6.3.2 The effects of 50 ng/ml TNF-α on intracellular Ca2+ levels and contractility in 
heart failure recovery sheep 
 
The specimen records of Fig 6-3A and 6-3C shows an example of the effect of TNF-α on Ca2+ 
dynamics in cells from heart failure recovery sheep. On average, diastolic Ca2+ was 
unchanged by TNF-α (n=25, p >0.05), but decreased by 1.42 ± 2.09 % during washout (n=24, 
p<0.05) (Fig 6-4C). Mean Ca2+ transient amplitude decreased by 16.09 ± 3.87 % with TNF-α 
(n=25, p <0.05) and was maintained during washout (n=24, p <0.05) (Fig 6-4A). 
 
The specimen records of Fig 6-3B and 6-3D shows an example of the effect of TNF-α on 
contractility in cells from a heart failure recovery sheep. On average, resting sarcomere 
length decreased by 0.86 ± 0.2 % with TNF-α (n=20, p <0.05) and was maintained during 
washout (n=19, p <0.05) (Fig 6-4D). Sarcomere shortening decreased by 12.6 ± 6.9 % with 
TNF-α (n=20, p <0.05), maintained during washout (n=19, p <0.05) (Fig 6-4B). 
 
The specimen record of Fig 6-3E demonstrates the effect of TNF-α on rate of relaxation and 
shortening in cells from a heart failure recovery sheep. Rate of sarcomere shortening 
unaffected by TNF-α and washout (n=20, p = 0.931) (Fig 6-4E), whilst rate of sarcomere 
relaxation was unaffected by TNF-α (n=20, p >0.05), but following washout the 50 % time of 
sarcomere relaxation decreased by 10.06 ± 3.5 % (n=19, p <0.05) (Fig 6-4F).  
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Figure 6-3. Specimen records of the effect of TNF-α on cytoplasmic Ca2+ and contractility in 
left ventricular myocytes from a sheep model allowed to recover from heart failure. (A) 
specimen record showing Ca2+ transients. (B) specimen record showing sarcomere 
shortening. (C) specimen mean Ca2+ transients for the periods highlighted in A.  (D) specimen 
mean sarcomere shortening traces for the periods highlighted in B. (E) specimen sarcomere 
shortening traces for the periods highlighted in B, with normalised diastolic and systolic 
levels. 
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Figure 6-4. The effects of TNF-α and washout on cytoplasmic Ca2+ and contractility in left 
ventricular myocytes from a sheep model allowed to recover from heart failure (n = 25 cells 
from 4 animals). (A) mean Ca2+ transient amplitude. (B) mean sarcomere shortening. (C) 
mean diastolic Ca2+. (D) mean resting sarcomere length. (E) mean 50 % sarcomere 
shortening time. (F) mean 50 % sarcomere relaxation time. * indicates p <0.05, NS denotes 
non-significance (p >0.05), SS = steady state. 
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6.3.3  The effect of TNF-α on SR Ca2+ content of both heart failure and recovery 
sheep 
 
An example of the effect of TNF-α on caffeine evoked Ca2+ transient amplitude, thus SR Ca2+ 
content in cells from a heart failure model and heart failure recovery model, is shown in the 
specimen records of Fig 6-5A and Fig 6-5B respectively. On average, Ca2+ transient amplitude 
decreased by 19.62 ± 4.58 % (n=28, p <0.05) (Fig 6-5C) and 24.13 ± 5.43 % (n=13, p = 0.002) 
(Fig 6-5D) with TNF-α in heart failure sheep and heart failure recovery sheep respectively. In 
both heart failure sheep (n=22, p <0.05) and heart failure recovery sheep (n=13, p <0.001) 
this was maintained following washout. 
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Figure 6-5. 10 mM caffeine evoked Ca2+ transient amplitudes in TNF-α treated cells from 
sheep models of heart failure (n = 28 cells from 10 animals) and heart failure recovery (n = 
13 cells from 3 animals). (A) specimen record for caffeine evoked Ca2+ transient following 
control, cytokine and wash steady states in TNF-α treated cells from a heart failure model. 
(B) specimen record for caffeine evoked Ca2+ transient following control, cytokine and wash 
steady states in TNF-α treated cells from a heart failure recovery model. (C) mean caffeine 
evoked Ca2+ transients in TNF-α treated cells from a heart failure model. (D) mean caffeine 
evoked Ca2+ transients in TNF-α treated cells from a heart failure recovery model. * indicates 
p <0.05, NS denotes non-significance (p >0.05). 
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6.3.4 The effect of TNF-α on major Ca2+ removal mechanisms in heart failure and 
recovery sheep 
 
The specimen records of Fig 6-6A and 6-6B shows an example of the effect of TNF-α on the 
rate of Ca2+ decay in normalised systolic Ca2+ transients (ksys) and caffeine evoked Ca
2+ 
transient (kcaff) in a cell from a heart failure model. No change to ksys (n=34, p = 0.582) (Fig 6-
6C), kcaff (n=25, p = 0.113) (Fig 6-6D) and kSERCA (n=25, p = 0.491) (Fig 6-6E) were found with 
TNF-α or washout. 
 
The specimen records of Fig 6-7A and 6-7B demonstrate the effect of TNF-α on rate of Ca2+ 
decay in normalised systolic Ca2+ transients (ksys) and caffeine evoked Ca
2+ transient (kcaff) in 
a cell from a heart failure recovery model. In heart failure recovery sheep, ksys (n=25, p = 
0.583) (Fig 6-7C), kcaff (n=12, p = 0.119) (Fig 6-7D) and kSERCA (n=12, p = 0.469) (Fig 6-7E) were 
unaffected by TNF-α or washout. 
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Figure 6-6. The effect of 50 ng/ml TNF-α on rate of Ca2+ removal in cells from a model of 
heart failure (n = 34 cells from 12 animals). (A) specimen trace of Ca2+ transients at control, 
TNF-α and washout steady state, with normalised diastolic and systolic levels. (B) specimen 
trace of caffeine-evoked Ca2+ transients at control, TNF-α and washout steady state, with 
normalised diastolic and systolic levels. (C) mean normalised ksys. (D) mean normalised 90-10 
% decay time of the Ca2+ transient. (E) mean normalised kcaff. (F) mean normalised kSERCA. * 
indicates p <0.05, NS denotes non-significance (p >0.05), SS = steady state. 
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Figure 6-7. The effect of 50 ng/ml TNF-α on rate of Ca2+ removal in cells from a model of 
heart failure recovery (n = 25 cells from 4 animals). (A) specimen trace of Ca2+ transients at 
control, TNF-α and washout steady state, with normalised diastolic and systolic levels. (B) 
specimen trace of caffeine-evoked Ca2+ transients at control, TNF-α and washout steady 
state, with normalised diastolic and systolic levels. (C) mean normalised ksys. (D) mean 
normalised 90-10 % decay time of the Ca2+ transient. (E) mean normalised kcaff. (F) mean 
normalised kSERCA. * indicates p <0.05, NS denotes non-significance (p >0.05), SS = steady 
state. 
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6.3.5  The early effect of 50 ng/ml TNF-α on systolic Ca2+ in heart failure and 
recovery sheep 
 
Preceding the decrease of systolic Ca2+ to a lower steady state in both the heart failure 
model (Fig 6-1 and 6-2) and the heart failure recovery model (Fig 6-3 and 6-4), certain cells 
TNF-α produced an early, short-lived potentiation of the Ca2+ transient amplitude lasting 1-3 
beats. As with young control sheep, described in section 3.3.5, potentiation was defined as a 
greater than 10 % increase of systolic Ca2+ compared to control. Potentiation was observed 
in 44 % of heart failure cells and 48 % of heart failure recovery cells exposed to TNF-α.  
 
An example of the effect of TNF-α on heart failure and recovery responders (presenting with 
1st beat potentiation) is demonstrated in the specimen records of Fig 6-8A and 6-8D 
respectively. In heart failure responders, TNF-α produced a 1st beat mean increase in Ca2+ 
transient amplitude by 42.52 ± 12.34 % (n=15, p <0.05) (Fig 6-8B), accompanied by a 
corresponding mean increase in sarcomere shortening by 76.21 ± 29.93 % (n=9, p <0.05) (Fig 
6-8C). In responders from the recovery model, TNF-α produced a similar 1st beat mean 
increase in Ca2+ transient amplitude by 40.16 ± 9.81 % (n=12, p <0.05) (Fig 6-8E), alongside 
an increase in sarcomere shortening by 94.49 ± 46.54 % (n=9, p <0.05) (Fig 6-8F). 
 
The specimen records of Fig 6-9A and 6-9D show the effect of TNF-α on heart failure and 
recovery non-responders (not presenting with potentiation). In non-responders from the 
heart failure model, TNF-α produced no immediate 1st beat effect on either Ca2+ transient 
amplitude (n=19, p >0.05) (Fig 6-9B), or sarcomere shortening (n=16, p >0.05) (Fig 6-9C). At 
steady state, Ca2+ transient amplitude decreased by 28.57 ± 4.72 %. In non-responders from 
the recovery model, TNF-α produced no immediate effect on Ca2+ transient amplitude (n=13, 
p >0.05), and sarcomere shortening (n=12, p >0.05). At steady state Ca2+ transient amplitude 
was reduced by 23.32 ± 4.27 % (n=13, p <0.05) (Fig 6-9E), coinciding with a mean decrease in 
sarcomere shortening by 14.84 ± 10.17 % (n=12, p <0.05) (Fig 6-9F). 
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Figure 6-8. The effect of 50 ng/ml TNF-α on the 1st beat Ca2+ transient amplitude and 
contractility of cells from both models showing signs of RyR potentiation (A) specimen 
record showing Ca2+ transients from a heart failure model, immediately prior to [black], 
during [dark red] and following [red] 1st beat application of TNF-α. (B) mean normalised Ca2+ 
transient amplitude with 1st beat application of TNF-α in cells from a heart failure model (n 
= 15 cells from 7 animals). (C) mean normalised sarcomere shortening with 1st beat 
application of TNF-α in cells from a heart failure model. (D) specimen record showing Ca2+ 
transients from a heart failure recovery model, with 1st beat application of TNF-α, as labelled 
in A. (E) mean normalised Ca2+ transient amplitude with 1st beat application of TNF-α in cells 
from a heart failure recovery model (n = 12 cells from 4 animals). (F) mean normalised 
sarcomere shortening with 1st beat application of TNF-α in cells from a heart failure 
recovery model. * indicates p <0.05, NS denotes non-significance (p >0.05), SS = steady state. 
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Figure 6-9. The effect of 50 ng/ml TNF-α on the 1st beat Ca2+ transient amplitude and 
contractility of cells from both models without signs of RyR potentiation (A) specimen record 
showing Ca2+ transients from a heart failure model, immediately prior to [black], during [dark 
red] and following [red] 1st beat application of TNF-α. (B) mean normalised Ca2+ transient 
amplitude with 1st beat application of TNF-α in cells from a heart failure model (n = 19 cells 
from 10 animals). (C) mean normalised sarcomere shortening with 1st beat application of 
TNF-α in cells from a heart failure model. (D) specimen record showing Ca2+ transients from 
a heart failure recovery model, with 1st beat application of TNF-α, as labelled in A. (E) mean 
normalised Ca2+ transient amplitude with 1st beat application of TNF-α in cells from a heart 
failure recovery model (n = 13 cells from 3 animals). (F) mean normalised sarcomere 
shortening with 1st beat application of TNF-α in cells from a heart failure recovery model. * 
indicates p <0.05, NS denotes non-significance (p >0.05), SS = steady state. 
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6.3.6 Differences in the magnitude of the effect of TNF-α on heart failure and 
recovery sheep in comparison to young control sheep 
 
For all measured parameters, the histograms below show the values with TNF-α and 
washout normalised against control steady state (Fig 6-10 to 6-14), and therefore show the 
mean magnitude of the effect in each of the 3 models. This allows for direct comparison in 
the magnitude of the effects of TNF-α in young control sheep, the tachypaced sheep heart 
failure model, and 5 week recovery model. 
 
Following TNF-α application to young control sheep, heart failure sheep and recovery sheep, 
there was no difference in the magnitude of change from control in Ca2+ transient amplitude 
(p = 0.552) (Fig 6-10A), diastolic Ca2+ (p = 0.285) (Fig 6-10C), sarcomere shortening (p = 
0.764) (Fig 6-10B) and resting sarcomere length (p = 0.298) (Fig 6-10D). With TNF-α washout, 
there remained no difference in the magnitude of change to Ca2+ transient amplitude (p = 
0.324) (Fig 6-11A), diastolic Ca2+ (p = 0.627) (Fig 6-11C), sarcomere shortening (p = 0.157) (Fig 
6-11B) and resting sarcomere length (p = 0.077) (Fig 6-11D) between the different models 
used. 
 
No difference was identified between the change to rate of sarcomere shortening (p = 
0.837) (Fig 6-10E), or rate of sarcomere relaxation (p = 0.261) (Fig 6-10F), with TNF-α 
between the control and experimental models. This was also true following washout, where 
there was also no change to rate of sarcomere shortening (p = 0.258) (Fig 6-11E) or 
relaxation (p = 0.185) (Fig 6-11F). 
 
The percentage change in caffeine-evoked Ca2+ transient amplitude (p = 0.443) with TNF-α 
was unchanged between the young control (n=20) and heart failure (n=28) and recovery 
(n=13) models (Fig 6-12A), nor did it change with washout (p = 0.353) (Fig 6-12B). 
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Figure 6-10. The comparative effect of 50 ng/ml TNF-α on Ca2+ dynamics and contractility in 
young control [black], heart failure [red] and heart failure recovery [blue] models. 
(A) mean normalised Ca2+ transient amplitude. (B) mean normalised sarcomere shortening. 
(C) mean normalised diastolic Ca2+. (D) mean normalised resting sarcomere length. (E) mean 
normalised rate of sarcomere shortening. (F) mean normalised rate of sarcomere relaxation. 
* indicates p <0.05, NS denotes non-significance (p >0.05). Mean data presented has been 
previously normalised to its own control steady state, allowing comparison of the relative 
change to these parameters with TNF-α. 
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Figure 6-11. The comparative effect of TNF-α washout on Ca2+ dynamics and contractility in 
young control [black], heart failure [red] and heart failure recovery [blue] models. 
(A) mean normalised Ca2+ transient amplitude. (B) mean normalised sarcomere shortening. 
(C) mean normalised diastolic Ca2+. (D) mean normalised resting sarcomere length. (E) mean 
normalised rate of sarcomere shortening. (F) mean normalised rate of sarcomere relaxation. 
* indicates p <0.05, NS denotes non-significance (p >0.05). Mean data presented has been 
previously normalised to its own control steady state, allowing comparison of the relative 
change to these parameters with washout. 
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Figure 6-12. The comparative effect of TNF-α and washout on caffeine evoked Ca2+ transient 
amplitude in young control [black], heart failure [red] and heart failure recovery [blue] 
models. (A) mean normalised caffeine evoked Ca2+ transient amplitude with TNF-α. (B) mean 
normalised caffeine evoked Ca2+ transient amplitude with TNF-α washout. * indicates p 
<0.05, NS denotes non-significance (p >0.05). Mean data presented has been previously 
normalised to the amplitude of its own control caffeine-evoked Ca2+ transient, allowing 
comparison between the models, of relative change to these parameters. 
 
 
The relative change to ksys (p = 0.943) (Fig 6-13A) and kcaff (p = 0.246) (Fig 6-13C) produced by 
TNF-α application when compared to control steady state did not differ between the young 
control and disease models. Whilst kSERCA did not alter significantly from control steady state 
in any model, the change in kSERCA from control with TNF-α in young control sheep (n=11) 
was significantly different in both heart failure sheep (n=25, p <0.05) and recovery sheep 
(n=12, p<0.05). The magnitude of change to kSERCA produced by TNF-α did not differ between 
the heart failure sheep and recovery sheep (p >0.05) (Fig 6-13E). 
 
With TNF-α washout, there remained no difference in ksys (p = 0.671) (Fig 6-13B) or kcaff (p = 
0.980) (Fig 6-13D) between these models, or kSERCA (p >0.05) (Fig 6-13F) between the heart 
failure (n=20) when compared to both young control sheep (n=3) and recovery sheep (n=12). 
kSERCA in recovery sheep is unchanged from control following TNF-α washout, this is different 
from that of young control sheep (p <0.05) where kSERCA increased by 91.67 ± 26.29 % with 
washout (Fig 6-13F). 
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Figure 6-13. The comparative effects of TNF-α and washout on rate of Ca2+ removal in young 
control [black], heart failure [red] and heart failure recovery [blue] models. (A) mean 
normalised ksys with TNF-α. (B) mean normalised ksys with washout. (C) mean normalised kcaff 
with TNF-α. (D) mean normalised kcaff with washout. (E) mean normalised kSERCA with TNF-α. 
(F) mean normalised kSERCA with washout. * indicates p <0.05, NS denotes non-significance (p 
>0.05). Mean data presented has been previously normalised to its own control steady state, 
allowing comparison between the models, of relative change to these parameters.  
 
 
The change to mean 1st beat change in Ca2+ transient amplitude with TNF-α in responders (p 
= 0.189) (Fig 6-14A) and non-responders (p = 0.477) (Fig 6-14C) was not different between 
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the young control, heart failure and recovery models. Similarly, the mean 1st beat change to 
sarcomere shortening in responders (p = 0.101) (Fig 6-14B) and non-responders (p = 0.091) 
(Fig 6-14D) with TNF-α did not differ between the models used. 
 
 
 
 
Figure 6-14. Comparisons between 1st beat responses to TNF-α. (A) mean Ca2+ transient 
amplitude in responders. (B) mean sarcomere shortening in responders. (C) mean Ca2+ 
transient amplitude in non-responders. (D) mean sarcomere shortening in non-responders. * 
indicates p <0.05, NS denotes non-significance (p >0.05). Mean data presented has been 
previously normalised to its own control steady state, allowing comparison of relative 
change to these parameters between the different models. 
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6.4   Discussion 
 
6.4.1 Does acute exposure to 50 ng/ml TNF-α alter Ca2+ handling and contractility in 
the heart failure and recovery models? 
 
In heart failure cells, TNF-α produced a maintained decrease in Ca2+ transient amplitude by 
21.08 ± 3.66 % (Fig 6-2A), while sarcomere shortening was unchanged (Fig 6-2B). Although 
Briston et al. (2011) did not study change to contractility in heart failure, Ca2+ transient 
amplitude is already known to reduce, and this has been associated with elevated TNF-α 
levels (Feldman et al., 2000). The depressant effect of TNF-α on contractility may therefore 
have already been saturated by previous exposure TNF-α, prior to TNF-α exposure in 
experiments. 
 
TNF-α also caused an irreversible decrease in diastolic Ca2+ by 3.19 ± 1.89 % in heart failure 
cells (Fig 6-2C). Diastolic Ca2+ is already reduced in heart failure (Briston et al., 2011), 
therefore it is interesting that TNF-α produces a further decrease in diastolic Ca2+ in heart 
failure cells, as this suggests that the effect on diastolic Ca2+ was not saturated by the effects 
of heart failure alone. 
 
In recovery sheep cells, the 16.09 ± 3.87 % decrease in the Ca2+ transient produced by TNF-α 
was associated with a 12.6 ± 6.9 % decrease in sarcomere shortening, both of which were 
maintained with washout (Fig 6-4A and Fig 6-4B). Given the time allowed for recovery, any 
previous effect elevated circulating TNF-α could have had on contractility in heart failure 
may have been reversed. This is likely, as a canine model of tachycardia induced heart failure 
found improved contractility and a restored ejection fraction as week after pacing was 
ceased (Howard et al., 1988). In CRT treated heart failure patients, contractility and ejection 
fraction could also be improved following months of treatment (Cleland et al., 2005; Mullens 
et al., 2008). As contractility would be expected to be improved in the recovery model, the 
depressant effect of TNF-α on contractility would therefore no longer be saturated, and as in 
young control cells (Fig 3-2B), application of TNF-α in the experiment would be capable of 
reducing shortening. 
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TNF-α produced an irreversible 0.86 ± 0.2 % decrease in resting sarcomere in cells from the 
recovery model, however this was associated with no change to diastolic Ca2+. However, 
during washout, diastolic Ca2+ did reduce by 1.42 ± 2.09 %. The changes in these parameters 
suggest that myofilament sensitivity to Ca2+ is elevated. As the recovery animals were paced 
to severe heart failure prior to the 5 weeks allowed for recovery, the effects of end-stage 
heart on myofilament sensitivity to Ca2+ may still be present (van der Velden, 2011). 
 
In both the heart failure and recovery models, the rate of sarcomere shortening (Fig 6-2E 
and 6-4E) and rate of relaxation (Fig 6-2F and 6-4F) were unaltered by TNF-α. TNF-α washout 
produced a decrease by 10.06 ± 3.5 % of the 50 % decay time of sarcomere relaxation in cells 
from the recovery model, indicating that the rate of sarcomere relaxation increased. This is 
similar to the 18.92 ± 7.11 % decrease of the 50 % decay time of sarcomere relaxation, 
observed with TNF-α washout in young control cells (Fig 3-2F). 
 
In heart failure reduced SERCA activity contributes to a lower rate of sarcomere relaxation 
(Lou et al., 2012). Heart failure cells are also less responsive to β-adrenergic stimulation, as 
such phosphorylation of PLN, therefore molecules such as PKA would not be capable of 
increasing SERCA activity and thus rate of Ca2+ removal to the same extent (Briston et al., 
2011; Phillips et al., 1998). If the effect which TNF-α washout has on young control and 
recovery models is mediated by PLN phosphorylation, that could explain why the effect on 
increase is not observed in the heart failure model. This also suggest the impaired response 
to PLN phosphorylation, and thus modulation of SR Ca2+ content found in heart failure 
(Phillips et al., 1998), is restored in the recovery model. Phosphorylation of PLN occurs over 
a period of minutes, it is therefore possible that this is a gradual effect of TNF-α, only evident 
in washout. What contradicts phosphorylation of PLN, as a possible mechanism of increased 
rate of relaxation is that, unlike in young control cells, kSERCA was not affected by TNF-α 
washout (Fig 6-7E). The contribution of NCX activity to Ca2+ removal increases in heart failure 
(Briston et al., 2011), and NCX is up-regulated in patients recovering from heart failure 
(Mullens et al., 2008). TNF-α or washout also had no effect on kcaff in recovery sheep. 
Increased SERCA or NCX activity cannot account for this increase in rate of relaxation in the 
recovery model, unless the changes are too small to detect. 
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6.4.2 How does 50 ng/ml TNF-α reduce Ca2+ transient amplitude in the heart failure 
and recovery models? 
 
Ca2+ transient amplitude is primarily regulated by SR Ca2+ content and ICaL. The latter was 
unable to be measured in this study, although Briston et al. (2011) found ICaL to be reduced in 
heart failure. Although reduced ICaL would be expected to decrease CICR, and thus blunt the 
Ca2+ transient amplitude, SR Ca2+ content has a larger role in modulation of Ca2+ release 
(Bers, 2002; Eisner, 2018). 
 
As previously discussed, the relationship between SR Ca2+ content and Ca2+ transient 
amplitude is cubic (Trafford et al., 2000). In the heart failure model, TNF-α decreased SR Ca2+ 
content to 80.01 % of control (Fig 6-5C). As (0.8001)3 = 0.5122, Ca2+ transient amplitude 
would be expected to decrease to 51.22 % of control.  TNF-α only decreased Ca2+ transient 
amplitude to 78.39 % of control (Fig 6-5D). In the recovery model, TNF-α decreased SR Ca2+ 
content to 76.46 % of control. As (0.7646)3 = 0.447, Ca2+ transient amplitude would be 
expected to decrease to 44.7 % of control with TNF-α. With TNF-α. Ca2+ transient amplitude 
decreased to only 82.95 % of control. As described in section 3.4.2, the method used to 
estimate SR Ca2+ content was through measuring the amplitude of caffeine evoked Ca2+ 
transients. TNF-α could have an effect on Ca2+ buffering, however the changes to SR Ca2+ 
content are large (decreasing by 19.62 ± 4.58 % and 24.13 ± 5.43 % in heart failure and 
recovery model cells respectively), therefore is it more likely that this is a true effect of TNF-
α on SR Ca2+ content. 
 
While reduced ICaL could also contribute to reduced Ca
2+ transient amplitude with TNF-α, in 
both models, the changes to SR Ca2+ content can account for the respective changes to Ca2+ 
transient amplitude alone. 
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6.4.3 How do TNF-α alter SR Ca2+ content in the heart failure and recovery models? 
Are the Ca2+ removal mechanisms affected? 
 
The TNF-α evoked reduction in SR Ca2+ content, as recorded in heart failure and recovery 
models in section 3.4.2, could be altered by either a reduction in SERCA activity, thus SR Ca2+ 
uptake, or an increase in RyR Po (Bers, 2002). First the effect of TNF-α on SERCA activity and 
other mechanisms of Ca2+ removal was explored in both experimental models. 
 
TNF-α and washout produced no change in any mechanism of Ca2+ removal – ksys, kcaff and 
kSERCA – in both the heart failure and recovery models. Whilst some proteins associated with 
Ca2+ removal are down-regulated in heart failure (Mullens et al., 2008), Briston et al. (2011) 
reported no change to overall rate of Ca2+ removal in a similar heart failure model, due to 
compensatory increased contribution of NCX to Ca2+ removal. Mullens et al. (2008) 
suggested that down-regulated proteins associated with Ca2+ removal – such as SERCA and 
PLN – were up-regulated to control levels in patients in recovery from heart failure. As such, 
no prior effect on rate of Ca2+ removal would be anticipated in either the heart failure or 
recovery model. Changes in Ca2+ removal with TNF-α would not therefore be expected differ 
in the experimental models, from the young control model.  
 
In young control cells ksys, kcaff and kSERCA were also unaffected by TNF-α, although with 
washout kSERCA increased by 91.67 ± 26.29 % (Fig 3-6D to 3-6F). In heart failure cells, there 
was no such change to kSERCA, this could be due to reduced PLN modulation of SERCA (Briston 
et al., 2011; Phillips et al., 1998). While this would not be expected to be the case in recovery 
cells, the restored levels of PLN and SERCA found by Mullens et al. (2008) in patients, were 
found following several months, which is much longer when compared to the period which 
the recovery model was allowed to recover (5 weeks). Any changes to protein regulation 
may have not occurred yet within that time. 
 
As the activity of Ca2+ removal mechanisms were not affected by TNF-α in these 
experimental models, the change to SR Ca2+ content cannot be accounted for by reduced SR 
Ca2+ uptake. As has been shown to be the case for young control sheep (see chapter 4), TNF-
α could also be increasing RyR Po in these models, leading to increased SR Ca
2+ leak. 
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6.4.4 TNF-α produces a temporary potentiation of systolic Ca2+ in the heart failure 
and recovery models – Could RyR sensitivity be increased? 
 
Decreased SR Ca2+ content can be caused by SR Ca2+ leak as a result of increased RyR Po 
(Belevych et al., 2007; Shannon et al., 2003). Of both the heart failure (Fig 6-8B) and 
recovery cells (Fig 6-8E), a proportion of cells presented with an immediate potentiation of 
systolic Ca2+. This was accompanied by a single beat increase in sarcomere shortening (Fig 6-
8C and 6-8D), indicating that this is a true phenomenon as opposed to a fluorescent artefact. 
Following this 1st beat potentiation of systolic Ca2+ in responder, a new lower Ca2+ transient 
amplitude steady state is reached. This produces a similar response to caffeine, known to 
potentiate RyR (Greensmith et al., 2014). This temporary potentiation is indicative of an 
increase in RyR Po, suggesting that as with young control cells (chapter 4), RyR Po is increased 
in heart failure and recovery cells in response to TNF-α. 
 
In non-responders belonging to both the heart failure (Fig 6-9B) and recovery (Fig 6-9E) 
groups there was no 1st beat increase in systolic Ca2+ or sarcomere shortening. The 
depressant effect of TNF-α on Ca2+ amplitude may be more rapid in this subgroup. 
 
As suggested in the young control animals, whilst the reduction in SR Ca2+ content can 
account for decreased systolic [Ca2+]i, an effect LTCC may also contribute, which may be 
more prominent in non-responders. In the heart failure and recovery models, the proportion 
of non-responders is far greater. In heart failure, RyR Po would already be expected to be 
increased due to hyperphosphorylation, and ICaL is known to decrease. The effect on TNF-α 
on further decreasing ICaL may be greater than that on RyR Po in these models. Prior 
hyperphosphorylation may have also saturated the effect on RyR Po in some cells. 
 
 
6.4.5 Does TNF-α alter the relationship between *Ca2+]i and sarcomere length in the 
heart failure and recovery models? 
 
In heart failure cells, TNF-α produced an irreversible decrease in Ca2+ transient amplitude by 
21.08 ± 3.66 % (Fig 6-2A). Reduced systolic [Ca2+]i would be expected to reduce the degree of 
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sarcomere shortening, as less Ca2+ is available to bind to myofilaments. With TNF-α, 
sarcomere shortening was unchanged (Fig 6-2B), despite the decrease in Ca2+ transient 
amplitude. This could indicate that in heart failure cells myofilament sensitivity to Ca2+ is 
increased with TNF-α. TNF-α also caused an irreversible decrease in both diastolic Ca2+ and 
resting sarcomere length by 3.19 ± 1.89 % and 0.8 ± 0.2 % respectively, in heart failure cells 
(Fig 6-2C and 6-2D). Once again, this could provide evidence that myofilament sensitivity to 
Ca2+ is increased. However, the effect on myofilament sensitivity could be an effect of heart 
failure as opposed to a result of TNF-α. Myofilament sensitivity to Ca2+ is already known to 
be increased at end-stage heart failure and may be a compensatory mechanism to help 
maintain cardiac output (van der Velden, 2011). In the model of heart failure used in this 
study, end-stage is the point at which the animals were sacrificed, thus myofilament 
sensitivity to Ca2+ may have be increased. 
 
 
6.4.6 Is the magnitude of the effect of TNF-α different in heart failure and 
recovery? 
 
Given that circulating TNF-α is elevated in heart failure and so it is assumed cells have been 
pre-exposed to TNF-α, this experiment aimed to determine whether cells from a model of 
heart failure had an altered response to TNF-α, and if this changed in that of a recovery 
model. If this was the case, this may suggest an increase or decrease in susceptibility of 
those with heart failure – or in recovery – to changes in cardiac function by TNF-α.  
 
When comparing the responses of young control cells, heart failure model cells and recovery 
model cells to TNF-α, there no difference between the magnitude of change to diastolic and 
systolic Ca2+, as well as that of the subsequent sarcomere shortening, with TNF-α (Fig 6-10) 
or washout (Fig 6-11). Nor was there a difference between the magnitude of decrease in SR 
Ca2+ content evoked by TNF-α, between the 3 models (Fig 6-12).  
 
Although the magnitude of change to the overall rate of Ca2+ removal (ksys) and rate of Ca
2+ 
efflux (kcaff) – primarily via NCX – were not affected by TNF-α or washout, there was a 
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difference identified in kSERCA, and thus change to SERCA activity, between the 3 models (Fig 
6-13E and 6-13F). 
 
Young sheep control cells treated with TNF-α did not have significantly altered kSERCA, 
however kSERCA at steady state in TNF-α was in between and not-significant from both control 
steady state and washout. In washout, kSERCA did significantly increase by 91.67 ± 26.29 %, 
this could suggest that the effect on kSERCA is gradual and that the method was not sensitive 
enough to detect any small increase in kSERCA in TNF-α (Fig 3-6F). However, in both the heart 
failure (Fig 6-6E) and recovery (Fig 6-7E) models, neither TNF-α or washout produced a 
change in kSERCA. As demonstrated in Fig 6-13E, kSERCA is comparatively lower in both the 
heart failure and recovery models, when compared to the young control model. During TNF-
α washout, kSERCA remained significantly lower (Fig 6-13F) in cells from the recovery model. 
 
Both CaMKII and PKA can modulate PLN through phosphorylation, this promotes PLN 
dissociation from SERCA, reversing its inhibitive effect on SERCA and increasing SERCA 
activity. This commonly occurs physiologically as part of a β-adrenergic response, although 
CaMKII and PKA activity can be raised in other circumstances also (Mattiazzi & Kranias, 
2014). Effects resulting from phosphorylation tend to require several minutes before an 
effect is observed. As such – and considering the generally short cytokine exposure periods – 
the changes to kSERCA, and thus rate of Ca
2+ uptake via SERCA, may have not become 
statistically evident until later, during the washout period. 
 
In an ovine tachycardia induced heart failure model studied by Briston et al. (2011), isolated 
cells were less susceptible to changes evoked by a β-adrenergic response. In particular, it 
was found that phosphorylation of PLN was found to be reduced in the heart failure model. 
Any effect TNF-α, or rather washout, may be having on elevated kSERCA, is not found in either 
experimental model. This suggest that the effect of TNF-α on increased kSERCA may be PKA or 
CaMKII mediated, further supporting why this is not found in heart failure. 
 
Whilst there was no recorded difference between the magnitudes of 1st beat increase in Ca2+ 
transient amplitude in the 3 models used (Fig 6-14A), potentiation was observed in a larger 
proportion of young control cells (71 %), when compared to that of heart failure cells (44 %) 
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and recovery cells (48 %). Fractional SR Ca2+ release is thought to be reduced in heart failure 
as a higher ICaL is required to induce SR Ca
2+ release (Phillips et al., 1998). Based on the 
previous experiments of this study (refer to chapter 4), TNF-α increases RyR Po. If the RyR Po 
in heart failure cells is lower than young control cells prior to TNF-α application, the 
increased RyR Po with TNF-α may still be lower than that of young control cells. The 
threshold for potentiation of the Ca2+ transient would therefore be higher and fewer cells 
would be expected to reach it. It is unknown whether the RyR Po would improve from heart 
failure in the recovery model, although the relative proportion of responders would indicate 
this not to be the case. 
 
In summary, TNF-α decreases Ca2+ transient amplitude through a similar mechanism 
identified in young control cells (chapter 3); decreased SR Ca2+ content as a result of 
increased RyR Po. The difference in the proportion of responders is lower in the heart failure 
and recovery models, which may be due to the reduction in RyR Po found in heart failure. In 
the heart failure model, some of the effects on contractility appear to have been saturated, 
and thus cannot be depressed further with TNF-α. This may be due to the previous effects of 
elevated circulating TNF-α in heart failure. This saturation did not occur in recovery cells, 
suggesting that contractility was at least partially restored. There was some evidence of 
increased myofilament sensitivity in both models, however this may be produced by heart 
failure as opposed to TNF-α, especially given that TNF-α has been shown to reduce 
myofilament sensitivity in young control sheep. In addition, the small increase in SERCA 
activity observed with TNF-α washout in young control sheep appears to be mediated by 
phosphorylation of PLN, thus is not found in the other experimental models, as PLN 
phosphorylation is often decreased in heart failure, and doesn’t appear to fully recover in 
the recovery model. 
 
 
 
 
188 
 
 
Chapter 7 
 
General discussion  
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7.1  The effect of TNF-α and IL-1β on excitation-contraction coupling 
 
7.1.1   The effect of TNF-α and IL-1β on global contractility 
 
There is evidence that in models of bacteraemia – one cause of sepsis – there is a reduction 
in left ventricular contractile force generation of tension. This left ventricular dysfunction 
was found to be due to a circulating myocardial depressant substance, such as a cytokine 
(Gomez et al., 1990; Jha et al., 1993). The effect of TNF-α and IL-1β on contractility have 
been explored in isolated whole rat hearts, which were found to reduce cardiac contractility 
(Schulz et al., 1995). Even in isolated ventricular myocytes TNF-α has been associated with 
reduced cell shortening (Greensmith & Nirmalan, 2013). 
 
In the young sheep used in this study, impaired contractility was also found with TNF-α, 
which reduced systolic sarcomere shortening by 20.31 ± 7.58 % (Fig 3-2B). Increased NO in 
response to TNF-α and IL-1β has been proposed as a mechanism for the reduction in 
contractility (Schulz et al., 1995). Unlike TNF-α, in young control sheep cells exposed to IL-1β 
there was no change to sarcomere shortening (Fig 3-4B), and as such IL-1β could not be 
directly associated with reduced contractility in sepsis. 
 
TNF-α produced an irreversible decrease in resting sarcomere length by 0.46 ± 0.1 % in 
young control sheep (Fig 3-2D), this is surprising given that no diastolic dysfunction was 
observed by Greensmith and Nirmalan (2013) with TNF-α in rat myocytes, however this 
further highlights the importance of using a large mammal model. Duncan et al. (2010) also 
found no evidence of diastolic dysfunction with both TNF-α and IL-1β in rat ventricular 
myocytes. In sheep however, IL-1β irreversibly decreased resting sarcomere length by 0.76 ± 
0.2 % (Fig 3-4D). In the case of both cytokines, these diastolic changes were small yet 
significant. 
 
The rate of sarcomere shortening and relaxation was not altered by TNF-α or IL-1β in young 
control sheep. With IL-1β, this disagrees with the work of Radin et al. (2008) in rat 
ventricular myocytes, who found IL-1β reduced the rate of cell relaxation. Whilst redox 
signalling can promote PLN phosphorylation and thus increase the rate of Ca2+ removal and 
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thus relaxation (Ho et al., 2014), elevations in NO and ROS have also been associated with 
impaired relaxation in acute inflammation of the heart (Y. Li et al., 2013). The balance 
between NO and ROS production by these cytokines, and in these models, could determine 
the overall effect on rate of relaxation. 
 
 
7.1.2  The effect of TNF-α and IL-1β on *Ca2+]i 
 
Previous work by Greensmith and Nirmalan (2013) and Radin et al. (2008) has found that in 
rat ventricular myocytes, both TNF-α and IL-1β individually reduced systolic Ca2+. This study 
found the same in sheep ventricular myocytes, with a 16.79 ± 3.16 % reduction in Ca2+ 
transient amplitude with TNF-α (Fig 3-2A) and a 23.63 ± 6.61 % decrease in Ca2+ transient 
amplitude with IL-1β (Fig 3-4A). While the decreased systolic Ca2+ with TNF-α can at least 
partially account for the reduced contraction, the decreased systolic Ca2+ with IL-1β cannot 
provide and explanation for why sarcomere shortening is unchanged, thus the mechanism of 
IL-1β may be more complex. 
 
As with contractility, previous work in rat ventricular myocytes did not identify changes to 
diastolic [Ca2+]i with TNF-α alone, or combined TNF-α and IL-1β treatment (Duncan et al., 
2010; Greensmith & Nirmalan, 2013). This was also true for IL-1β, which did not alter 
diastolic Ca2+ in young control sheep (Fig 3-4C). TNF-α altered diastolic *Ca2+]i in young 
control sheep, producing and irreversible decrease by 4.35 ± 1.67 % (Fig 3-2C). 
 
 
7.1.3  The effect of TNF-α and IL-1β on SR Ca2+ content 
 
Change to SR Ca2+ content can modulate systolic SR Ca2+ release and therefore alter Ca2+ 
transient amplitude at steady state, as not only does this affect the Ca2+ available for release, 
but also increased luminal [Ca2+] can elevate RyR Po.  
 
TNF-α decreased the caffeine evoked Ca2+ transient amplitude by 27.32 ± 3.41 % in young 
control cells (Fig 3-5C). This agrees with findings in rat ventricular myocytes, in which TNF-α 
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was also shown to decrease SR Ca2+ content (Greensmith & Nirmalan, 2013). Similarly, IL-1β 
also decreased the caffeine evoked Ca2+ transient amplitude by 41.39 ± 3.43 % (Fig 3-5D). All 
off the above effects were maintained in washout, thus the effect on SR Ca2+ content with 
both cytokines appears to be irreversible. 
 
As calculated and discussed in sections 3.4.2 and 6.4.2, the cubic relationship between SR 
Ca2+ content and Ca2+ transient amplitude allowed prediction of the expected effect that the 
recorded change in SR Ca2+ content would have on systolic Ca2+ release, and thus Ca2+ 
transient amplitude. The change to SR Ca2+ content with both TNF-α and IL-1β could more 
than account for the decrease in Ca2+ transient amplitude. Given the large changes in 
caffeine-evoked Ca2+ transient amplitude, the expected reductions to systolic Ca2+transient 
amplitude were actually greater than those achieved. 
 
Caffeine was rapidly applied in order to indirectly measure SR Ca2+ content prior to and 
following treatment in all models used. Caffeine application increases RyR Po in a Ca
2+ 
independent manner. This RyR potentiation allows measurement of mass Ca2+ release from 
the SR, which is relative to SR Ca2+ content, although caffeine does not completely empty the 
SR. By using fluorescence to measure this Ca2+ release, only free cytoplasmic Ca2+ can bind to 
the fluorophores. Buffered Ca2+ is not detected. Furthermore, this sudden rise in [Ca2+]i 
drives rapid Ca2+ extrusion, primarily via NCX, although PMCA may also contribute to a much 
smaller degree. This indirect method can therefore underestimate SR Ca2+ by approximately 
25 %, and as a result SR Ca2+ content (J. W. Bassani, Bassani, & Bers, 1994). Furthermore, it 
does not take into account altered Ca2+ buffering. As use of the caffeine-evoked Ca2+ 
transient amplitude is more likely to underestimate SR Ca2+ content, the smaller than 
expected change to systolic Ca2+ transient amplitude could be due to underestimation of the 
Ca2+ release in systole, which would indicated Ca2+ buffering may be increased. Additionally, 
as contractile proteins within the myofilaments are also Ca2+ buffers, the decreased 
myofilament sensitivity to Ca2+ previously identified would be a mechanism for decreased 
Ca2+ buffering. Although Ca2+ buffering may be altered in response to both cytokines, the 
magnitude of the decrease to the caffeine-evoked Ca2+ transient amplitude is large. This 
indicates a true effect on SR Ca2+ content, as a change to Ca2+ buffering alone would not be 
able account fully for this change.  
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Patch clamping is another method which can more accurately determine SR Ca2+ content 
through measurement of the Ca2+ efflux following caffeine application. This method is not 
unaffected by Ca2+ buffering, due to its lack of sole reliance on Ca2+ inside the cell interacting 
with fluorophores. The resources and equipment required in order to patch clamp were 
unavailable, however use of fluorescent signals in response to caffeine application to 
estimate SR Ca2+ content is an accepted method in the field. 
 
As both cytokines caused a reduction in SR Ca2+ content, this contradicts work of Jha et al. 
(1993), which recorded no change with septic serum. As the proportional concentrations of 
cytokines in this septic serum were unknown, the effect of other cytokines could have 
increased SR Ca2+ content, compensating for the decrease by TNF-α and IL-1β. Additionally, 
the activity of these cytokines when interacting with others is also unknown. This may also 
be the case in a study by Hobai, Edgecomb, LaBarge, and Colucci (2015), where no change in 
SR Ca2+ content was identified in rat ventricular myocytes treated with a mixture of LPS and 
multiple cytokines. 
 
SR Ca2+ content is dependent on SR Ca2+ uptake by SERCA and Ca2+ release by RyR. Both TNF-
α and IL-1β are known to promote ROS production (Brandes et al., 2014; X. Chen et al., 2008; 
Fauconnier et al., 2011; D. Yang et al., 2007) as well as reactive nitrogen species – such as NO 
– production (Evans et al., 1993; Finkel et al., 1992). This increase NO and redox signalling 
can in turn promote PKA activation (Beck et al., 2015; El-Ani et al., 2014). 
 
ROS can decrease SR Ca2+ content (Ichinose et al., 2007) and NO can also contribute to 
decreased SR Ca2+ content through increasing RyR Po, however the latter only occurs when 
PKA activation is low (Lim et al., 2008). With NO, the situation is more complex, as at high 
levels, NO can prevent further ROS production, leading to increased SR Ca2+ content 
(Ichinose et al., 2007). 
 
The level of PKA activation can also determine the effect NO has on Ca2+ release, as PKA can 
also phosphorylate RyR, and at high levels of PKA activation, NO greatly reduces RyR Po (Lim 
et al., 2008). PKA activation can also increase SERCA activity through phosphorylation of PLN 
(El-Ani et al., 2014). 
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The effect of increased ROS production on SR Ca2+ content must be greater than that of PKA 
activation for SR Ca2+ content to be reduced. Also, as the effect of ROS on RyR Po is 
irreversible (Xu, Eu, Meissner, & Stamler, 1998), this mechanism could explain why the effect 
on SR Ca2+ content is maintained with washout. Although ROS activity is the most likely 
candidate, NO may also contribute to reduced SR Ca2+ content if PKA activation is low. 
 
 
7.1.4  The effect of TNF-α and IL-1β on RyR Po  
 
Early and short-lived potentiation of systolic Ca2+ was observed in a proportion of cells 
isolated from young control sheep in response to both TNF-α and IL-1β, increasing by 57.75 
± 10.23 % and 51.72 ± 12.61 % respectively (Fig 3-8B and 3-8E). This was accompanied by a 
corresponding increase in sarcomere shortening (Fig 3-8C and 3-8F). While the magnitude of 
the increase in systolic Ca2+ was similar with both cytokines, this early potentiation was 
observed in a larger proportion of cells exposed to TNF-α (71 %), when compared to cells 
exposed to IL-1β (52 %). This may suggest that the effect of TNF-α on RyR Po is more rapid.  
 
This agrees with the findings of Greensmith and Nirmalan (2013) which acknowledged an 
early potentiation of the Ca2+ transient with 50 ng/ml TNF-α application in rat myocytes. This 
had not been further investigated in rat, however the simultaneous changes to Ca2+ and 
shortening in this study suggests that this is a true phenomenon, as opposed to a fluorescent 
artefact.  
 
In non-responders, on average Ca2+ transient amplitude was either initially unaffected by 
cytokine application – in TNF-α treated cells (Fig 3-9B) – or immediately began to decrease; 
as with IL-1β treated cells (Fig 3-9E). This indicated that in this subgroup of cells the effect of 
both cytokines on decreased systolic Ca2+ was more rapid. This could also suggest that IL-1β 
has a more immediate effect on decreased systolic Ca2+, whilst TNF-α has a more rapid, or 
possibly more potent effect on RyR. 
 
TNF-α and IL-1β both decreased wave Ca2+ amplitude (Fig 4-3A and 4-5A), while 
simultaneously increasing wave frequency (Fig 4-3B and 4-5B) on a time-dependent basis. 
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This is indicative of reduced SR Ca2+ content threshold for waves and so increased RyR Po. 
During wave experiments, ouabain and high [Ca2+]o were used to artificially and perpetually 
increase SR Ca2+ to basal threshold SR Ca2+ content to produced waves. Under control 
conditions this produced waves at a frequency and amplitude that are proportional to rate 
Ca2+ entry and RyR Po thence threshold SR Ca
2+ content respectively (Diaz et al., 1997). This 
was then used to ascertain the effect of TNF-α and IL-1β wave dynamics; Ca2+ wave 
frequency and amplitude. Given the increase to frequency and decrease to amplitude, and 
that the rate of Ca2+ influx and SR Ca2+ uptake is presumably constant under these artificial 
conditions, any change to wave dynamics are as a result of change RyR Po. 
 
In the case of both cytokines, the data highly suggests RyR Po is increased, as the SR Ca
2+ 
threshold has clearly decreased. As demonstrated in figure 7-1, Ca2+ waves occur more 
frequently because at a constant rate of influx, threshold is reached more quickly, resulting 
in more waves occurring over the same period of time. As those waves occur at a lower SR 
Ca2+ content, the waves are smaller in amplitude (Bers, 1991). 
 
 
 
 
Figure 7-1. A diagram demonstrating the effect of increased [blue] and decreased [red] RyR 
Po on the SR Ca
2+ threshold for waves when Ca2+ influx and SR Ca2+ uptake are constant. 
Arrows above indicate the time points which a Ca2+ wave would be evoked. 
 
 
Following 5 minutes cytokine treatment, wave frequency increased by 38.22 ± 8.11 % (Fig 3-
3B) and amplitude decreased by 46.13 ± 5.75 % (Fig 3-3A) with TNF-α. IL-1β produced a 
28.35 ± 11.35 % increase in wave frequency (Fig 3-5B) and 34.42 ± 6.82 % decrease in 
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amplitude (Fig 3-5A). This could indicate that the effect of TNF-α on RyR Po is more rapid 
than IL-1β in young control cells, as the magnitude of change in both parameters is smaller 
with IL-1β over the same time period. In addition, significant changes to both parameters 
were observed at earlier time points with TNF-α. Comparisons in the degree of potency of 
these cytokines on RyR Po must be interpreted with caution, as although the same 
concentration was used (50 ng/ml), the level of activity may differ. 
 
The amplitude of caffeine-evoked SR Ca2+ release during the onset of a Ca2+ wave indicated 
the SR Ca2+ threshold at that point. After approximately 5 minutes exposure to TNF-α and IL-
1β, the caffeine-evoked Ca2+ wave amplitude decreased by 49.16 % and 52.94 % respectively 
(Fig 4-6). This provides further supports that the SR threshold for waves is decreased with 
both cytokines. It is therefore possible to conclude that TNF-α and IL-1β increases RyR Po and 
that this effect was time-dependent. This time-dependency of an effect on SR Ca2+ leak has 
also been identified in a CLP model of sepsis (X. Zhu et al., 2005). 
 
Previous work in rat ventricular myocytes and mice atrial myocytes, identified a similar 
effect of TNF-α and IL-1β on increased frequency of spontaneous SR Ca2+ release events, 
such as Ca2+ sparks and waves, with prolonged exposure (2-3 hours) (Duncan et al., 2010; 
Zuo et al., 2018). While this study also indicates SR Ca2+ leak is increased via RyR in response 
to both cytokines, the early potentiation and cytokine exposure times used in these 
experiments – over minutes as opposed to hours – indicates an effect on RyR Po may be 
more rapid than previously thought. 
 
As previously discussed, both cytokines increase NO and ROS production. In myocardial 
dysfunction the levels of NO and ROS are imbalanced, and both are capable of interacting 
with the RyR (Hare & Stamler, 2005). 
 
IL-1β is known to modulate contractility through activation of a myocardial L-arginine-NO 
pathway (Evans et al., 1993), while in isolated hamster muscular tissue TNF-a can also 
reversibly induce inotropy through increased NO (Finkel et al., 1992). Three forms of NO 
synthase which are found in cardiac myocytes are NOS1, NOS2 (iNOS) and NOS3 (eNOS) and 
both are responsible for production of the highly reactive free radical, NO (Hare & Stamler, 
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2005; Lim et al., 2008). Activation of NOS3 is more involved in physiological modulation of 
cardiac RyR, such as in response to stretch, aided by its proximity to LTCC (Hare & Stamler, 
2005; Lim et al., 2008). NO derived from NOS2 is generally considered to be Ca2+-
independent as NOS2 is closely associated with high basal levels of Ca2+/CaM, competitively 
inhibiting Ca2+ binding, unlike NOS1 and NOS3 (Hare & Stamler, 2005).  
 
NO can directly modify cardiac RyR through S-nitrosylation, in which NO attaches covalently 
to reactive thiol residues, often within the amino acid cysteine (Hare & Stamler, 2005; Lim et 
al., 2008). RyR Po increases with progressive S-nitrosylation of an increasing number of thiol 
sites on RyR, leading to increased Ca2+ spark frequency (Lim et al., 2008; Xu et al., 1998). ROS 
can also increase RyR Po through oxidation of more than 7 thiols per RyR subunit (Xu et al., 
1998). NO can also decrease RyR Po when the level of PKA activation is high, however IL-1β 
mediated production of NO via NOS2 requires PKA activation (Lim et al., 2008; Oddis, 
Simmons, Hattler, & Finkel, 1996), therefore with IL-1β, when NO is high, so is PKA. This 
could explain why a lower proportion of cells presented with early potentiation of systolic 
Ca2+ than in TNF-α treated cells. A direct effect of elevated NO production may therefore not 
be the primary mechanism of the increased RyR Po with IL-1β.  
 
Another possible mechanism of RyR modulation is CaM mediated. The concentration of CaM 
can determine whether RyR is activated or inactivated (Sigalas et al., 2009), as can the 
binding affinity between CaM and RyR (Y. Yang et al., 2014). If 4 CaM bind to RyR this can 
greatly reduce cardiac RyR Po through, inhibiting SR Ca
2+ release (Balshaw et al., 2001). TNF-
α is known to reduce the affinity of CaM binding to RyR, and as such increase RyR Po 
(Balshaw et al., 2001; Y. Yang et al., 2014). 
 
As previously mentioned, proinflammatory cytokines can activate ROS producing enzymes 
such as Nox (D. Yang et al., 2007). In addition to the direct effects of ROS on RyR, Nox is 
associated with redox signalling and can promote CaMKII oxidation (Ho et al., 2014). CaMKII 
oxidation contributes to increased phosphorylation of RyR. Previous work has implicated 
that IL-1β promotes CaMKII oxidation and thus phosphorylation of RyR (Monnerat et al., 
2016). Although this phosphorylation of RyR by CaMKII would increase RyR Po, it would 
cause only a brief increase in systolic Ca2+ (Eisner, George, Smith, Trafford, & Venetucci, 
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2010; Ho et al., 2014). This would mimic the 1st beat potentiation identified with both 
cytokines. That said, phosphorylation is slow when compared to redox signalling. Given that 
effect is rapid, as per the 1st beat potentiation of the Ca2+ transient, ROS or S-nitrosylation 
are more likely candidates for the early effects on RyR Po. The elevation of ROS could 
contribute to CaMKII oxidation, and further elevation in RyR Po, providing a possible 
mechanism for the time dependency of the cytokine’s effects on RyR Po. 
 
 
7.1.5  The effect of TNF-α and IL-1β on ICaL  
 
Previous work has indicated that both TNF-α and IL-1β can produce small decreases in ICaL. at 
varying concentrations, although neither TNF-α or IL-1β alter LTCC expression (El Khoury et 
al., 2014). In rat myocytes exposed to a combination of LPS and various cytokines, including 
TNF and IL-1, Ca2+ influx via LTCC reduced by ~38 % (Hobai et al., 2015), although whether 
TNF and IL-1 were the active components on LTCC is unknown. Also, this effect could be 
greater than the individual effects of the cytokines, due to synergism. In rat ventricular 
myocytes, 50 ng/ml TNF-α reduced peak ICaL by 11 % (Greensmith & Nirmalan, 2013), whilst 
in murine ventricular myocytes, the lower concentration of 30 pg/ml had no effect on ICaL (El 
Khoury et al., 2014). In smooth muscle, the effect of TNF-α on reduced ICaL was shown to be 
concentration dependent (Reyes-Garcia et al., 2016). 30 pg/ml IL-1β has also produced a 36 
% reduced ICaL by in murine ventricular myocytes (El Khoury et al., 2014). 
 
While decreased ICaL could theoretically contribute to reduction in Ca
2+ transient amplitude, 
through decreasing CICR, the effects of these cytokines are fairly small. As the ICaL and 
resultant Ca2+ influx are fundamentally similar in both rat (Greensmith & Nirmalan, 2013) 
and young sheep (Dibb et al., 2004), similar effects would be expected in sheep. In addition, 
the afore mentioned effects of these cytokines on SR Ca2+ content (section 7.1.3), are more 
likely to contribute to decreased Ca2+ transient amplitude. 
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7.1.6  The effect of TNF-α and IL-1β on SERCA activity 
 
kSERCA was unaffected by both TNF-α and IL-1β, thus indicating that SERCA activity was not 
altered by the presence of either cytokine. During washout, changes to kSERCA were identified 
in the young control model only, with an increase of 91.67 ± 26.29 % in TNF-α treated cells 
(Fig 3-6F) and an increase of 78.26 ± 17.67 % in IL-1β treated cells (Fig 3-7F). The dynamics of 
this change with washout will be further discussed in section 7.2.3. 
 
Modification to SERCA activity is regulated by PLN. When PLN is phosphorylated, SERCA 
activity and SR Ca2+ uptake are increased. Phosphorylation can take minutes before an effect 
is observed, and so it is possible that the effect recorded in washout may be the result of a 
prolonged effect of the cytokines and not a true effect of washout. 
 
Elevated redox signaling via cytokine activated Nox stimulates CaMKII oxidation and CaMKII-
mediated phosphorylation of PLN. TNF-α can also mediate increased PLN phosphorylation 
via PKA.  Both mechanisms would increase SERCA activity (El-Ani et al., 2014; Ho et al., 
2014). 
 
If increased PLN phosphorylation were responsible for the effect on SERCA activity in 
response to both cytokines, the gradual change would only appear after several minutes; in 
washout, as found in these experiments. In addition, increased SERCA activity would not be 
expected to appear in the other experimental model as phosphorylation in heart failure is 
known to decrease (Briston et al., 2011; Lou et al., 2012; Phillips et al., 1998), this was also 
the case in the study (Fig 6-6E and 6-7E). 
 
This data suggests that altered SERCA activity is not the cause for change in SR Ca2+ content 
produced cytokines, as even a gradual increase in SERCA activity would be expected to 
increase, not decrease SR Ca2+ uptake. This would also suggest that the effect on decreased 
SR Ca2+ content – most likely a result of increased SR Ca2+ leak via RyR, as previously 
discussed in section 7.1.4 – would be greater than the effect on SERCA activity and thus Ca2+ 
uptake. 
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7.1.7  The effect of TNF-α and IL-1β on sodium – calcium exchange 
 
TNF-α had no effect on kcaff in cells isolated from young control sheep, and thus no effect on 
sarcolemmal Ca2+ efflux, in which NCX is the predominant method of Ca2+ removal. This 
method does not isolate Ca2+ removal via PMCA, however, the contribution of PMCA to Ca2+ 
removal in the heart is relatively small. Regardless, the collective pathways for Ca2+ extrusion 
appear to be unaffected by TNF-α. This supports the suggestion that TNF-α has no effect on 
the rate of Ca2+ removal by NCX. 
 
Contrary to work by Radin et al. (2008) which suggested IL-1β reduced the rate of Ca2+ 
removal, this study found that in young sheep,  IL-1β increased the overall rate of Ca2+ 
removal. With IL-1β, ksys increased by 24.04 ± 6.5 %. Although the change to 90 - 10 % decay 
time of the Ca2+ transient with IL-1β was unchanged, this method of measurement may have 
not been sensitive enough to detect a small change. IL-1β increased kcaff by 29.47 ± 10.55 % 
(Fig 3-7E), indicating that IL-1β increased Ca2+ extrusion. The increase in the overall rate of 
Ca2+ removal is therefore most likely due to elevated NCX activity. This could provide a 
possible explanation for the small decrease in diastolic Ca2+ with IL-1β, as Ca2+ efflux would 
be more rapid, leading to lower [Ca2+]i. 
 
 
7.1.8  The effect of TNF-α and IL-1β on myofilament sensitivity to Ca2+ 
 
In the earlier experiments of chapter 3 there were indications that both TNF-α and IL-1β may 
have a positive effect on myofilament sensitivity to Ca2+, due to the simultaneous changes in 
both diastolic Ca2+ and resting cell length with cytokine application. In the young control 
model, TNF-α produced an irreversible decrease in both diastolic Ca2+ and resting sarcomere 
length, and with IL-1β, diastolic Ca2+ was unaltered, while resting sarcomere length was 
irreversibly decreased. These diastolic changes while significant, were small, therefore use of 
them to infer the relationship between [Ca2+]i and contractility must be interpreted with 
caution, especially as no diastolic dysfunction had been previously observed with TNF-α and 
IL-1β by Greensmith and Nirmalan (2013) and Duncan et al. (2010) in rat myocytes. These 
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changes did however give reason to investigate the effects of these cytokines on 
myofilament sensitivity to Ca2+ in young control sheep, through a more robust method. 
 
Through measuring the degree of shortening in response to various elevations in [Ca2+] in 
permeabilised cells, the change in the relationship between [Ca2+]i and contractility with 
TNF-α and IL-1β could be measured in a more robust way. The relationship between 
increased Ca2+ and reduced sarcomere length in permeabilised cells was blunted with both 
cytokines. This strongly suggests that both cytokines decreased myofilament sensitivity to 
Ca2+ (Fig 5-8). This agrees with the work of Goldhaber et al. (1996) which also identified that 
TNF-α reduced myofilament sensitivity to Ca2+ in rabbit cardiac myocytes. IL-1β also severely 
blunted the response of myofilaments to change in pH (Fig 5-9), suggesting that IL-1β may 
have saturated the effect on myofilament sensitivity to Ca2+.  
 
Both cytokines produced a depressed sarcomere shortening with increased [Ca2+]i in 
permeabilised cells to a similar extent (Fig 5-8), suggesting they both have a similar degree of 
potency on myofilament sensitivity to Ca2+. It is therefore possible that they may alter 
myofilament sensitive through the same or a similar mechanism. Goldhaber et al. (1996) has 
previously determined that the negative effect of TNF-α on myofilament sensitivity to Ca2+ 
was not primarily due to change to pH from TNF-α induced ROS production. Cytokine 
mediated elevation in NO and ROS production are a possible mechanism for decreased 
myofilament sensitivity to Ca2+ in acute myocardial inflammation (Y. Li et al., 2013). In a 
murine model of sepsis, S-nitrosylation of myofilament associated proteins by increased NO 
was associated with decreased myofilament sensitivity to Ca2+ leading to contractile 
dysfunction (Sips et al., 2013). Increased ROS production was also shown to decrease 
myofilament sensitivity to Ca2+ in a murine model of sepsis, however high NO levels can 
prevent the production of ROS through endotoxin-induced pathways (Ichinose et al., 2007), 
therefore NO has both a direct negative effect and indirect positive effect on myofilament 
sensitivity (Ichinose et al., 2007; Sips et al., 2013). S-nitrosylation through increased NO may 
not be the primary mechanism for the negative effect on myofilament sensitivity, as 
inhibition of NO production enzymes did not improve contractility in a rat model of 
endotoxemia. Another possible mechanism of decreased myofilament sensitivity is PKA-
mediated phosphorylation of TnI (Tavernier et al., 2001). In both cardiac and non-cardiac 
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cells, cytokines – including TNF-α and IL-1β – have been shown to increase PKA activation, 
through NO and ROS signalling (Beck et al., 2015; El-Ani et al., 2014).  
 
The negative effect on myofilament sensitivity appears to occur over a matter of minutes. In 
the experiments of chapter 5 changes to myofilament sensitivity were detected after more 
than 100 s exposure to the cytokines, and even then, the main differences were observed in 
150 nM Ca2+, after a further 100 s. PKA-mediated phosphorylation is therefore a possible 
mechanism for the decrease in myofilament sensitivity to Ca2+ with TNF-α and IL-1β. 
Elevated ROS production may also contribute to reduced myofilament sensitivity. While the 
reduction in contractility with TNF-α can be explained by the reduction in Ca2+ transient 
amplitude, both of these mechanisms could exacerbate myocardial depression. 
 
 
 
Figure 7-2. A diagram demonstrating the identified effects of 50 ng/ml TNF-α [red] and IL-1β 
[blue] on excitation-contraction coupling in left ventricular sheep myocytes. In the case of 
both cytokines increased RyR Po provides a mechanism for the decrease in SR Ca
2+ content, 
which leads to a reduction in systolic [Ca2+]i. Only with TNF-α did this reduced contractility. 
Both cytokines were shown to decrease myofilament sensitivity to Ca2+. 
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7.2  Relative reversibility of TNF-α vs IL-1β 
 
7.2.1  Intracellular Ca2+ and contractility 
 
The effect of TNF-α on sarcomere shortening was completely reversed during washout, 
although systolic Ca2+ remained depleted. This suggests that the effect on contractility is 
readily reversible, however the effect on [Ca2+]i is not. In IL-1β treated cells, no effect on 
contractility was found prior to washout, however as discussed in section 7.1.1, the 146.01 ± 
59.32 % increase in sarcomere shortening recorded during washout (Fig 3-4B), may be a 
prolonged effect of IL-1β. If this is the case, the fact that the effect present during washout, 
implies that it is non-reversible. While both cytokines have non-reversible changes to [Ca2+]i, 
the effects of TNF-α on contractility appear to be more reality reversible that that of IL-1β. 
With both TNF-α and IL-1β, any changes to rate of shortening and relaxation occurred during 
washout. During washout, the rate of sarcomere relaxation increased, as the 50 % decay 
time decreased by 18.92 ± 7.11 % (Fig 3-2F) and 50.46 ± 3.84 % (Fig 3-4F) in TNF-α and IL-1β 
respectively. During IL-1β washout, this was also accompanied by a decrease in the 50 % 
decay time of shortening by 28.54 ± 10.16 % (Fig 3-4E), suggesting that rate of shortening 
also increased. Once more, if these are prolonged effects of the cytokines, then they may be 
irreversible, or take longer to both appear and reverse than the time course of this study. 
 
 
7.2.2  RyR Po 
 
As determined by the wave frequency and amplitude, the effects of both TNF-α (Fig 4-3) and 
IL-1β (Fig 4-5) on RyR Po were non-reversible during the course of the experiment, no further 
effect on RyR Po was observed. While the effect of TNF-α on the SR Ca
2+ threshold was not 
reversible (Fig 4-6C), partial recovery of SR Ca2+ threshold was evident with washout in IL-1β 
treated cells. This was however not significant from both control and IL-1β (Fig 4-6D). What 
is certain is that the effect of IL-1β on SR Ca2+ threshold is not fully reversible during the 2 
minute washout period. Further or complete recovery of SR Ca2+ threshold to control levels 
may have occurred over a longer washout in IL-1β treated cells. 
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The potential difference in reversibility of the effect on RyR Po could be dependent on the 
mechanism by which it is altered. As the effect of ROS on RyR is irreversible (Xu et al., 1998), 
as were the effect of both cytokines on wave frequency and amplitude with washout (Fig 4-3 
and 4-5), the early potentiation and more permanent effects could be attributed to direct 
ROS activity. RyR phosphorylation has also been suggested as a mechanism for altered RyR 
Po. Phosphorylation is reversible, which could explain the partial recovery of the SR Ca
2+ 
threshold with IL-1β washout (Fig 4-6). 
 
 
7.2.3   Ca2+ removal 
 
In IL-1β treated cells, ksys increased by 80.54 ± 18.12 % greater than control during washout. 
This indicated an elevated rate of systolic Ca2+ removal with IL-1β washout, which was 
further confirmed by an 11.88 ± 9.41 % decrease in the 90 - 10 % decay time of the Ca2+ 
transient. As the increase in kSERCA is only observed in washout – by 78.26 ± 17.67 % (Fig 3-7F) 
– NCX may be the predominant Ca2+ removal mechanism with IL-1β when overall Ca2+ 
removal is much lower. The increased involvement SERCA in Ca2+ removal may combine with 
the already established effect on increased NCX during washout, contributing to the greater 
overall rate of Ca2+ removal (Fig 3-7C). 
 
TNF-α during washout kSERCA increased by 91.67 ± 26.29 % (Fig 3-6F), as alluded to in section 
7.1.6, this may also be a prolonged effect of the cytokine, due to the time required for 
phosphorylation to occur. This increase in SERCA activity did not, however, affect overall rate 
of Ca2+ removal, as ksys was unaffected (Fig 3-6E). It appears that during washout rate of Ca
2+ 
removal is more effected in IL-1β treated cells than those exposed to TNF-α. 
 
With both cytokines, the increase in SERCA activity during washout had no effect on SR Ca2+ 
content and thus did not replenish SR Ca2+ content to control levels (Fig 3-5C and 3-5D). This 
may have been due to the maintained increase in RyR Po
 with cytokine washout, having a 
greater effect on SR Ca2+ content than the effects on increased SR Ca2+ uptake.  
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7.2.4   Myofilament sensitivity to Ca2+ 
 
The pH control experiment (Fig 5-9), gave some indication to the reversibility of the effects 
of TNF-α and IL-1β on myofilament sensitivity to Ca2+, as cytokines were not present in the 
additional pH solutions, and therefore these solutions mimicked a washout protocol. 
Following this washout, the depressive effect of TNF-α on myofilament sensitivity to Ca2+ 
was restored to control-like levels (Fig 5-9). This could provide a mechanism for how 
contractility improves during washout despite the maintained decrease in Ca2+ transient 
amplitude (Fig 3-2A and 3-2B). With IL-1β, the blunted relationship between *Ca2+] and 
shortening does not change during washout (Fig 5-9). Overall, this indicates that the effect of 
TNF-α on myofilament sensitivity to Ca2+ is more readily reversible than that of IL-1β. 
 
 
7.3   The effect of TNF-α in heart failure and recovery 
 
7.3.1   Does TNF-α alter ECC in models of heart failure and recovery? 
 
In cells isolated from the recovery model, sarcomere shortening decreased by 12.6 ± 6.9 % 
(Fig 6-4B), however in cells isolated from the heart failure model, contractility was 
unaffected by TNF-α (Fig 6-2B). The altered contractility observed in the recovery model can 
be explained by the change in systolic Ca2+, which decreased by 16.09 ± 3.87 % (Fig 6-4A). In 
the heart failure model, TNF-α also produced a decrease in Ca2+ transient amplitude, by 21.1 
± 3.66 % (Fig 6-2A), this can support that Ca2+ handling is impaired with TNF-α, but that 
systolic contractile function is not altered further. In both the heart failure and recovery 
models, the resting sarcomere length irreversibly decreased by 0.8 ± 0.2 % and 0.86 ± 0.2 % 
respectively with TNF-α (Fig 6-2D and 6-4D). This may be expected to contribute to further 
diastolic dysfunction in heart failure. TNF-α did not however alter the rate of sarcomere 
shortening and relaxation in both models. 
 
In the heart failure model diastolic Ca2+ decreased by 3.19 ± 1.89 % but was not changed in 
the recovery model (Fig 6-2C and 6-4C). As kcaff was unaltered with TNF-α in either model 
(Fig 6-6E and 6-7E), this explains why diastolic Ca2+ is unaffected in the recover model but 
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not the decrease found in the heart failure model. This may indicate further dysfunction in 
the heart failure model with TNF-α. 
 
In both the heart failure and recovery models, the caffeine evoked Ca2+ transient amplitude 
also decreased with TNF-α (Fig 6-5C and 6-5D). These changes produced by TNF-α to SR Ca2+ 
content in both models could more than account for decreased Ca2+ transient amplitudes. 
Whilst kSERCA was unaffected by TNF-α in both models, and therefore a decreased rate of SR 
Ca2+ uptake is not responsible for the decrease in SR Ca2+ content. 
 
Increased RyR Po is a possible candidate for the mechanism behind decreased SR Ca
2+ 
content. While this was not measured directly, the early potentiation of systolic Ca2+ 
identified in cells isolated from both experimental models (Fig 6-8B and 6-8E), provides 
evidence that RyR Po may be increased. In TNF-α non-responders (Fig 6-9B and 6-9E), there 
was no immediate effect on Ca2+ transient amplitude, and so the effect on decreased systolic 
Ca2+ may have been predominant. 
 
The experiments of chapter 6 also identified changes to diastolic function which could 
suggest myofilament sensitivity to Ca2+ was increased in the heart failure and recovery 
models with TNF-α. As in young control sheep, TNF-α was associated with a decrease in 
diastolic Ca2+ and resting sarcomere length. In the recovery model resting sarcomere length 
decreased with no change to diastolic Ca2+. The magnitude of these changes was not 
different from those found in young control sheep, and thus these small changes must once 
again be taken with caution. Another aspect to consider is that both experimental models 
had at one point reached end-stage heart failure, in which myofilament sensitivity is already 
known to increase (van der Velden, 2011). Whether the effect on the relationship between 
diastolic Ca2+ and sarcomere length is due to TNF-α exposure or due solely to heart failure 
pathology is unknown. If the latter is the case, this could also suggest that the increased 
myofilament sensitivity to Ca2+ observed in end-stage heart failure remains following 5 
weeks of recovery. 
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7.3.2  Does the magnitude of the effects of TNF-α differ in heart failure?  
 
While contractility was unaffected by TNF-α in cells isolated from the heart failure model (Fig 
6-2B), this was attributed to possible saturation of the effect on depressed contractility. The 
saturation of the effect on contractility was not observed in cells isolated from the recovery 
model, where sarcomere shortening decreased by a similar proportion to that of the young 
control model with TNF-α (Fig 6-4B and 6-10B). 
 
The similar degrees of reduction to systolic Ca2+ in the experimental models and the young 
control sheep (Fig 6-10A) can be attributed to the similar magnitudes of decrease to the 
caffeine evoked Ca2+ transient amplitude (Fig 6-12). Although this suggests that the change 
to SR Ca2+ content produced by TNF-α did not alter between the models (Fig 6-12), RyR Po 
may have been affected. The relative potency of TNF-α on RyR Po between these models is 
fairly consistent, with 42.52 ± 12.34 % (Fig 6-8B) and 40.16 ± 9.81 % (Fig 6-8E) 1st beat 
increases in Ca2+ transient amplitude in responders from the heart failure and recovery 
models respectively. The magnitude of these changes did not differ from those found in 
young control responders (Fig 6-14). Early potentiation of systolic Ca2+ was observed in 44.12 
% of heart failure cells and 48 % of heart failure recovery cells exposed to TNF-α. This is a 
lower proportion than in young control cells (71 %), suggesting the effect of TNF-α on RyR Po 
is far more rapid in young control sheep. 
 
In section 7.1.4, it was suggested the RyR Po could be altered by NO, ROS and 
phosphorylation. As RyR is already hyperphosphorylated in heart failure and the effects of 
further phosphorylation are minimal (Briston et al., 2011; Lou et al., 2012; Phillips et al., 
1998), this could explain the small proportion of responders. Potentiation of systolic Ca2+ 
indicates that RyR Po still occurs in heart failure with TNF-α. The mechanism behind this 
change could differ from the young control model. Y. Yang et al. (2014) found that in a rat 
heart failure model with high TNF-α levels the CaM–RyR binding affinity was decreased. This 
would increase RyR Po. In the heart failure and recovery models, any change to RyR Po could 
be contributed to or mediated by the altered affinity between CaM and RyR. 
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While kSERCA did not differ significantly from control with TNF-α in all models (Fig 6-13E), 
there was a difference in kSERCA between the 2 experimental models and control, but not 
between the heart failure and recovery models alone. This may suggest a subtle change in 
kSERCA at TNF-α steady state that has not been detected in the young control model. This also 
provides further evidence that the 91.67 ± 0.26 % increase kSERCA during TNF-α washout was 
not a true effect of washout, but rather a prolonged effect of cytokine exposure, as per 
section 7.1.6. kSERCA was not altered by TNF-α or washout in either of the experimental 
models (Fig 6-6E and 6-7E). Overall, this suggests that SERCA activity gradually increases, 
initiated by TNF-α, in the young control model, and that due to the prolonged nature of this 
effect, this is identified in washout, but that in the heart failure and recovery models SERCA 
activity is unchanged. The mechanism behind the change in young control cells is likely 
mediated by PLN phosphorylation, inducing a slow increase in SERCA activity. The effect on 
SERCA may not be found in the heart failure cells as PLN phosphorylation is generally lower 
in heart failure (Briston et al., 2011; Lou et al., 2012; Phillips et al., 1998). This could also 
provide insight into the levels of PLN phosphorylation in the recovery model, which this lack 
of an effect on SERCA could suggest do not improve from heart failure with 5 weeks of 
recovery. 
 
During TNF-α washout, the rate of sarcomere relaxation increases, as the 50 % decay time 
decreases by 18.92 ± 7.11 % (Fig 3-2F) and 10.06 ± 3.5 % (Fig 6-4F), in young control model 
and recovery model respectively. That of the heart failure model was not affected by 
washout (Fig 6-2F). Although overall Ca2+ removal (ksys) was unchanged with TNF-α in all 
models tested, the previously discussed increase in SERCA activity (kSERCA) may partially 
account for increased rate of relaxation in young control cells (Fig 3-6F). This could not 
account for improved relaxation in the recovery model. Phosphorylation of myofilament 
associated proteins could also alter rate of relaxation (Tavernier et al., 2001). If this is the 
mechanism of increased relaxation, the involvement of phosphorylation may support why 
this phenomenon is not found in the cells from the heart failure model. Improved rate of 
sarcomere relaxation could therefore be a compensatory mechanism in young control cells, 
which is lost in the heart failure model, but restored with 5 weeks recovery. 
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7.4  Clinical implications in sepsis 
 
7.4.1 Do the effects of TNF-α and IL-1β provide a cellular basis for myocardial 
depression? 
 
As discussed in sections 1.1.5 and 1.1.6, myocardial depression is a leading cause of death in 
sepsis. In myocardial depression, left ventricular contractility is reduced contributing to a 
reduction in LVEF by ~75 % and cardiac output. Ventricular dilation and loss of compliance 
are also present in myocardial depression; this along with increased end-diastolic volume 
can be compensatory mechanisms to help restore cardiac output (Ognibene et al., 1988; 
Parker et al., 1984; Parrillo, 1989). 
 
With both TNF-α and IL-1β, systolic Ca2+ was reduced, providing further evidence of impaired 
Ca2+ handling in myocardial depression. In response to both cytokines, this decrease in 
systolic Ca2+ was mediated by reduced SR Ca2+ content due to elevated SR Ca2+ leak via RyR. 
Increased RyR Po could provide a mechanism for the increased SR Ca
2+ leak found in a CLP 
model of sepsis (X. Zhu et al., 2005). 
 
The reduction in systolic Ca2+ produced by TNF-α, contributed to a 20.31 ± 7.58 % decrease 
in sarcomere shortening (Fig 3-2B); TNF-α could therefore provide a cellular basis for systolic 
dysfunction and may contribute in part to reduced left ventricular contractility in myocardial 
depression and other inflammatory conditions of the heart. Unlike TNF-α, IL-1β had no effect 
on sarcomere shortening (Fig 3-4B). As such, IL-1β cannot provide a cellular basis for loss of 
contractility and the resulting decrease in LVEF in sepsis but may contribute to diastolic 
dysfunction instead. 
 
Both cytokines produced a small decrease in resting sarcomere length (Fig 3-2D and 3-4D), 
despite a decrease or lack of change to diastolic Ca2+ (Fig 3-2C and 3-4C). This shortened 
resting sarcomere length could provide a cellular basis for loss of compliance in myocardial 
depression, as these TNF-α and IL-1β treated myocytes show an inability to distend during 
diastole. This may also contribute to ventricle dilation, as the shorter resting sarcomere 
length would be expected to reduce the chamber size. 
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7.4.2  Restored function in survivors of sepsis 
 
In survivors of sepsis, cardiac function is restored and thus symptoms of myocardial 
depression disappear. As discussed in section 1.1.6.2, a common LVEF is restored to 50 % 
during recovery from sepsis and full cardiac function is recovered following 10 – 28 days in 
survivors (Ognibene et al., 1988; Parker et al., 1984; Parrillo, 1989). Both cytokines could 
provide a mechanism for improved contractility in those recovering from myocardial 
depression, and thus at least partially restored LVEF. The TNF-α produced decrease in 
sarcomere shortening returned to control levels with washout in young control (Fig 3-2B), 
and although IL-1β did not affect shortening, sarcomere shortening increased with washout 
(Fig 3-4B). In patients with myocardial depression in sepsis, symptoms of myocardial 
depression are reversible over a number of days, whereas these effects took only minutes to 
take place. The washout phase of experiments in this study used solutions containing no 
cytokines, in physiological conditions the time taken for serum cytokine concentrations to 
drop may be much slower. 
 
Even though resting sarcomere length remained decreased with cytokine washout, 
suggesting that some loss of compliance is still present, there is some evidence suggesting 
compliance may be beginning to improve with washout. In both TNF-α and IL-1β treated 
cells the rate of sarcomere relaxation increased during washout, with IL-1β the rate of both 
sarcomere shortening was also elevated. Improved relaxation would allow sarcomeres to 
distend more easily and aid both compliance and recovery from ventricular dilation. 
Improvements to diastolic function, such as increased compliance, may take longer to be 
restored than that of systolic function. In cells from the heart failure, rate of sarcomere 
relaxation did not increase with TNF-α washout. Recovery to this aspect of myocardial 
depression may not be as rapid or occur at all in heart failure patients. 
 
 
7.4.3   Is there a cellular basis for the increased incidence of arrhythmias in sepsis 
 
In early sepsis the likelihood of both atrial and ventricular arrhythmias increases especially in 
patients with low phosphate levels. The prevalence of ventricular fibrillation is also 
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particularly high in severe sepsis cases. This occurrence of arrhythmia in sepsis is indicative 
of high mortality (Schwartz et al., 2002; Shahreyar et al., 2018).  
 
In chapter 4, the data suggests that TNF-α and IL-1β increase RyR Po and this could account 
for negative inotropy. Increased RyR Po is also pro-arrhythmogenic, however this requires a 
simultaneous increase of SR Ca2+ content (Venetucci et al., 2007). In other words, for 
arrhythmic evoking spontaneous Ca2+ release, though increasing RyR Po may reduce the 
threshold for waves, that threshold must be met. Although TNF-α and IL-1β increased RyR 
Po, both also reduced SR Ca
2+ (Fig 3-5), the combined effect of which would be negatively 
arrhythmic. 
 
Modulation of SERCA activity and RyR Po can be mediated by phosphorylation, this is often 
associated with β-adrenergic stimulation. Pi can inhibit SERCA activity and increase SR Ca
2+ 
leak from RyR (Smith, Duncan, Neary, Bruce, & Burton, 2000). Although this would be 
expected to lower the SR threshold for waves, the SR Ca2+ content would also be reduced 
beyond this point. If Pi is low, as with the patients with sepsis who have been identified as 
more prone to development of arrhythmia (Schwartz et al., 2002), this would promote SR 
Ca2+ uptake through PLN phosphorylation and decrease RyR Po (Smith et al., 2000). Alone, 
the effects of low Pi would not induce waves, but would increase SR Ca
2+ content. Given that 
both TNF-α and IL-1β increased RyR Po, this would lower the threshold for waves, when 
combined with the increase in SR Ca2+ content, this would produce Ca2+ waves, providing a 
mechanism for arrhythmia is sepsis. In vivo, the effect on RyR Po may become very 
important, as this will reduce the SR threshold for Ca2+ waves, however other factors could 
influence SR Ca2+ content. Spontaneous Ca2+ release would occur if the effect on RyR Po is 
greater than that on depleted SR Ca2+ content. In addition, the situation is more complex in 
patients, as low phosphate or β-adrenergic stimulation would increase SR Ca2+ content. The 
combined effects of increased SR Ca2+ content and decreased threshold, lead to a much 
higher chance of arrhythmia. The effects of TNF-α on the dynamics of spontaneous Ca2+ 
release events is similar in atrial myocytes, and as such may also help explain the occurrence 
of atrial arrhythmias in sepsis (Zuo et al., 2018). 
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In the paced experiments of this study there was no evidence of arrhythmia, however no β-
adrenergic substrates were applied to drive phosphorylation. As demonstrated with 
caffeine, which is also known to increase RyR Po, spontaneous Ca
2+ waves did not occur in 
the absence of β-adrenergic stimulation (Venetucci et al., 2007). 
 
 
7.5  The cellular role of cytokines in clinical heart failure 
 
As those with heart failure have pre-existing cardiac dysfunction and are likely to have had 
prior exposure to high levels of TNF-α, it was supposed that the effect of TNF-α may have 
different effects on ECC or alter the magnitude of these changes. One hypothesis was that 
some of the effects of TNF-α on ECC may be saturated in these experimental models. 
 
Both CaMKII expression and ROS production are high in heart failure (Wagner et al., 2011). 
These were some of the common suggested mechanisms of cytokine mediated alteration for 
ECC, as such the effect on ECC may be expected to be greater in heart failure. That said, the 
elevation in both CaMKII and ROS in heart failure, may be greater than in healthy individuals, 
but equivalent to in those with sepsis. This may be the case as the magnitude of change 
produced by TNF-α was not different for the majority of parameters – including both 
diastolic and systolic Ca2+ – in the heart failure and recovery model. This suggested that the 
effects of TNF-α are not saturated in the heart failure or recover models, nor are they 
amplified. This indicates that even if cytokines were previously elevated in the heart failure 
model, Ca2+ handling can still be altered by subsequent exposure to TNF-α. There are 
however some small differences, which could alter the clinical response to elevated TNF-α in 
heart failure patients or those in recovery. 
 
Diastolic Ca2+ is already decreased in heart failure, however this did not alter the magnitude 
of change to diastolic Ca2+ in the heart failure model, which irreversibly decreased by 3.19 ± 
1.89 % with TNF-α (Fig 6-2C). In the cells from the recovery model, while washout produced 
a 1.42 ± 2.09 % decrease in diastolic Ca2+, diastolic Ca2+ was unchanged by TNF-α itself (Fig 6-
4C). This was unlike both control and heart failure cells, perhaps then given the previously 
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decreased diastolic Ca2+ in heart failure, the recovery model is less susceptible to changes 
alteration of diastolic Ca2+.  
 
In the young control cell, the depression of sarcomere shortening with TNF-α was restored 
to previous control levels washout, however in the cells from the recovery model, the 12.6 ± 
6.9 % decrease with TNF-α was maintained (Fig 6-4B). The restored contractile function 
found in survivors of sepsis, following myocardial depression, therefore may not be found in 
patients in recovery from heart failure. Sarcomere shortening was unaffected by TNF-α 
application or washout in cells from the heart failure model (Fig 6-2D), despite the decrease 
in Ca2+ transient amplitude. It is proposed that the effect on sarcomere shortening has been 
saturated by previous exposure to TNF-α. Heart failure patients may be less susceptible to 
depressive effects of TNF-α upon re-exposure, but also show no sign of improved 
contractility with washout. Those with heart failure or in recovery would therefore be more 
susceptible to prolonged contractile dysfunction if they were to succumb to sepsis and the 
associated myocardial depression. 
 
 
7.6  Implications for therapeutic approaches 
 
One possible therapeutic approach when treating myocardial depression is to combat the 
cytokine evoked changes in ECC directly through administration of antibodies. As explained 
in section 1.3, TNF-α and IL-1β can bind to multiple receptors specifically, each producing 
different effects. For instance, TNF-α can bind to TNFR1, promoting cardiac remodelling, or 
bind to TNFR2, encouraging recovery and preventing damage which could further impair 
cardiac function. Similarly, IL-1β can self-regulate its own production and activity through 
binding to IL-1RII or IL-1RI (Idriss & Naismith, 2000; Kelly et al., 2010; Monden et al., 2007; 
Oppenheim et al., 1989; Subramaniam et al., 2004). There is some evidence that this course 
of treatment can improve ventricular function in severe sepsis, such as work by Vincent et al. 
(1992), who administered antibodies against TNF-α. One issue with this method is that in 
inhibiting the cytokines themselves, not only are the negative, cardiac remodelling pathways 
inhibited, but also those pathways which can prevent further cardiac dysfunction and those 
which aid the immune response against the pathogen causing sepsis. 
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Alternative therapeutic approaches involve prevention of the increased NO and ROS levels 
produced by these cytokines. It is thought that use of anti-oxidants and NOS inhibitors may 
aid treatment of sepsis and other inflammatory conditions, through preventing the direct 
effects of both NO and ROS, as well as indirect effects mediated by CaMKII and PKA activity 
(Beck et al., 2015). 
 
Petros et al. (1994) used NG monomethyl-L-arginine – an NOS inhibitor – to treat 
hypotension in sepsis. While this course of treatment did have positive effects on 
cardiovascular function, such as elevated blood pressure, it also led to a further decrease in 
cardiac output. Whilst elevations in NO production with these cytokines may contribute 
myocardial depression, NO activity can be dependent on other components, such as PKA. In 
some cases, the effects of high NO may promote maintenance of cardiac output, thus 
inhibition of NOS may not always be beneficial. 
 
Antioxidant supplementation has also been explored as a treatment to the negative effects 
of inflammation in sepsis and trauma conditions (Berger & Chiolero, 2007; Galley, Howdle, 
Walker, & Webster, 1997; Marik, Khangoora, Rivera, Hooper, & Catravas, 2017). 
Antioxidants prevent further ROS production and are often found naturally in serum of 
healthy individuals. Examples of antioxidants include N-acetyl-L-cysteine (NAC), selenium 
and various vitamins, including vitamin C (ascorbic acid). Of these, basal levels of both 
selenium and vitamin C are depressed in sepsis, so supplementation may be beneficial 
(Berger & Chiolero, 2007; Galley et al., 1997). Although NAC has not produced desired 
results in clinical trials alone, when combined treatment with selenium and vitamins, this 
was capable of preventing organ failure, improving both mortality and clinical outcome 
(Berger & Chiolero, 2007). 
 
Vitamin C treatment also has also been effective at reducing the risk of multiple organ failure 
and improved cardiovascular function. While antioxidant treatment such as this can prevent 
further oxidation by ROS, it cannot affect oxidation which had already occurred (Galley et al., 
1997; Marik et al., 2017). Early administration of antioxidants, as a preventive treatment in 
sepsis, may be able to perturb the myocardial depressant effects of both direct ROS activity 
and downstream effects like CaMKII oxidation. This would also not affect other signalling 
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carried out by the cytokine, which may be beneficial to recovery from both the infection and 
myocardial depression. 
 
 
7.7  Limitations 
 
Although all the methods used in this study allowed the individual effects of TNF-α and IL-1β 
to be categorised in a robust way, it would have been possible to gain some further insight 
into possible effects on ICaL and NCX activity through use of patch clamping. This would also 
improve measurements of SR Ca2+ content, as it would not be influenced by Ca2+ buffering. 
However, the recorded changes to SR Ca2+ content in this study were considerable; as such 
any influence from Ca2+ buffering may be negligible. Unfortunately, the equipment required 
to patch clamp was not available. 
 
 
7.8  Future work 
 
This study characterised the individual effects of TNF-α and IL-1β on ECC, including the 
effects on RyR Po and myofilament sensitivity to Ca
2+. The effects of these cytokines on RyR 
Po, and so spontaneous SR Ca
2+ release, can be investigated further through measurement of 
Ca2+ sparks using confocal microscopy. This could support the finding of this study, whilst 
also determining the magnitude of the effect on RyR Po. 
 
Future work will also investigate the mechanisms behind the identified effects on ECC. As 
previously discussed, the effects of these cytokines may be mediated by elevated ROS or NO 
production. Studies will be carried out to determine the magnitude of ROS and NO 
production in response to 50 ng/ml of each cytokine. This will support whether the 
concentrations of ROS and NO produced can contribute to the effects seen. On-going work 
within the laboratory group is being carried out to study whether the individual effects of 
TNF-α on myocytes can be limited through treatment with the known ROS inhibitor, NAC. 
Current results indicate that NAC may attenuate the effect of TNF-α on decreased cell 
215 
 
viability. Future work will explore whether this is also true for changes to Ca2+ handling and 
contractile function. 
 
Previous studies have indicated that the effects of cytokines of myocardial contractility are 
dose dependent. Another next step would be to determine whether the same effects occur 
with TNF-α and IL-1β at clinical concentrations, and to what extent. The effects on ECC of 
other proinflammatory cytokines elevated in sepsis and other inflammatory conditions could 
also be characterised. 
 
 
7.9  Summary 
 
50 ng/ml TNF-α and IL-1β perturbed Ca2+ handing in sheep left ventricular myocytes. Both 
cytokines increased RyR Po, which may provide a mechanism for the decreased SR Ca
2+ 
content and systolic Ca2+ also identified. TNF-α produced a decrease in contractility, these 
changes may account for systolic dysfunction in myocardial depression, such as reduced 
ventricular contractility. Whilst IL-1β did not cause loss of contractility, there was some 
evidence of diastolic dysfunction with both cytokines, such as reduced resting sarcomere 
length; and reduced diastolic Ca2+ with TNF-α. This diastolic dysfunction has not been 
identified in many previous studies in small mammal models and could potentially 
contribute to diastolic dysfunction in myocardial depression, such as reduced compliance 
and ventricular dilation. 
 
Both TNF-α and IL-1β decreased myofilament sensitivity to Ca2+. This may have contributed 
to the reduced contractility in TNF-α treated cells, and may account for the muted response 
to changes in [Ca2+]i. Although many aspects of Ca
2+ handling were not restored, with 
washout both cytokines either restored or increased contractility. This could explain the 
recovery of contractile function in survivors of sepsis and myocardial depression. 
 
In work investigating the effect of TNF-α on cells isolated from models of heart failure and 5 
week recovery, TNF-α was able to produce a similar effect on ECC. There was however some 
evidence indicating that the effect on contractility had already been saturated in the heart 
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failure model. The restored or improved contractility found in the young control models was 
also not replicated in either experimental model. 
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